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CHAPTER I 
INTRODUCTION 
Approximately 7% of all infants in western countries have a birth weight below 
2500 gram, which is the definition of a low birth weight (LEW) infant. The survival 
of LBW infants, particularly that of very low birth weight (VLBW) infants with a 
birth weight below 1500 gram (approximately 0.6% of all live births), has improved 
dramatically over the past decades. 
Most of these infants are fed special "preterm" formulas. These formulas differ 
in several ways in their compositions, reflecting unanswered questions regarding the 
optimal composition of such feedings. After a few optimistic reports on the 
beneficial effects of the addition of medium-chain triglyceride (MCT) oil to special 
preterm formulas, most manufacturers have included this "artificial foodstuff" in 
their formulas. However, more recent clinical studies have shown contradictory 
results while our understanding of the specific metabolism of MCTs in the preterm 
neonate is still insufficient. With the increasing survival of VLBW infants, the 
possible effects of optimal nutrition on fmal outcome and quality of life of survivors 
become increasingly more important. Some twenty years after the introduction of 
MCTs in preterm formulas there is still no common opinion on the benefits of its 
use. Even so, we feed many infants this artificially prepared food fat in amounts that 
are much higher than human breast milk would ever provide. 
In this chapter several issues regarding basal understanding of MCT metabolism. 
and possible clinical benefits will be addressed. At the end of the chapter specific 
questions and hypotheses will be formulated. 
Historical background of MCT1 
In the early 1950s V.K. Babayan, research organic chemist for the Drew 
Chemical Corporation, started experimenting with the fatty acids of eight and ten 
carbon atoms that were isolated by distillation as an early fraction during the 
'Source: Medium Chain Triglycerides, John R. Senior (ed.), Univ. of Pennsylvania Press. 
1968: Introductory remarks by the chairman. 
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processing of coconut oil, in order to reesterify them into a triglyceride mixture. 
According to a well known anecdote, he was stimulated to do so by Mr. Drew 
himself who noticed the piling up of these fractions as a "waste product" of the 
manufacturing of long-chain triglycerides from coconut oil and challenged his 
biochemist to develop a "fatless fat". The story also suggests that the challenge to 
devise an oil that would provide a satisfying diet without the risk of excess weight 
accumulation was inspired by Mr. Drew's well known tendency towards corpulence. 
Babayan developed a new manufacturing process where free fatty acids were 
liberated from coconut oil by steam hydrolysis, doubly distilled, and the most 
volatile fraction containing the 8- and !0-carbon length fatty acids was used for the 
reesterification of glycerol, carried out with a finely divided zinc catalyst. 
The first trial of MCTs in animals supposedly occurred in 1955 in the laboratory 
of H. Kaunitz at Columbia, revealing that rats could consume approximately twice 
as much MCT as lard and maintain equal weight, without toxicity. Soon, the first 
three studies of MCT administration to humans [1-3] initiated other studies to find 
applications for the clinical use of MCTs in human medicine. 
In table 1 the fatty acid composition of three "normal" sources of fat providing 
predominantly long-chain fatty acids (LCFAs), (soy oil, milk fat, and olive oil) are 
compared with coconut oil and MCT oil. It is evident that coconut oil is much 
higher in fatty acids with a chain length of less than sixteen carbon atoms than the 
first three fat sources. Furthermore, the "MCT oil", which is distilled from the 
latter, contains in its rum fatty acids with an average chain length much shorter than 
coconut oil itself. 
METABOLISM OF MC'f 
Physicochemical properties 
A typical, commercially available "MCT oil" is made up of a mixrure of C6:0 
(1 to 2%), CS:O (65 to 75%), ClO:O (25 to 35%), and Cl2:0 (1 to 2%) fatty acids, 
obtained by the hydrolysis of coconut oil followed by the fractionation of the fatty 
acids. The medium-chain fatty acids (MCFAs) are subsequently esterified again with 
glycerol to form the rriacylglycerols [4]. 
Although it is obvious that the vast majority of the "MCT oil" is formed by 
MCFAs with chain length of eight- and ten carbon atoms (typically over 96%), some 
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Table 1 
Typical composition of some food fats (weight%). 
Only fatty acids that are present in significant amounts are mentioned. 
Source Soy oil olive oil milk fat coconut MCToil 
oil 
C6:0 5.5 0.5 1.0 
C8:0 i.S 7.0 61 
CIO:O 3.0 6.0 37 
Cl2:0 3.5 46 1.0 
Cl4:0 11 19 
Cl6:0 11 11 28 9.5 
Cl6:l 1.5 2.5 
Cl8:0 4.0 2.4 10 3.0 
Cl8:1 22 72 25 7.5 
Cl8:2 55 8.0 3.0 2.0 
Cl8:3 7.5 1.0 0.5 
authors consider MCFAs to be all fatty acids with a chain length ranging from C6:0 
to Cl2:0. Others reserve the term MCFAs specifically for C8:0 and CIO:O. As 
Cl2:0 and Cl4:0 take in many aspects of their metabolism an intermediate position 
between LCFAs and MCFAs the separate term "intermediate-chain fatty acids" 
(ICF As) is warranted. Also in this thesis we will reserve the term MCF A for fatty 
acids with a chain length of 8 and 10 carbon atoms. As an illustration figure I 
shows the appearance of the different fatty acids in the portal blood versus the 
thoracic duct after a feed [5]. From this it is evident that Cl2:0 cannot be 
considered a MCFA, as (in contrast to C8:0 and ClO:O) transport after absorption is 
predominantly in the thoracic duct lymph, much more like the LCFAs. C6:0 can be 
considered a short chain fatty acid (SCFA) or a MCFA, merely depending on 
exactly what behavior during certain chemical processes or what specificity of 
certain enzyme systems is deemed important by the author. The issue is not that 
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relevant to this thesis, as the level of C6:0 in food fats is always extremely low. 
The melting point of the MCFAs is much lower (C8:0, 16.7'C; ClO:O, 31.3'C) 
than that of the long-chain fatty acids (LCFAs) (e.g. Cl6:0, 63.1 'C; Cl8:1, 
33.3'C). As a consequence MCFAs, but also the MCTs, are liquid at room 
temperature. Due to their smaller molecular size MCFAs are more soluble in water: 
octanoate for instance is about hundred times more soluble in water at 20'C than is 
palmitate (680 mg/1 for C8:0 versus 7.2 mg/1 for C16:0). The fact that MCFAs are 
relatively weak acids and are highly ionized at neutral PH contributes to their 
solubility in biological fluids. These different properties have profound effects on 
several aspects of metabolism, which differs greatly from the "regular" food fats, 
which are LCTs. 
Absorption 
Probably due to their smaller molecular weight and higher solubility MCTs are 
hydrolysed faster and more completely by pancreatic lipase than LCTs. In the case 
of mixed triacylglycerols the MCF As are liberated preferentially. The products of 
MCT hydrolysis are absorbed much faster than LCTs, virtually at the same rate as 
glucose [6]. Due to their rapid and complete hydrolysis MCTs are absorbed mainly 
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as free fatty acids. There is evidence that in case of bile salt and/or pancreatic lipase 
deficiency, a part of the MCTs can be absorbed as intact triacylglycerols [7]. Earlier 
studies [8] found also evidence in vivo in rats for absorption of unhydrolyzed 
trioctanoin and the existence of an intestinal lipase in the enterocyte hydrolyzing 
subsequently all medium-chain acylglycerols into MCFAs and glyceroL 
In the intestinal cells, unlike LCFAs, MCFAs are probably not incorporated to a 
significant extent into triacylglycerols again for transport as lymphatic chylornicrons 
(see figure 1). Instead, MCFAs are ta.'<en up in the portal system and transported as 
such to the liver, either bound to albumin or in free fatty acid form [9]. 
Hepatic metabolism 
Once in the hepatocyte, MCF As are not significantly incorporated into the lipids 
synthesized by the hepatic tissue [10]. They cross the double mitochondrial 
membrane very rapidly and, unlike the LCFAs, they probably do not require the 
presence of carnitine [10]. In the mitochondrion, MCFAs are acylated by an 
octanoyl-CoA synthetase, after which a rapid and supposedly complete $-oxidation 
occurs [11-13]. The acetyl-CoA formed can partially enter the Krebs cycle, but 
generally a surplus of acetyl-CoA will be formed. This non-oxidized acetyl-CoA is 
predominantly redirected towards the formation of ketone bodies which are utilized 
in the peripheral tissue. 
Extra-hepatic metabolism 
Except for the utilization of ketone bodies, the extra-hepatic metabolism of 
MCT is limited because of their rapid portal absorption and hepatic oxidation. Bach 
and Babayan [13] postulated that there might be only significant metabolism by extra 
hepatic tissues when MCTs are supplied intravenously. 
In general it is accepted that extra hepatic tissues do not incorporate MCFAs to a 
significant extent. Sarda et al. [14] using direct transmethylation of fatty acids, have 
argued that up to 12% of the ingested MCFA are incorporated in the subcutaneous 
fat of infants receiving MCT-containing formulas. However, they included lauric 
acid in the defmition of MCT and this fatty acid was responsible for the majority of 
the MCFAs stored in adipose tissue. We argued before that C12:0 is either in an 
intermediate position between MCF As and LCFAs or belongs to the LCF As, but 
behaves metabolically clearly distinct from the MCFAs. In a comment from two of 
the leading authorities in the field, the same point of view is taken [15]. 
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CLINICAL USE 
For almost 40 years, use have been made of the special properties of MCTs in 
huma.~ medicine, particularly in cases where the digestion, absorption or transport of 
usual dietary fats is disturbed. Successful use of MCTs has been reported in patients 
with the following disorders: [ref. 13 and references therein] 
- disorders of lipid digestion, including: 
major resections of esophagus or stomach 
biliary atresia, obstructive jaundice and primary biliary cirrhosis 
blind-loop syndrome 
pancreatitis and pancreatectomy 
cystic fibrosis 
- disorders of lipid absorption, including: 
massive resection of small intestine 
celiac disease, Whipple's disease and Crohn's disease 
enteritis and gluten enteropathy 
tropical or idiopathic sprues 
- disorders of lipid transport, including: 
congenital IJ-lipoprotein deficiency and oiher states of deficient 
chylomicron synthesis 
intestinal lymphangiectasia and other lymphatic disorders due 
to engorgement 
chyluria, chylous ascites, chylothorax and other lymphatic dis-
orders due to leakage 
However for many of these indications for the use of MCTs, data are scarce or 
contradictory. 
MCTs have also been used in several other disorders not related to fat 
absorption, like cholesterol-related cholelithiasis, ketogenic diet as anticonvulsive 
therapy, hyperalimentation and obesity control [13]. The fact that MCTs have been 
advocated for so many purposes, including for instance both for parenteral 
hyperalimentation and as an aid in obesity control, is more a sign of its popularity 
than a proof of its merits. As these indications for MCTs fall far beyond the scope 
of this thesis we will refrain from discussing them any further at this point. 
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USE OF MCT IN PRETERM INFANTS 
Introduction 
Preterm infants often show significant fat malabsorption compared with term 
infants and older children. There are several physiological limitations to the 
digestion and absorption of fat blends in prematures which are related to immaturity, 
the most identified causes being a lower bile salt secretion and a lower pancreatic 
lipase secretion. Duodenal bile acid secretions are often well below critical micellar 
concentrations in preterm infants [16,17]. Watkins eta!. have shown that this is due 
to a reduction in bile acid pool size as well as synthesis rate, both of which are 
reduced to 30-50% of the values found at term [18]. 
Preterm infants also have a reduced pancreatic response to secretin and 
cholecystokinin [19], low lipase activity in duodenal fluids [20,21] and increased 
concentrations of duodenal triglycerides [20]. 
Recent evidence suggests that the newborn probably depends on several 
alternative mechanisms for efficient fat absorption. Lingual and gastric lipases -
which are biochemically difficult to distinguish- appear before 26 weeks of gestation 
and have high activity at birth [22]. The products of intragastric lipolysis (fatty acids 
and monoglycerides) can theoretically compensate for low bile salt levels by 
emulsifying the lipid mixture. 
The infant fed (non-pasteurized) breast milk benefits also from the "bile salt 
stimulated lipase" of human milk, but this enzyme is outside the scope of this thesis 
dealing about formula fed infants and thus will only be mentioned here. 
A higher rate of hydrolysis of MCT as compared to LCT has been described for 
all lipases, but this is probably primarily an in vitro phenomenon, as a consequence 
of the higher solubility in water of MCTs and thus accessibility by the enzyme. For 
most events no reliable in vivo data are available. Hamosh et a!. [23] showed in a 
group of premature infants with equally good absorption of high- or low MCT 
formula, that intragastric hydrolysis was 20% for MCT versus 16% for LCT 
formula, a difference that was not statistically significant. 
Fat provides the major source of energy for growing premature infants. In 
human milk about 50% of the energy comes from fat, and in commercial formulas 
fat provides 40% to 50% of the energy. It has been known for a long time that the 
low birth weight infant digests and absorbs poorly the predominantly saturated 
triglycerides of cow's milk. The recognition of the magnitude of this fat 
16'-----------------------------------------------C~HAP~~T~E~R~·~I 
malabsorption led to the use of low-fat formulas for feeding premature infants in the 
1940s and 1950s. By 1960, after it was recognized that (poly-)unsaturated long-chain 
triglycerides from vegetable oils were much better absorbed than were cow's milk 
fats, such fats were used in commercial formulas for feeding premature infants. 
Soon after the development of MCT oils it was recognized that the nutrition of 
premature infants could be an important clinical application of this artificial food 
stuff. 
Theoretically, one of the greatest benefits could be expected in the orally fed 
preterm infant. After the first study of Yamashita et a!. [24], several studies have 
appeared where the effects on growth of different levels of MCT in formulas for low 
birth weight infants have been compared. Results have been very inconsistent. 
Beneficial effects 
Studies on grov.th and nitrogen retenlion 
In the first 10 years after the ;,,troduction of MCTs in premature infant feeding 
several studies were published showing more or less positive effects of the addition 
of MCT to premature formulas [24-27]. It was found that fat balance significantly 
improved when using MCT in all studies and in all but one study [26], growth was 
also better with MCT. In two studies [26,27] nitrOgen balance was studied and it 
was found that the latter improved significantly with MCTs in some subgroups, 
although remarkably enough not in the ones where improved growJJ was found. 
These positive reports have attributed certainly to the fact that since then more and 
more special premature formulas have been developed that contained -and most 
formulas do so until today- up to 50% of fat as MCTs. 
Later studies could only report on a relatively small improvement on fat 
absorption without an effect on growth [28,29] or on a total absence of any effect on 
energy absorption [30,31] or fat absorption [23]. For the sake of completeness it 
must be noted that the group of Jensen et a!. [29] have published their data on fat 
balance in more detail in a different publication [32] and that Hamosh et a!. recently 
published a report similar to the one mentioned earlier, describing essentially the 
same results [33]. 
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Studies on mineral absorption 
Administering a mineral supply to the orally fed preterm neonate so that 
intrauterine accretion rates can be approached is quite difficult. Several studies have 
shown the existence of a certain correlation between the fecal excretion of fat and 
minerals, in particular calcium [34]. In 1978 Tantibhedhyangkul performed the first 
study on the effects of MCT on mineral metabolism, reporting a significant 
improvement in calcium absorption with MCTs [35]. Two later studies [28,29] did 
not report on any significant improvement in the mineral absorption rates with 
MCTs. One important observation however is that in the study of Okamoto et a!. 
calcium, magnesium and nitrogen absorption all showed a very clear tendency to 
improve on MCT feeding. A relatively small number of patients was investigated 
and it can be estimated from their data that p values must have been almost 
significant. Thus it can be concluded that data are contradictory in this aspect of the 
use of MCTs. 
Effects on ketones 
In 1986 Wu et a!. [36] reported that in preterrn infants, like in adults, a mild 
ketosis could be provoked by feeding a formula containing 50% of fat as MCT. He 
found that levels of 3-hydroxybutyrate but not acetoacetate were increased, a pattern 
similar to the one observed by Lucas et al. [37] in breast-fed term infants in a 
comparative study of two groups of neonates that were either breast- or formula fed. 
Wu et a!. suggested that there could be a beneficial effect in the preterm infant of 
the well known ketogenic properties of MCTs, because of the presumed central role 
of ketone bodies in brain lipid synthesis and as alternative oxidative substrates. 
On the other hand, Brooke mentioned that MCT replacement of dietary fat at 
two levels of energy intake in preterm infants was associated with a tendency 
towards acidosis [30]. He ascribed the higher incidence of metabolic acidosis (which 
was not statistically significant) to the "potentially undesired ketogenic effect of 
MCT". Until now, both points of view have not been etablished as clinically 
relevant, but the fact that the ketogenic properties of MCTs are explained in such 
diverse ways proves how little is known about both the metabolism of ketone bodies 
and MCTs in the preterm neonate. 
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Potentially detrimental effects 
Effects on gastric emptying 
Several authors [38], reporting an increased incidence of lactobewars in preterm 
infants since the introduction of special premature infant formulas, have attributed 
this to the change in fat source from LCTs to MCTs, based on studies in adults that 
showed delayed gastric emptying in some instances [39,40], Using 99m-technetium 
sulphur colloid, Sidebottom et aL [41] could not show any difference in gastric 
emptying time in preterm infants between formulas containing 14% or 50% of the 
lipids as MCTs. 
Dicarboxylic aciduria 
The medium-chain dicarboxylic acids sebacic, suberic, and adipic acid are 
produced in the cytoplasm by w-oxidation of medium-chain fatty acids. This is 
normally a minor pathway and only small amounts of dicarboxylic acids are excreted 
in the urine. In 1980 Mortensen et aL [42] drew attention to dicarboxylic aciduria in 
infants on MCT feeding, leading to confusion in the diagnosis of inherited defects of 
the ~-oxidation pathway, One year later it was established that (w-1)-hydroxy-
monocarboxylic acids also were increased in (preterm) infants fed MCTs [43], An 
increased excretion of both organic acids during MCT feeding was confirmed in a 
comparative study between two formulas fed to preterm infants containing either 4% 
or 54% MCTs [44], In the same year Henderson et al. [45] also drew attention to 
the problem and suggested that further studies were warranted to exclude toxic 
effects of dicarboxylic acids, as Passi et al, showed an antimitochondrial effect of 
dicarboxylic acids in topical cream used for the treatment of melanocytic skin tumors 
[46]. However, no further evidence has been provided on the issue until today. 
In terms of energy balance the excretory loss of the measured organic acids is 
negligible (i.e. <I% of energy intake) in all studies, and the clinical significance of 
these findings remain to be established. 
Gastrointestinal disturbances 
In the study of Okamoto et al. [28], the majority of the infants fed one of the 
two MCT -containing formulas developed transient gastrointestinal symptoms like 
vomiting, bilious or blood-containing gastric aspirates, abdominal distension, or 
loose stools. Although no statistics were given, it can be deduced from their data 
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that the incidence of these gastrointestinal disturbances was certainly significantly 
higher in the MCT groups. In two other studies remarks were made on a possibly 
higher incidence of loose stools [24,27] and "mild to moderate" abdominal 
distension [27]. However, with current MCT formulas this phenomenon seems to be 
uncommon in clinical practice and several other studies specifically reported on 
either a good gastrointestinal tolerance [47], or no difference in stool frequency or 
vomit count between MCT- and LCT formula groups [48]. All other comparative 
studies do not comment on any remarkable difference in gastrointestinal tolerance 
between formulas containing high- or low amounts of MCTs. 
Inhibition of fl6-desaturase 
Carnielli et al. [49] reported on lower levels of Poly-Unsaturated Fatty Acids 
(PUFAs) during MCT feeding as compared with mothers own mill<. However, it is 
more likely that these lower levels of PUFAs with MCT feeding are related to the 
formula feeding per se and not specifically to MCTs, as levels of the longer-chain 
PUF As are !mown to be much higher in human milk than in formulas, regardless 
whether the fat source is MCT or LCT. 
SUMMARY 
Although it is clear that in some studies certain clinical benefits of MCT 
formula have been reported, the existing evidence is insufficient to support the view 
that MCT is definitely indicated for (certain groups of) premature infants. Fat 
absorption is increased in some infants on MCT formula, but not consistently so. 
Growth and nitrogen retention have also been reported to improve with MCT, and 
after.vards several studies specifically reported to have found no advantages in this 
regard. 
The discrepancy between increased energy absorption on one hand and the 
absence of increased weight gain on the other hand renders suspicion about the 
metabolic fate of MCTs. Keeping in mind the fact that in an overfeeding design in 
animals a lower food efficiency (the original aim of MCTs!) was found, it seems 
likely that increased heat production with MCTs can play a role in these findings in 
humans. An increased heat production can be explained in several ways: Several 
authors assume an "obligatory oxidation of MCTs"', because much higher oxidation 
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rates than with LCTs have been measured in animals and in adults, whereas storage 
as MCTs is very limited compared with LCTs. If MCTs are indeed oxidized 
preferably compared to LCTs, one could imagine a situation where heat production 
is increased because of ongoing oxidation of other substrates like LCTs. In other 
words, metabolic control falls shon in the case of MCTs, compared to the normal 
tight regulation of substrate oxidation as in the "Randle cycle" of glucose and fatty 
acids where oxidation of one substrate decreases the oxidation of the other. 
Another possible cause for a lower food efficiency with MCTs is a high rate of 
lipogenesis, which is an energy requiring process. As MCTs are hardly stored as 
such, MCFAs that are not oxidized, have to be convened into LCF As before 
storage. Available data suggests that the mechanism of this conversion during MCT 
feeding is predominantly de novo lipogenesis. A similar situation occurs if MCTs 
decrease glucose oxidation while glycogen reserves have already been saturated, as 
excess carbohydrates also have to be convened into LCFAs before storage. 
Regarding mineral balance, and especially calcium balance which is probably 
the most imponant for the preterm infant, available data show contradictory results 
and evidence is insufficient to say if-, and under what circumstances, mineral 
balance improves with MCT feeding. 
Finally, although several potentially adverse effects of MCTs have been 
reponed, the fact that observations have not been consistent eventhough MCTs have 
been included in many preterm formulas for several years, probably indicates that 
there are no major disadvantages of MCTs. Of course the ultimate proof would lie 
in a very large study where the influence of MCT feeding on long-term follow up 
with regard to growth, lipid profiles, bone density and even neurological outcome is 
being studied. However, before studying such a large number of infants more clear 
shon term benefits must have been established. 
From the available data the following questions were formulated: 
1- What is the reason for the observed discrepancy between improved fat balance 
and the absence of increased weight gain in MCT fed prematures, more specifically, 
does MCT feeding increase metabolic rate? 
2- If food efficiency is lowered by an increased metabolic rate, is this caused by 
increased lipogenesis during MCT feeding or by an increased total fat oxidation due 
to the obligatory oxidation of MCFAs? 
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3- What is the fate of the MCF As, oxidation or conversion into other substrates? 
4- What is the composition of new tissue during growth when feeding the VLBW 
infant an MCT formula compared to an LCT formula? 
5- Does the calcium balance improve with MCT feeding in the stable VLBW infant, 
and are there any signs of mineral deficiency on LCT formula? 
6-· Are the benefits of MCTs more pronounced in the nutritional management of the 
very small and very young premature infant? 
These central questions and some related issues are dealt with in the following 
chapters, after which a general discusion follows in chapter 9 and where possible, a 
synthesis of new knowledge and proposition for further research is formulated. 
Finally, the results of the studies are briefly summarized in chapter 10. 
In Chapter 2 we describe the fat and protein balances in two groups of clinically 
stable and growing VLBW infants fed either a high- or a low MCT formula. 
Balances were combined with indirect calorimetry in order to be able to calculate the 
composition of the new tissues laid down on these diets. In this way we would be 
able to answer question 1 as well as 4. 
In Chapter 3 we describe mineral balances and relevant hormone levels in the same 
groups of relatively healthy prematures in order to answer question number 5. 
Mineral absorption rates are also correlated with data from Chapter 2. 
In Chapter 4 questions 2 and 3 are addressed, by investigating the oxidation rate of · 
MCT with stable isotopes, using [l-13C]-octanoate as a tracer, arguing that a 
complete oxidation of MCTs (as found in fasted individuals) would point towards an 
obligatory oxidation, whereas an incomplete oxidation would indicate the need for 
conversion into other substances and probably increased lipogenesis from MCT-
derived acetyl-CoA. The percentage of substrate oxidized also informes us on the 
metabolic fate of MCTs in the preterm infant. 
ln Chapter 5 question 2 is (partially) addressed by investigating the effects of MCT 
on glucose metabolism in two groups of pretenn neonates. A stable isotope labeling 
technique is used to investigate glucose oxidation, production, storage and recycling. 
Combined with simultaneously performed indirect calorimetry, calculations are 
performed for the rate of lipogenesis from glucose with MCT versus LCT feedings. 
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In Chapter 6 we use a newly developed high-sensitivity determination of the 
enrichment of fatty acids after administration of the MCFA octanoic acid labeled 
with a 13C stable isotope. The on-line coupling of a gas chromatograph to an 
isotope-ratio-mass spectrometer is being employed (GC-!RMS) for the in vivo 
investigation of chain elongation from MCT, relating specifically to questions 3 and 
2. 
In Chapter 7 using newly developed equations we elaborate on our earlier findings 
on octanoate oxidation. Using GC-!RMS measurements after oral and intravenous 
tracer administration the splanchnic and peripheral oxidation rates of octanoate are 
investigated separately. 
In Chapter 8 the last of our studies is described, even though it could also have 
been the "first chapter" of a new set of investigations. We studied extremely-low-
birth-weight infants in order to answer (partially) question 6. Too little is lmown 
about the specific needs of these infants due to the fact that they are often "too ill to 
be studied". Using a non-invasive diaper collection and anthropometry we have tried 
to gain a first insight into the usefulness of MCT in this particular patient group. 
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CHAPTER II 
COMPARISON OF TWO PRETERM FORMULAS WITH OR 
WITHOUT ADDITION OF :MEDIUM-CHAIN 
TRIGLYCERIDES (MCTs) I: EFFECTS ON NITROGEN AND 
FAT BALANCE AND BODY COMPOSITION CHANGES. 
E.J. Sulkers, J.B. van Goudoever, C. Leunisse, J.L.D. Wattimena1, 
P.J.J. Sauer. 
Department of Pediatrics, dept. of Internal Medicine1, Sophia Children's 
Hospital and University Hospital Dijkzigt I Erasmus University 
Rotterdam, Rotterdam, The Netherlands. 
SUMMARY 
Medium-chain triglycerides (MCTs) are included in the fat blend of several 
preterm formulas because of their complete absorption and rapid oxidation. The 
effects of two different fat blend compositions on nitrogen and fat balances and 
macronutrient oxidation were investigated in 28 healthy very-low-birth weight infants 
at four weeks of age. A preterm formula with a traditional com oii/MCT blend, 
containing 38% MCTs (MCT group) was compared to a new fat blend, designed to 
resemble human milk more, containing 6% MCTs (LCT group). There were no 
differences in nitrogen absorption or in excretion. Median nitrogen retention was 
74% (MCT) vs. 71% (LCT) of intake. Fat absorption was higher (p < 0.05) in the 
MCT group (88%) vs. 79% in the LCT group (median values). MCTs did not 
stimulate fat oxidation as measured by indirect calorimetry, so fat deposition was 
also higher on the MCT formula. As weight gain was not different between groups, 
the percentage of weight gain consisting of fat accretion was significantly (p < 
0.005) higher with the MCT formula (24% vs. 21 %). On the other hand, there was 
no increase in percent protein accretion (both 15% of weight gain). We conclude 
that the existence of a slightly lower fat absorption in the healthy growing neonate 
fed a LCT formula as compared with a MCT formula does not impair growth or 
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nitrogen retention, but merely induces a slight decrease in the high relative fat 
accretion encountered in the preterm neonate. 
l.l'ITRODUCTION 
The fat blend of most special formulas for preterm infants consists of 30- to 
50% medium--chain triglycerides (MCTs), the triglycerides of C8:0 and ClO:O fatty 
acids, primarily in order to enhance fat absorption. The clinical benefit, however, of 
adding MCT oil to preterm formula has been questioned by some authors [1,2], 
pointing out the lack of proof regarding the advantages on one hand, and the 
increased incidence of gastrointestinal symptoms and dicarboxylic- and w-1-hydroxy 
fatty acid excretion in urine as a sigo of increased w-oxidation on the other hand. 
Although initial reports described striking improvements in fat absorption [3-6], 
later reports described only marginally improved fat absorption [1,2] or no 
difference in fat- [7] or energy- [8,9] absorption. Also, the initially described 
improved weight gain [4-6] or nitrogen retention [3,4] has not been confirmed in 
other studies [1,2,8-10]. 
From the finding of increased fat absorption without improved weight gain in 
some of the studies [1-3] one might expect that infaots fed a MCT--containing 
formula in some instances either have an increased energy expenditure or lay down 
more fat. 
We compared a corn oil based formula containing 38% of fat as MCT to a new 
formula with a fat blend that more closely resembles human milk and to which no 
MCT was added, in 28 very-low-birth weight infants. Results from indirect 
calorimetric measurements and from nitrogen and fat balances were combined to 
calculate macronutrient accretion rates. 
PATIENTS AND METHODS 
Subjects 
Twenty-eight patients were randomized before the introduction of oral feedings 
to receive either a preterm formula in which 40% of the fat consists of MCTs (MCT 
group, n = 15) or a formula with no MCTs added (LCT group, n = 13). 
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Only infants with a binh weight of less than 1600 g, initially admitted to the 
neonatal intensive care unit of the Academic Hospital Rotterdam/Sophia Children's 
Hospital were ir1cluded in the study. Infants were eligible for inclusion if they were 
free from major metabolic problems or congenital malformations and if they were 
clinically stable breathing room air at the introduction of oral feedings. All infants 
received total parenteral nutrition (TPN) during their first postnatal week. This 
protocol has been shown to be an important tool in the prevention of necrotizing 
enterocolitis [11]. At day 7, enteral feedings were gradually introduced by 
continuous nasogastric gavage feeding until a full intake of 150 ml/kgld was reached 
at postnatal day 16-19. The composition of both feedings is given in table 1. 
Table 1 
Composition of the two formulas (per 100 ml) 
MCT LCT 
Energy content (kcal) 83.2 83.7 
Carbohydrates (g) 8.0 8.0 
- lactose/maltodextrins 50150 50150 
Protein (g) 2.19 2.23 
- casein/whey 40/60 40/60 
Fat (g) 4.51 4.50 
- Fatty acid composition (%) 
C4:0 0.4 
C6:0 !.2 0.2 
C8:0 22.8 3.0 
C10:0 14.0 2.4 
C!2:0 2.0 16.9 
C!4:0 7.4 
Cl6:0 6.4 9.8 
Cl6:1 0.3 0.4 
C18:0 !.6 3.3 
Cl8:1 19.1 35.5 
Cl8:2 31.7 17.0 
Ci8:3 0.3 1.7 
C20:0 0.3 0.3 
C20:1 0.3 0.2 
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Both formulas were specially manufactured by Nutricia (Zoetermeer, The 
Netherlands) with a completely equal composition, except for their fat blend. The 
batch of MCT formula in this study contained 38% medium chain fatty acids 
(MCFAs) in the fat blend. The MCFAs in the MCT formula are present as triacyl-
glycerols consisting of nearly exclusively MCFA. The 6% MCFA in the LCT 
formula derived from coconut oil, are predominantly present in the 3-position of the 
triacylglycerols with lauric acid (Cl2:0) at the 2-position and Cl4:0 and Cl6:0 at 
the !-position. 
One and the same batch from each formula was used during the study. For each 
batch, concentrations of nutrients were measured and gross energy intake was 
calculated using appropriate conversion factors. The caloric value of a mixture of 
lactose (value taken from ref. 12) and dextrins (value taken from ref. 13) was 
assumed to be 4.03 kcal/g, whereas the values for the fat blends were calculated to 
be 9.02 and 9.12 kcal/g for MCT and LCT respectively [12]. A value of 4.704 
kcal/ g was assumed for food proteins, assuming urea, ammonia and creatinine to be 
the end products in a 90:5:5 ratio [12]. 
A 72 hr balance period was performed at least 3 days after the infant had 
received full oral feedings, and a second study was done another 3-5 days later. 
Indirect calorimetry was performed on the second day of both 3 day balance periods. 
For each patient, an individual standard deviation score (SDS) was determined, 
defined as the actual birth weight of the infant minus the mean birth weight for that 
gestational age, divided by one standard deviation for that gestation according to the 
growth curves of Usher and McLean [14]. The gestational age was determined by 
medical history, ultrasound data and Ballard score [15]. 
The mean birth weight, gestational age, SDS, and study weight of the patient 
groups are described in table 2. 
Table 2 
Characteristics of the two groups studied 
MCT (n=15) 
LCT (n=l2) 
Birth weight 
(grams) 
1129 ± 218 
1271 ± 165 
Gestational age 
(weeks) 
31 ± 1.9 
32 ± 1.8 
SDS Study weight 
(grams) 
-2.1 ± 1.9 1488 ± 270 
-1.9 ± 1.5 1629 ± 217 
Results presented as mean ± 1 SD, with non of the differences significant. 
Study day 
(days) 
26 ± 5 
29 ± 5 
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Weight gain was calculated from the growth during the 4th week of life as difference 
in weight between days 28 and 21 divided by the average weight during this period. 
One infant in the LCT group was excluded from the original group and is not 
presented in this study as will be discussed in the Results section. Infants were only 
included after obtaining informed consent from at least one of the parents. The study 
protocol was approved by the medical ethical committee of the hospital. 
Methods 
Indirect calorimetry 
Metabolic rate and substrate utilization were measured in a closed circuit 
indirect calorimeter. Continuous measurements were performed for 6-8 hrs, as 
previously described [16]. Briefly, an air mixture devoid of carbon dioxide enters 
the incubator. In the air leaving the incubator the C02 concentration is measured at 
one side of a differential infrared meter (Unor 6N, Maihak, Hamburg, Germany), 
whereafter all carbon dioxide is filtered out by a soda-lime filter. Then C02 is 
injected again into the airflow by a mass flow injector system at such a rate that the 
same concentration of C02 is measured at the other side of the differential meter, 
where the air flow has returned via a loop in the system. The amount of carbon 
dioxide injected into the system equals the carbon dioxide production of the infant. 
Thereafter, all C02 is filtered by a second filter. The amount of oxygen consumed 
by the infant is equal to the amount of oxygen that has to be injected into the system 
to keep the oxygen tension constant, as measured by polarographic oxygen cells 
(type 6223771, Beckman, La Brea, USA) in the system and in a reference vessel. In 
order to compensate for changes in air pressure, the reference vessel is connected to 
the flow circuit by means of a capillary. Oxygen consumption and carbon dioxide 
production are measured with an accuracy of 0.2 ml/min; the respiratory quotient 
(RQ) during calibration with butane was within 2% of the theoretical value. 
Urine was collected in plastic bags over periods of three days. The urinary 
nitrogen concentration of a pooled sample was determined by combustion in an 
automatic nitrogen analyzer (ANA 1400; Carlo Erba, Italy). 
The metabolic rate and protein, fat, and carbohydrate oxidation (utilization) was 
calculated from nitrogen excretion, V02, and VC02 using the tables of Lusk [17]. 
The term utilization is used in accordance with Frayn [18], indicating that in the 
presence of metabolic processes such as lipogenesis, the apparent rate of 
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carbohydrate oxidation is the sum of the rates of utilization for oxidation and for 
lipogenesis. Likewise, fat utilization represents fat oxidation minus fat formed from 
glucose through lipogenesis. By using the term utilization instead of oxidation, it 
becomes more clear that, for instance, fat storage, calculated as metabolizable fat 
intake minus fat utilization, also includes the amount of fat derived from lipogenesis. 
The correct way to calculate fat accretion, therefore, is as the difference between fat 
absorption and fat utilization. Assuming the fat accretion to be equal to energy 
retention ignores accretion of carbohydrate and therefore would not be correct. 
Balance study 
The feces nitrogen concentration of freeze-dried aliquots of samples pooled over 
the three day periods were determined by combustion in the automatic nitrogen 
analy=. Fat excretion in feces was determined using a modification of the 
Jeejeebhoy method [19], with twice as much hydrochloric acid added. In a few 
randomly chosen samples (n = 9), the total energy excreted per gram of dry weight 
of feces was checked also by combustion in a adiabatic calorimeter (IKA C-4000, 
Janke & Kunkel, Staufen, Germany). This value was compared with a value 
calculated from nitrogen and fat excretion, assuming a caloric value of 9.25 kcal/g 
for fat and 5. 65 kcal/ g for protein [9]. 
Statistics 
Data are presented as mean ± I SD. In cases of apparent nonnormality, data 
are presented as median with interquartile range (25-75%) in parentheses. 
Differences between the MCT and the LCT groups were tested using Wilcoxon's 
rank-sum (Mann-Whitney two-sample) test. Differences in body composition changes 
between groups and the reference fetus were tested using Wilcoxon's matched 
sample sign test. Correlations given were calculated by simple linear regression 
analysis and confirmed with the non-parametric rank correlation test of Spearman. 
To separate the effects of fecal weight and fecal fat on fecal nitrogen excretion, 
multiple linear regression analysis was performed. 
A value of p < 0.05 was considered statistically significant. 
RESULTS 
There were no significant differences between the two study groups in any of 
the parameters described in table 2. The study weight and age at the time of the 
study described here are the mean values of the two balance periods. As the two 
balance periods and the two calorimetric measurements showed no trend in any of 
the examined parameters, all results presented are the average values of the two 
periods. One infant in the LCT group was excluded because of a technical defect of 
the calorimeter during that period from this study, but his balance data are reported 
elsewhere [20]. 
The results of the fat and nitrogen balances are described in table 3. 
There were no significant differences in any of the parameters regarding 
nitrogen metabolism. Nitrogen losses in stool tended to be higher in the LCT group, 
but not significantly so (p = 0.12). Fat intake -like nitrogen intake- was not 
different between groups. However, fat losses in stool were significantly greater in 
Table 3 
Results from nitrogen and fat balances in the two study groups 
MCT LCT p 
(n = 15) (n = 13) 
Nitrogen (mg/kg/day) 
Intake 525 ± 18 532 ± 17 NS 
Stools 53 (40- 76) 72 (54- 99) NS 
Urine 84 (67 • 94) 77 (67 - 93) NS 
% Absorption 90 (86- 92) 86 (81 - 90) NS 
Retention 386 (372 - 402) 380 (336 - 403) NS 
% Retention 74 (71 - 76) 71 (63 - 75) NS 
Total fat (glkg/day) 
Intake 6.8 ± 0.35 6.8 ± 0.30 NS 
Stools 0.79 (0.73 - 0.99) 1.4 (1.1 - 2.0) <0.005 
% Absorption 88 (85- 89) 79 (70- 83) <0.02 
Absorption 6.0 (5.8 - 6.0) 5.4 (4.8- 5.6) <0.02 
Results presented as mean ± 1 SD, or median with interquartile range in case of apparent 
nonnorrnality. NS, not significant. 
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the LCT group, and hence the % absorption and the absolute retention of fat were 
significantly lower in the LCT group. Fecal nitrogen excretion was correlated with 
fecal fat excretion (r = 0.51, p < 0.01), but also with fecal weight (r = 0.69, p < 
0.00005). Indeed, when fecal fat was entered into the multiple linear regression 
model for fecal nitrogen after entering the fecal weight, there was no increase in R2 
(both were 0.50), as a measure of the percentage of the variability in fecal nitrogen 
explained by the entered variables. 
In itself, fecal output (g!kg/d) also tended to be higher in the LCT group, 
although this did not reach statistical significance (2.6 ± 0.84 vs. 3.6 ± 1.4 g/kg/d, 
MCT vs. LCT, p = 0.06). 
The total energy excreted per gram of dry weight of feces as measured by bomb 
Table 4 
Results of calorimetric measurements in the two study groups 
MCT LCT 
(n = 15) (n = 13) 
Nonprotein V~ (ml/kg/day) 8.0 ± 0.5 8.0 ± 0.6 
Nonprotein V~ (ml/kg/day) 7.4 ± 0.5 7.3 ± 0.5 
Nonprotein RQ 0.93 ± 0.032 . 0.91 ± 0.033 
Carbohydrate intake 12.1 ± 0.4 12.0 ± 0.4 
(g/kg/day) 
Carbohydrate utilization 11.1 ± 1.6 10.4 ± 1.6 
(g/kg/day) 
Carbohydrate storage 1.0 ± 0.3' 1.6 ± 1.6' 
(g/kg/day) 
Fat absorption 6.0 (5.8 - 6.0) 5.4 (4.8- 5.6) 
(g/kg/day) 
Fat utilization 2.0 (1.1 - 2.2) 2.2 (1.2- 2.7) 
(g/kg/day) 
Fat storage 4.3 ± 0.7 3.2 ± 0.9 
(g/kg/day) 
Metabolic rate (kcal/kg/day) 62 ± 3.5 62 ± 3.8 
Results presented as mean ± 1 SD. or median with interquartile range. 
,., Significantly different from zero at p < 0.01 by t test. 
p 
NS 
NS 
NS 
NS 
NS 
NS 
<0.02 
NS 
<0.005 
NS 
calorimetry was 98 ± 18% of the value calculated from nitrogen and fat data in the 
MCT group (n = 5) and 102 ± 9% in the LCT group (n = 4). 
Results of indirect calorimetry and the calculated fat and carbohydrate storage 
using these results are presented in table 4. There were no significant differences in 
any of the parameters between both groups regarding indirect calorimetry. 
Therefore, fat storage was significantly higher in the MCT group. The metabolic 
rate correlated inversely (fig. 1) with the SDS at birth as a measure of intrauterine 
growth retardation (metabolic rate (kcallkg/d)= 60 - L3 x SDS, p < 0.0005). 
Using the Spearman test, a significance level of p < 0.001 was found. 
Anthropometric parameters are described in table 5. Again, none of the 
measured parameters showed any statistically significant difference between the 
MCT and the LCT group. Figure 2 shows that the weight gain was correlated with 
the nonprotein RQ (weight gain (g!kg/d)= -14 + 33 x nonprotein RQ, p < 0.05 
both Pearson's correlation coefficient and Spearman's rho). The weight gain was not 
correlated with metabolic rate, energy losses in stools, or a combination of these 
parameters. 
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Fig. 1 
Relationship between SD score of weight for gestational age as a measure of intrauterine 
growth retardation and metabolic rate during the study period: Y = 60 - 1.3X. 
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TableS 
Anthropometric parameters of the two study groups 
Weight gain (g/kg/day) 
Length gain (em/week) 
Head circumference gain 
(em/week) 
MCT 
(n = 15) 
16.6 ± 2.42 
0.87 ± 0.47 
1.2 ± 0.56 
LCT 
(n = 12) 
16.1 ± 3.23 
1.1 ± 0.42 
1.0 ± 0.27 
·Results presented as mean ± 1 SD~ with no significant differences. 
p 
NS 
NS 
NS 
Combining the results of tables 3, 4, and 5 the percentage of weight gain 
consisting of fat and protein retention was calculated. Figure 3 compares the 
calculated proportional fat and protein content of the daily weight gain (median 
values) from the two formulas with the intrauterine values at postconceptional age 
35-36 weeks according to the data of Ziegler eta!. [21]. 
25 Growth (gram/kg/d) 
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non-protein RQ 
Fig. 2 
Relationship between the nonprotein Respiratory Quotient and weight gain during the fourth 
week of life: Y = -14 + 33X. 
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F.g. 3 
Accretion of fat and protein as a percentage of total weight gain in the two study groups 
compared with the reference fetus. Black bars, protein; striped bars fat; white bars, other. 
The percent fat accretion was significantly (p < 0.005) higher in the MCT 
group (24% (range of 23-28%) vs. 21% (range of 17-22%)), whereas the % protein 
retention was equal in both groups (15% (range of 14-16%) vs. 15% (range of 12-
18%)). The fat accretion percentage was higher in both groups than in the reference 
fetus (p < 0.0001); protein accretion was not significantly different from the 
reference fetus in both groups. In a multiple regression analysis, the SDS at birth as 
a measure of growth retardation did not enter the equation significantly both alone 
and in combination with the feeding group. 
DISCUSSION 
For the last 15 years, most preterm infant formulas available have contained 
MCT oil in order to enhance fat absorption and to promote weight gain. Some 
promote the use of MCTs in order to provide "a readily available source of energy", 
although this seems to be a rather vague concept when administering (semi)-
continuous feeds to the preterm neonate. Concern has been raised about the side 
effects of such an unphysiological fat intake in terms of fat deposition spectrum [22], 
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and in view of the existence of limited pathways for metabolism besides oxidation 
and hence dicarboxylic- and w-1-hydroxy fatty aciduria [23]. Several investigators 
have reported an increased incidence of gastrointestinal symptoms with MCT feeding 
[1,2,4]. The European Society of Paediatric Gastroenterology and Nutrition 
(ESPGAN) has been proclaiming cautiousness but only advised an upper lintit of 
MCT intake of 40% of fat calories [24]. In this study, we compared two formulas 
differing only in their fat composition. The MCT formula is based on a corn 
oii/MCT oil blend as incorporated in one of the commercial formulas in The 
Netherlands from the 1970s until 1988. The LCT formula is based on a new fat 
blend, designed to be closer to breast milk, while still being sufficiently absorbed. 
Consequently, the new formula contains an amount of a-linolenic acid in line with 
the recent ESPGAN recommendations [24], accepting the essentiality of the c.>-3 
series of the polyunsaturated fatty acids next to that of the c.>-6 series. The amount of 
linoleic acid was lowered also according to the ESPGAN guidelines and to obtain a 
physiologic ratio between the c.>-6 and the c.>-3 series of the essential fatty acids. 
Compared with human mil:k [22], the LCT blend contains less palmitic acid (Cl6:0) 
but more lauric acid {Cl2:0). The former fatty acid is known to be absorbed less 
well from infant formulas than from human milk. This phenomenon is attributed to 
the preferential esterification of palmitic acid at the 2-position of the glycerol 
molecule, whereas in vegetable oils it is primarily situated at the 1- and 3- positions 
within the triglycerides. The levels of the MCFAs C8:0 and ClO:O were about eight 
times less than that in the MCT formula and approached levels normally found in 
human milk. 
This study shows that there are no differences in nitrogen losses in stool or 
urine between the two groups. In addition, although fecal nitrogen and fat excretion 
were correlated, fecal output (in g!kg/ d) alone was the best predictor for fecal 
nitrogen excretion. Thus, we cannot conclude that fecal nitrogen is influenced by fat 
excretion, as variability in intestinal transit rate might have caused the variability in 
fecal weight and the variability in fat and nitrogen excretion. 
Infants on LCT feeding excreted significantly more fat in the feces. If we 
examine the fatty acid composition of the two fat blends again (table 1), we can see 
that besides the fact that MCT is replaced by Cl2:0 and Cl4:0, there are also 
significant differences in Cl8:1 and C18:2 between the formulas. However, several 
studies [25,26] have shown a difference of no more than 2% in the relative 
absorption rates of these fatty acids; we can assume that the difference in fat 
absorption found is related to the MCT content of the two different formulas. The 
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extra loss of fat (median value 0.6 gram/kg/d) causes an extra loss of about 5-6 kcal 
in the LCT group. Although some energy can be lost during MCT feeding in the 
urine as metabolites of the MCFAs, this does not contribute significantly to the 
energy balance [23]. Fat utilization was not higher in the MCT group, and hence fat 
deposition was greater in the MCT-fed infants. As there were no differences in 
growth rate, relative fat deposition was higher in the MCT group. This can explain 
the findings of increased fat absorption without increased weight gain in some 
groups that were studied [1-3]. Remarkable is the fact that MCT-fed infants did not 
show a higher fat-utilization; in fact, their mean nonprotein RQ was higher than in 
the LCT-fed infants, although not significantly so. The fat utilization as measured by 
indirect calorimetry, represents oxidation minus lipogenesis from glucose [18]. Thus, 
a preferential oxidation of MCT could still have taken place, but must have been 
counterbalanced by increased lipogenesis from glucose. 
It has been suggested [9], that the disparity between reports of equal energy 
absorption [8,9] on MCT and LCT using bomb calorimetry and other studies 
reporting higher fat absorption [1,2] was partly due to underestimation of MCT 
losses with fat extraction methods, even with the Jeejeebhoy method [19], which has 
been designed to measure fecal fat content of MCT diets. Our data on bomb 
calorimetry in a limited number of samples do not support this suggestion, as total 
energy calculated from fat- and nitrogen data was not different from the measured 
total energy excretion in both groups. The finding that energy losses can be 
explained completely by protein and fat excretion is in agreement with negligible 
carbohydrate losses in pretenn infants [27]. 
The relation found between metabolic rate and the SDS at birth allows us to 
calculate the mean difference in metabolic rate between appropriate for gestational 
age (AGA) and small for gestational age (SGA) infants: as the mean SDS in our 
study is -0.19 for AGA infants and -3.12 for SGA infants, and the coefficient of the 
regression equation is -1.6, the average metabolic rate of SGA infants is nearly 4 
kcal/kg/d higher than that of AGA infants, confirming our earlier findings in this 
patient population [28]. This study also confirms another, remarkable fmding 
reported by us before [29] in an entirely different group of patients, namely the 
existence of a correlation between the nonprotein RQ and weight gain without the 
presence of such a correlation between metabolic rate and/ or energy losses and 
growth. In a very recent publication, a similar observation was made concerning the 
relationship between RQ and weight gain in obese adults [30]. However, the exact 
underlying mechanisms regarding this observation are not yet understood. 
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Our study is the first to show that the percent fat accretion on MCT formula is 
higher without a beneficial effect on nitrogen accretion, weight gain or linear 
growth. The percent fat accretion on LCT formula is closer to the observed intra-
uterine fat accretion. There is no evidence yet from human studies that a high fat 
accretion in preterm neonates can have adverse effects in later life. From a purely 
theoretical standpoint, it seems reasonable to strive for a fat accretion closest to the 
intrauterine fat accretion, as long as there is no negative influence of this caloric 
restriction on linear growth or nitrogen accretion. The percentage of weight gain 
consisting of fat accretion is still higher than intrauterine in the LCT group-and the 
question remains whether we still give too many calories to healthy preterm infants. 
In conclusion, the study presented indicates that MCTs have no advantage in the 
routine feeding regimen of otherwise healthy, growing preterm infants. The small 
increase in fat absorption and hence energy retention that results from it in the orally 
fed, older preterm infant does not promote nitrogen retention, but only increases fat 
deposition. Further studies are needed to exantine whether MCTs have a place in the 
treatment of younger and more immature preterm infants. 
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CHAPTER Ill 
COMPARISON OF TWO PRETERM FORMULAS WITH OR 
WITHOUT ADDITION OF :MEDiliM-CHAIN 
TRIGLYCERIDES (MCTs) II: EFFECTS 
ON MINERAL BALANCE. 
E.J. Sulkers, H.N. Lafeber, H.J. Degenhart, J. Lindemans, 
P.J .J. Sauer. 
Department of Pediarrics, Sophia Children's Hospital and University 
Hospital Dijkzigt I Erasmus University Rotterdam, Rotterdam, The 
Netherlands. 
SUM:MARY 
Medium-chain triglycerides (MCTs) are included in the fat blend of several 
preterm formulas because of their complete absorption and rapid oxidation. The 
effects of two different fat blend compositions on calcium (Ca), phosphorus (P), and 
magnesium (Mg) balances and plasma levels and on plasma levels of parathyroid 
hormone (PTH), alkaline phosphatase (AP), and 1,25--dihydroxyvitarnin D (1,25-
(0H)2D) were investigated in 28 healthy very-low-birth weight infants at four weeks· 
of age. A preterm formula with a traditional corn oil/MCT blend containing 38% 
MCTs (MCT group) was compared to a new fat blend, designed to resemble human 
milk more, containing 6% MCTs (LCT group). There was a higher absorption of Ca 
in the MCT group (73% vs. 60%, p < 0.005), and an eqnal absorption of P (both 
92%). The excretion of Ca correlated with the excretion of fat (p < 0.00005). The 
LCT group showed a higher median PTH level (MCT: 2.1 pmol!l, LCT: 4. 7 
pmol/1, p < 0.01) and a higher urinary P excretion (p < 0.001). Mg absorption 
was also lower with LCT, but retention of Mg exceeded intrauterine values in both 
groups. Mineral plasma levels were in the normal range in both groups. AP was not 
different between groups and in the upper part of the reference range, whereas 1,25-
(0H)2D levels were above the normal range and also not different between groups. 
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We conclude that with the LCT formula, Ca absorption is slightly lower than with 
the MCT formula, whereas P absorption is unaffected. The resulting imbalance in 
absorption is compensated for by an increased utinary excretion of P. We conclude 
that current recommendations for the maximum Ca/P ratio in preterm formulas (2: 1) 
might be too low in formulas containing only LCT. 
INTRODUCTION 
The fat blend of most preterm formulas available consist of 30- and 50% fat as 
medium-chain triglycerides (MCTs) in order to enhance fat absorption. In an earlier 
study in 28 very-low-birth weight infa.'lts [1], we compared a formula containing 
38% of fat as MCTs to a new formula with a fat blend that more closely resembles 
human milk and to which no MCTs was added. Fat and nitrogen balance, energy 
substrnte utilization, and body composition were investigated and a slightly higher 
fat absorption and deposition were found in the infants fed the MCT -containing 
formula. It is known that a relatively high fecal excretion of fat correlates with the 
presence of increased amounts of minerals in the feces, in particular Ca [2]. Reports 
on the effect of MCT oil in preterm formula on mineral absorption are contradictory 
[3,4]. Therefore, we investigated the effects of the presence of MCTs in an infant 
formula on Ca, P and Mg balances and plasma levels of these minerals as well as 
those for AP, 1,25-(0H)2D and PTH. 
PATIENTS AND METHODS 
Subjects 
Twenty-eight patients were randomized before the introduction of oral feedings 
to receive either a preterm formula in which 40% of the fat consists of MCTs (MCT 
group, n = 15) or a formula with no MCTs added (LCT group, n = 13). 
Only infants with a birth weight of less than 1600 g, initially admitted to the 
neonatal intensive care unit of the Academic Hospital Rotterdam/Sophia Children's 
Hospital, were included in the study. Infants were only eligible for inclusion if they 
were free from major metabolic problems or congenital malformations and if they 
were clinically stable breathing room air at the introduction of oral feedings. All 
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infants received routine total parenteral nutrition during their first postnatal week, 
containing 40 mg of Ca and 20 mg of P/kg/day. This protocol has been shown to be 
an important tool in the prevention of necrotizing enterocolitis [5]. 
At day 7, enteral feedings were gradually introduced by continuous nasogastric 
gavage feeding until a full intake of 150 ml/kg/day was reached at days 16-19. The 
macronutrient composition of the formulas is described in table 1. The composition 
of the fat blend has been described in more detail earlier [1]. Both formulas were 
especially manufactured by Nutricia (Zoetermeer, The Netherlands) with a 
completely equal composition, except for their fat blend. One and the same batch 
from each formula was used during the study. 
Table 1 
Composition of the two formulas (per 100 ml) 
MCT LCT 
Energy content (kcal) 80 80 
Carbohydrates (g) 8 8 
- lactose/maltodextrins 50150 50150 
Protein (g) 2.2 2.2 
- casein/whey 40/60 40/60 
Fat (g) 4.5 4.5 
-% MCFA 38% 6% 
Calcium (mg) 
Freshly prepared 100 100 
Formula administered 80 79 
Phosphate (mg) 
Freshly prepared 51 52 
Formula administered 43 44 
Magnesium (mg) 
Freshly prepared 9 9 
Formula administered 9 9 
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Feedings were prepared daily by adding demineralized water to the powdered 
formula. After arrival on the ward, 2-hr dosages were aspirated into syringes and 
stored in a refrigerator until feeding. The syringes were emptied at 10-15 minutes 
intervals over the two hours. Each infant received supplemental vitamin D up to a 
total of 600 IU/day. No infant was withdrawn from the study once the test feedings 
were introduced. 
A 72 hr balance period was performed at least 3 days after the infant had 
received full oral feedings, and a second balance study was performed another 3-5 
days later. Blood samples were obtained by venipuncture during the balance periods 
for determination of Ca, P, Mg, i'J?, 1,25-(0H)zD, and PTH. 
To determine the intake of minerals, samples were taken from freshly prepared 
formula, from the bottles before aspiration into syringes and from simulated 
nasogastric tube feeding. The routine nursery preparation of the formula resulted in 
some sedimentation of Ca and P due to delay in aspiration into syringes and lack of 
shaking. As tests of the resulting concentrations of minerals proved to be 
reproducible, and concentrations were equally lowered in both study groups, no 
attempts were made to alter this feeding routine during the study. The resulting Ca 
and P concentrations are described in table 1. No significant further loss occurred 
with the administration of the feeding through the nasogastric tube. 
For each patient, an individual standard deviation score (SDS) of weight at birth 
for gestational age was determined, as described before [1]. Mean birth weight, 
gestational age, SDS and study weight of the patient groups are described in table 2. 
Infants were only included after obtaining informed consent from at least one of the 
parents. The study protocol was approved by the medical ethical committee of the 
hospital. 
Table 2 
Characteristics of the two groups studied 
Birth weight Gestational age SDS Study weight Study day 
(grams) (weeks) (grams) (days) 
MCT (n = 15) 1129 ± 219 31 ± 1.9 -2.1 ± 1.9 1488 ± 270 26 ± 5 
LCT (n = 13) 1290 ± 173 32 ± 1.7 -1.8 ± 1.5 1639 ± 211 28 ± 5 
Results presented as mean ± 1 SD, with non of the differences significant 
Methods 
Balance study 
Urine and stools were collected separately and stored at -20°C until assayed. 
All glassware was acid soaked for at least 24 hrs and rinsed six times with 
demineralized water (Milli-Q system/Millipore). The total amount of feces collected 
during the three day balance period was weighed, homogenized and a small sample 
of the homogenate was freeze-dried. An aliquot was destroyed by heating for three 
hrs at 300°C in 5 ml of a concentrated HNO:Jiconcentrated H2S04 mixture (2: 1). Ca 
and Mg were measured with an atomic absorption spectrophotometer (Perkin-Elmer 
2380). The total urine volume was measured and urinary Ca and Mg were also 
measured by atomic absorption spectrophotometry. Phosphate was measured by a 
colorimetric method [6]. In all cases, matrix effects were eliminated by means of the 
standard addition method. Urine and feces nitrogen concentrations of freeze-dried 
aliquots of a pooled sample were determined by combustion in an automatic nitrogen 
analyzer (ANA 1400, Carlo Erba, Italy). 
Fat excretion was determined using a modification of the Jeejeebhoy method [7], 
with twice as much hydrochloric acid added. 
Blood samples were collected in heparinized tubes. After separation, plasma 
samples were stored at -80°C until assayed. Plasma Ca and AP were determined 
using commercially available analysis kits (Hoffman-La Roche, France and 
Boehringer, Germany respectively). Plasma inorganic phosphate was determined by 
the same method as described for urine. Plasma PTH(l-84) was determined with the 
PTH-kit of Medgenix Diagnostics SA (Belgium). Intra- and interassay variation was 
2.4 and 6.8%, respectively (n = 20). 1,25-(0H)2D was determined with a 
commercial kit (Incstar, Minn, USA), with extraction over a Sep-pak C18- cartridge 
(Waters, Millipore corp., Mass, USA). Intra- and interassay variation in 12 samples 
was 6.4 and 4.7% respectively. PTH and 1,25-(0HhD assays were performed at the 
laboratory of Dr. W.H.L. Hackeng (Rotterdam, The Netherlands). 
Statistics 
Data are presented as mean ± I SD. ln case of apparent nonnormality, data are 
presented as the median with interquartile range (25-75%) in parentheses. 
Differences between the MCT and the LCT groups were tested using the Mann-
Whitney U test. Correlations given were calculated by simple linear regression 
analysis and confirmed with the non-pa.rametric rank correlation test of Spearman. 
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To separate the effects of fecal weight and fecal fat on fecal mineral excretion, 
multiple linear regression analysis was performed. A value of p < 0.05 was 
considered statistically significant. 
RESULTS 
There were no significant differences in mean birth weight, gestational age, 
SDS, study weight and average day of the balance periods between the two groups, 
as is shown in table 2. 
As no trend was detected in the results of the first and the second balance 
period, the two values were averaged for each patient. All results presented here 
were calculated from these averaged values. 
Results of the mineral balance studies are presented in table 3. In both groups 
the mean intake volume (expressed as mllkg/day) was identical and because the 
mineral concentrations in the two formulas were also identical, the intake of 
minerals in both study groups was highly comparable. As the fecal losses of Ca 
were significantly higher in the LCT group, and the urioary losses were very small 
in both groups, the absorption and retention of Ca was significantly lower in the 
LCT group. 
P losses in stools and hence the absorption percentages of P were the same in 
both groups. However, due to a significantly higher urioary phosphate excretion in 
the LCT group, the retention and percentage retention of phosphate was lower in the 
LCT group. 
The Mg balances followed the same pal:'cern as the Ca balance, showing a 
significantly higher fecal loss in the LCT group and hence a lower percent 
absorption. Also, urinary excretion was not different and retention of Mg was 
significantly higher in the MCT group. All correlations that will be presented are 
calculated using data from both feeding groups. There was a significant correlation 
between urioary Ca and Mg excretion (r = 0.69, p < 0.0001; fig. 1). 
As reported earlier, fat absorption was significantly higher in the MCT group 
(88 % vs. 79% in the LCT group, p < 0.02), but the median nitrogen retention was 
equal in both groups (386 and 380 mg/kg/day) [1]. 
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Table 3 
Results of calcium~ phosphate, and magnesium balances in the two study groups 
MCT LCT p 
(n- 15) (n-13) 
Intake (ml/kg/day) 150 ± 5 150 ± 4 NS 
Calcium (mg/kg/day) 
Intake 121 ± 4 119 ± 4 NS 
Stools 33 (29- 43) 49 (43 -58) <0.02 
Urine 1.6 (0.65 - 2.4) 0.92 (0.43 - 1.31) NS 
% Absorption 73 (64- 76) 60 (51 - 63) <0.005 
Retention 86 (77- 89) 70 (59 - 75) <0.005 
%Retention 71 (64- 74) 59 (SO- 63) <0.005 
Phosphate (mg/kg/day) 
Intake 64 ± 3 65 ± 3 NS 
Stools 5.4 (3.8- 6.3) 5.4 (4.3 - 6.6) NS 
Urine 3.9 (0.85 -7.1) 12 (9.0- 15) <0.001 
% Absorption 92 (90- 94) 92 (90- 93) NS 
Retention 54 (51 -59) 48 (46- SO) <0.002 
% Retention 85 (79- 92) 73 (10- 77) <0.001 
Magnesium (mg/kg/day) 
Intake 13 ± 1 13 ±I NS 
Stools 2.9 (2.5 - 3.9) 4.0 (3.2- 4.8) <0.05 
Urine 0.37 (0.20 - 0.69) 0.32 (0.11 - 0.53) NS 
% Absorption 78 (71 - 82) 69 (63 - 76) <0.02 
Retention 10 (9.0- 10) 8.7 (7.6- 9.5) <0.005 
% Retention 75 (67- 77) 68 (59- 74) <0.05 
Results presented as mean ± 1 SD, or median with interquartile range in the case of 
apparent nonnormality. NS, not significant. 
The fecal excretion of Ca was correlated with the excretion of fat (fig. 2). In a 
multiple regression model, fecal fat alone was the best independent variable 
(compared to fecal weight alone, or a combination with fecal weight) for fecal Ca (r 
= 0.69, p < 0.00005). The same goes for fecal Mg (r = 0.68, p < 0.0001) but 
not for fecal phosphate or nitrogen excretion. 
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The plasma levels of Ca and phosphate at the time of the study (table 4) were 
well within normal ranges and not different between the groups. AP was not 
significantly different between groups and at the upper part of the normal range for 
neonates (80-280 IU/1). 1,25-(0HhD was also not significantly different between 
groups; both groups showed levels above our adult reference range (36-118 pmoi/L). 
PTII levels in the LCT group were higher (p < 0.01) than in the MCT group, and 
also higher than the adult reference range (0.3-4.0 pmoVI). PTII was significantly 
correlated with urinary P excretion (fig. 3). However, no correlation was found 
between Ca levels and PTH levels. A weak but significant correlation was found 
between the Ca/P ratio (weight/weight) after absorption (amount of Ca absorbed/ 
amount of P absorbed) and the urinary phosphate excretion (r = 0.43, p < 0.05; 
fig. 4). Due to this excretion of phosphate, the Ca/P ratio (median and interquartile 
range) of the retained minerals (amount of Ca retained/amount of P retained) became 
1.4 (1.2-1.5) in the LCT group whereas the Ca/P ratio of the absorbed minerals in 
that group was 1.1 (1.0-1.3). In the MCT group, the ratio of the absorbed minerals 
was 1.5 (1.3-1.6) a:td the ratio of the retained minerals was 1.6 (1.4-1.7). This 
phenomenon is depicted graphically in f".g. 5, combined with the data about mineral 
concentrations that were also used for table 1. 
Table 4 
Plasma values during the study period in the two study groups 
Calcium (mmol/1) 
Phosphate (mmol/1) 
Magnesium (mmolll) 
Alkaline phosphatase (!U/1) 
1,25-(0HhD (pmol/1) 
Parathyroid hormone (pmol/l) 
MCT 
(n= 15) 
2.4 ± 0.12 
2.2 ± 0.29 
0.89 ± 0.12 
256 (218- 321) 
216 (173 - 249) 
2.1 (1.1- 5) 
LCT 
(n= 13) 
2.4 ± 0.081 
2.3 ± 0.21 
0.82 ± 0.06 
288 (270 - 327) 
233 (216- 293) 
4.7 (4.0- 6.7) 
p 
NS 
NS 
NS 
NS 
NS 
<0.01 
Results presented as mean ± 1 SD, or median with interquartile range in the case of 
apparent nonnormality. NS. not significant. 
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Fig. 3 
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DISCUSSION 
This study confirms an earlier report of increased Ca and Mg absorption with. 
MCT-containing preterm formula [3]. The difference in Ca and Mg absorption was 
much less compared with this earlier study, probably because fat absorption differed 
more in that study group [8]. We also could confirm the existence of a correlation 
berween fecal fat excretion and Ca excretion [2]. The absolute retention of Ca and P 
was below the intrauterine accretion rate, although the intakes of Ca and P were 
within the recommended range [9]. 
Administering a mineral supply large enough so that intrauterine accretion rates 
can really be achieved is quite difficult. Several studies showed that larger Ca and 
phosphate intakes can be achieved by experimental formulas [10,11] or by separate 
supplementation of Ca salts [12]. Reports of a formula with a high Ca content [4, 13] 
that is in stable solution have recently been questioned [14]. 
Even so, the fact remains that overt bone disease can probably be prevented by 
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relatively low amounts of supplementation [11], as is also shown in our results with 
AP levels t.1at are only marginally higher than values of term neonates. The fact that 
1,25-(0HhD levels are above the adult range, might indicate that there is still a 
need for more Ca and P in both study groups. On the other hand, the European 
Society of Paediatric Gastroenterology & Nutrition (ESPGAN) has recently 
recommended not to exceed a level of intake of 140 mg Ca/100 kcal, considering the 
possible complications of very high Ca intakes and the lack of evidence that such 
high concentrations are beneficial [9]. Further study is needed to define mineral 
needs by measuring resulting bone mineralization in vivo and combining this with 
accurately performed balance studies. 
This study clearly shows that with LCT fat, Ca absorption is impaired whereas 
P absorption is not. The Ca/P ratio of 2:1 in the formulas was lowered to about 
1.8: I in the formulas because of sedimentation of preferentially Cain both formulas. 
More importantly, the Ca/P ratio was significar1tly lower in the infants fed LCT 
after absorption than in the MCT group (fig. 5). Our results indicate that LCT-fed 
infants probably have a relatively low Ca/P ratio after absorption, which is then 
increased by increasing P excretion in the urine, mediated by an increased PTH 
level. The resulting ratio of the retained minerals is not significantly different any 
longer between groups. If we assume that the mechanism of adjusting the P 
excretion in urine in order to retain the correct ·ratio of minerals is indeed mature in 
these infants, then the fact that MCT-fed infants raised their Ca/P ratio of 1.5:1 after 
absorption only to 1.6:1, without showing large excretion in the urine of one of the 
two minerals, might indicate that t!tis level is close to the ideal situation. This would 
be in agreement with a reported ratio for Ca and P accretion of 1.6: I during a 
postconceptional age of 35-36 weeks [15]. It also means that if formulas are 
designed with LCT fat (or with a high Ca content, most often also causing a relative 
decrease in Ca absorption), Ca/P ratios might be needed that are above the 
recommended maximum ratio of 2:1 [9,16]. Several experimental formulas with a 
Ca/P ratio higher than 2:1 have been used before [10,17], although no fat balances 
were reported. Taking into account the absorption rates of Ca and P for the LCT 
formula, we can estimate that the ratio for Ca and P upon dietary intake should be 
around 2.3:1to obtain an absorption at a 1.6:1 ratio, or even 2.5:1 if there would be 
a relatively higher sedimentation rate of Ca, like in our study. However, because the 
fat balance might worsen if too much Ca is added and also because some infants 
have high Ca absorption rates and also need sufficient P, it seems prudent at the 
moment to try to improve the solubility of calcium salts in premature formula first. 
The amount of Mg in both formulas was slightly above the recommended intake 
[16] and retention rate appeared to be higher than the intrauterine retention in both 
groups. The intake of Mg from most standard formulas ranges from 12-30 
mg/kg/day and may be as much as threefold greater than the highest suggested daily 
intake [16]. As Mg levels in plasma were within the normal range, the significance 
of this remains to be established. 
In conclusion, the most important difference between formulas designed for 
feeding preterm infants containing only LCT fat blends or containing 60% LCT/ 
40% MCT blends is the slightly lower Ca absorption rate with the LCT formula. 
This causes a Ca/P imbalance, inducing a compensating increased urinary excretion 
of P. Although a Ca!P ratio slightly above 2: I might be needed in LCT -containing 
preterm formulas, it seems prudent to first investigate whether the Ca source can be 
improved in LCT formulas. 
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CHAPTER IV 
QUANTITATION OF OXIDATION OF MEDIUM-CHAIN 
TIUGLYCERIDES IN PRETERM INFANTS. 
E.J. Sulkers, H.N. Lafeber, P.J.J. Sauer. 
Department of Pediatrics, Sophia Children's Hospital and University 
Hospital Dijkzigt I Erasmus University Rotterdam, Rotterdam, The 
Netherlands. 
SUMMARY 
Medium-chain triglycerides (MCTs), with a chain-length of eight and ten carbon 
atoms form up to 50% of the total fat content in some preterm infant formulas. In 
20 small preterm infants (birth weight: 1153 ± 227 g; mean ± S.D.) fed a special 
formula containing 40% MCTs, a primed constant oral infusion study of [l-13C]-
potassium octanoate was conducted to quantify the oxidation of MCTs. A plateau in 
13C en..richment in breath C02 was reached in all patients within 1·3 hrs. 
Simultaneously, substrate utilization was measured using a closed system indirect 
calorimeter. No significant difference was found between appropriate for gestational 
age (AGA, n = 8) and small for gestational age (SGA, n = 12) infants in the 
percentage of the administered tracer that was oxidized (44.9 ± 9.1% vs. 48.5 ± 
11.0%). In all patients, the recovery was calculated to be 47.1 ± 10.2%, which is 
less than previously estimated and corresponds to a mean MCT oxidation of 1.26 ± 
0.27 g/kg/day. With indirect calorimetry, a total fat oxidation of 1.42 ± 0.84 
g/kg/day in AGA and 2.00 ± 0.85 g/kg/day in SGA infants was found, indicating 
that MCTs accounted for around 85% of the total fat oxidation in AGA versus 65% 
in SGA infants. 
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INTRODUCTION 
The optimal composJ!J.On of the oral feeding solution for a preterm infant 
remains a matter of debate. Milk from mothers who delivered preterm, although 
containing more protein and minerals than milk from mothers who delivered at term, 
may not be sufficient to prevent deficiencies or to produce weight galn equivalent to 
the intrauterine growth curve [1,2]. 
The various formulas specially designed for preterm infants differ considerably, 
reflecting unanswered questions regarding the optimal composition of such formulas. 
Some preterm infant formulas contain up to 50% of the fat as MCTs, intended 
·to enhance fat absorption and to provide a readily available energy source. Improved 
weight gain and retention of fat, protein, and calcium have been described with 
MCT-contalning formulas [3,4]. No reliable data exist regarding the percentage of 
orally admi.'listered MCTs that is oxidized by the preterm infant. The objectives of 
this study were to quantify octanoic acid oxidation as an indication of MCT 
oxidation and to measure utilization of other substrates in pretenn infants receiving a 
formula contalning 40% of fat as MCTs. 
MATERIALS AND METHODS 
Subjects 
Infants with a birth weight of less than 1600 g were included in the study after 
they were on full oral feedings, gaining weight, and clinically stable breathing room 
alr. Twenty patients entered the study, eight patients appropriate for gestational age 
(AGA), group I, and twelve patients small for gestational age (SGA), group II. 
AGA was defined as a birth weight within 2 SD of the mean for gestation, 
according to the growth curves of Usher and McLean [5]. SGA was defined as a 
birth weight more than 2 SD below the mean. Gestational age was determined by 
medical history and Ballard score [6]. All infants were initially admitted to the 
neonatal intensive care unit of the Academic Hospital Rotterdam/Sophia Children's 
Hospital, five in group 1 and six in group II had been ventilated for the respiratory 
distress syndrome in the neonatal period. Mean body weight, gestational age and age 
at the time of study are shown in table 1. 
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Table 1 
Clinical parameters of infant groups studied 
Birth weight Gestational age Age when Weight when 
(g) (wk) studied (d) studied (g) 
Total (n = 20) 1153 ± 227 31.0 ± 1.7 28 ± 6 1508 ± 313 
AGA (n = 8) 1362 ± 170 30.3 ± 1.7 28 ± 7 1761 ± 243 
SGA (n = 12) 1014 ± 134 31.4 ± 1.6 28 ± 6 1340 ± 233 
p < 0.001 NS NS p < 0.005 
Values expressed as mean ± 1 SD 
Methods 
Feeding regimen 
All infants received a formula feeding (Nenatal, Nutricia, Zoetermeer, The 
Netherlands) in which 40% of the fat is provided as l>ICTs, from the day oral 
feedings were started, usually at day 7. The composition of the formula is given in 
table 2. In our ward very-low-birth weight (VLBW) infants routinely are fed by 
continuous nasogastric gavage. Infants were studied at least three days after they had 
reached the maximum intake of 150 mllkgiday of the formula. During the studies, 
the gavage feeding was administered using a syringe pump (Perfusor Secura Fr, 
Braun, Melsungen, FRG). 
Study procedure 
The study protocol was approved by the Human Subject Review Committee of 
the Academic Hospital Rotterdam and Erasmus University. Written informed consent 
was obtained from the parents. 
The study design was as follows. In the 4th postnatal week urine was collected for 
72 hrs. In the middle of this collection period, indirect calorimetry was performed 
for a 6- to 8-hr period. During indirect calorimetry, a primed constant infusion of 
[l-13C]-potassium octanoate was given. 
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Table 2 
Composition Nenatal 07 (Nutricia, The Netherlands) per 100 ml* 
Energy 
Protein 
Carbohydratt:S 
Lactose 
Fat 
Dextrine maltose 
MCT 
C8:0 
CIO:O 
LCT 
CJ6:0 
CJ8:0 
Cl8:1 
Cl8:2 
Sodium 
Potassium 
Calcium 
Phosphorus 
*Composition before September 1988. 
Indirect calorimetry 
80 kcal 
2.2 g 
8.0 g 
4.0 g 
4.0 g 
4.5 g 
l.lg 
0.7 g 
0.3 g 
0.1 g 
0.9 g 
1.4 g 
23 mg 
60 mg 
100 mg 
50 mg 
Metabolic rate and substrate utilization were measured by a closed circuit 
indirect calorimeter. Continuous measurements were performed for 6-8 hrs, as 
previously described [7]. Briefly, an air mixture devoid of carbon dioxide enters the 
incubator. In a sample of the air leaving the incubator the C02 concentration is 
measured, whereafter all carbon dioxide is filtered out by a soda-lime filter. The 
C02 is injected again into the airflow by a mass flow injector system until the same 
concentration of C02 is measured by the infrared meter (Unor 6N, Maihak, 
Hamburg, FRG). The amount of carbon dioxide injected into the system equals the 
carbon dioxide production of the infant. Thereafter all COz is filtered by a second 
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filter. The amount of oxygen consumed by the infant is equal to the amount of 
oxygen that has to be injected into the system to keep the oxygen tension constant, 
as measured by polarographic oxygen cells (type 6223771 Beckman, Fullerton, Ca., 
USA) in the system and in a reference vessel. To compensate for changes in air-
pressure, the reference vessel is connected to the flow circuit by means of a 
capillary. Oxygen consumption and caroon dioxide production are measured with an 
accuracy of 0.2 ml/min, the RQ during calibration with butane was within 2% of the 
theoretical value. Urine was collected in plastic bags over a period of three days. 
Urinary nitrogen concentration of a pooled sample was determined by combustion in 
an automatic nitrogen analyzer (ANA 1400; Carlo Erba, Milano, Italy) by the 
Dumas procedure [8]. 
Measurement of ocumoate oxidation 
Octanoic acid oxidation was measured using [I-13C]-potassium octanoate. The 
labeled octanoic acid (99% purity,. Sigma Chemical Co., St. Louis, USA) was 
converted into its potassium salt by means of titration with KOH in our laboratory 
and diluted in sterile water. To determine the natural background of 13C, three 
baseline breath samples were collected during 15 minutes each before starting the 
isotope infusion. The bicarbonate pool was then primed with 6.9 l'mol.kg-1 of a 6.9 
mmol/1 solution of NaH13C03 (80% purity, Merck Isotopes, Montreal, Canada) as 
previously described [9]. At the same time, a [l-13C]-octanoate priming dose of 2 
mg/kg was given, followed by a constant infusion of 2 mg/kg/br for 6-8 brs. All 
isotopes were administered through a separate nasogastric tube. The delivery rate of 
the pump during the study was measured by dividing the difference in weight of the. 
syringe before and after the experiment by the duration of the experiment to 
determine the actual quantity of [I -13C]-octanoate administered. Once the isotope 
infusion was started, 15 minutes C02 breath collections were made every hour for 4 
hours, and every 30 minutes for 2-4 more hours. Breath C02 was collected by 
passing a sample of the air leaving the incubator through an all glass spiral conden-
ser, containing 10 ml of a fresh I mol/! NaOH solution. Samples were transferred to 
Vacutainers and stored at -20'C until analysis. Trapping of C02 was shown to be 
complete during 15 minutes at a flow of approximately 10 ml/min and hence isotopic 
fractionation was prevented. In a study conducted without the administration of 
isotopes, a shift in natural background over time was ruled out, as could be expected 
during a continuous feeding regime. 
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Isotopic Ratio Mass Spectrometric Analysis 
Respiratory carbon dioxide was liberated at < 10·3 torr by adding 85% 
phosphoric acid to the NaHC03 solution. Pure C02 was collected in a small glass 
container in liquid nitrogen whereas the water is trapped in a methanol dry ice bath. 
The glass oontainer with pure C02 was connected to a VG Sira 10 isotope ratio 
mass spectrometer (Vacuum Generators, Winsford, Cheshire, UK). Results of 13c 
abundance of both baseline and plateau were calculated as APE/reference C02 tank 
standard sample. Isotopic plateau was defined by eyeballing as the absence of a 
change in abundance with time. 
Calculations 
The percentage of 13C02 recovery was calculated as follows: 
1) 13C02 production (.umol/kg!hr) = 
VC02 x 60 H 100 
22_4 X 100 X C X 1000 
VC02 = carbon dioxide production (STPD) in ml/kg!min; H = plateau height 
13C02 above baseline in APE; C = oorrection factor for 13co2 retention in the 
bicarbonate pool, calculated from the energy intake of the infant [9]. 
2) 13c administered (.umol/kg!hr) = [l-13C]-octanoate (.umol!kg/hr) x 0.99 
0.99 =purity of [l-13C]-octanoate 
3) 13c recovery = 13 C02 production -..,.,--__::_:~----- X 100% 
13 C02 administered 
4) The percentage 13C recovery was considered to be equal to the percentage of the 
tracer that was oxidized. 
5) Nonprotein V02 and nonprotein VC02 were derived from V02 and VC02 
by oorrecting the values for the protein oxidation, calculated as 6.25 x the 
timed urinary nitrogen-excretion. 
6. Metabolic rate and partition of the nonprotein macronutrients were calculated 
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from nonprotein RQ and nonprotein V02 using the tables of Lusk [10]. 
7. Statistical analysis of the differences between the results of the two groups 
was conducted using the N!ann-Whitney U test. 
RESULTS 
The energy and substrate intake of the infants is shown in table 3. There were 
no differences in inta.'<e between SGA and AGA infants. The results of indirect 
calorimetry are shown in table 4. The metabolic rate was significantly higher in the 
SGA infants (p < 0.005) per kilogram bodyweight, as described earlier [11], 
probably due to a higher fat oxidation (2.00 ± 0.85 versus 1.42 ± 0.84 g/kg/day), 
although the difference in fat oxidation did not reach statistical significance. 
The production of 13C02 in breath rose in the first hour in all patients and a plateau 
was reached in all patients within 1-3 hrs. An example of a characteristic study is 
shown in figure 1. The results of the isotopic studies are shown in table 5. These 
results show a 13co2 reoovery for AGA and SGA infants of 44.9% and 48.5% 
respectively. The difference between the tv.ro groups is not significant, and the mean 
13C02 recovery of the labeled octanoate in all patients is 47% with a SD of 10% 
and a range of 32 to 64%. 
Table 3 
Substrate and total caloric intake of infant groups 
Intake Total fat intake MCT intake Glucose intake 
(kcal/kg/day) (g/kg/day) (g/kg/day) (g/kg/day) 
Total (n = 20) 120 ± 4 6.71 ± 0.20 2.69 ± 0.08 11.23 ± 0.41 
AGA (n = 8) 119 ± 2 6.71 ± 0.10 2.68 ± 0.04 11.19 ± 0.16 
SGA (n = 12) 120 ± 5 6.73 ± 0.26 2.73 ± 0.10 11.26 ± 0.52 
NS NS NS NS 
Values expressed as mean ± 1 SD 
66'--------------------------------------------~C~~~~E~R~.~4 
Fig. l. 
0.05 
0.04 
~ 0.03 
oi 
o; 
< 0.02 
0.01 
«E--- 1-UCOCTANOATEORAL-------.;. 
•• • 
• • • 
• • • 
CD O 0 0 
• 
0.00 '---'----'-----"------'~--'--~---"--~-----' 
-1 0 2 3 4 5 6 7 8 
Time (hours) 
Time course of 13CO'J enrichment in breath after a primed constant oral infusion of 
[l-13C]-octanoate in ;ne patient. Three baseline breath samples were taken before the 
isotope administration. 
Table 4 
Results of indirect calorimetric measurements 
Total (n = 20) AGA (n = 8) SGA (n = 12) p 
vo2 (mlikg/min) 8.34 ± 0.64 7.90 ± 0.35 8.63 ± 0.63 <0.01 
vco2 (mllkgimin) 7.58 ± 0.58 7.23 ± 0.38 7.81 ± 0.58 NS 
RQ 0.91 ± 0.03 0.92 ± 0.03 0.91 ± 0.03 NS 
Metabolic rate 61.7 ± 4.5 58.4 ± 2.4 63.6 ± 4.5 <0.005 
(kcal/kg/day) 
Fat utilization 1.77 ± 0.87 1.42 ± 0.84 2.00 ± 0.85 NS 
(g/kg/day) 
Glucose utilization 10.77 ± 1.91 10.77 ± 1.95 10.77 ± 1.97 NS 
(g/kg/day) 
Values expressed as mean ± 1 SD 
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Table 5 
Results of stable isotopic measurements 
Recovery MCT oxidation 
(%) (g/kg/day) 
Total (n = 20) 47.1 ± 10.2 1.26 ± 0.27 
AGA (n = 8) 44.9 ± 9.1 1.20 ± 0.24 
SGA (n = 12) 48.5 ± 11.0 1.30 ± 0.29 
NS NS 
Values expressed as mean ± 1 SD 
DISCUSSION 
Premature infants have a relative deficiency of pancreatic lipase and bile salts, 
causing loss of part of the administered lipids in the feces [12,13]. Orally 
administered ~CTs are absorbed mainly as free fatty acids, because their intralumi-
nal hydrolysis is rapid and almost complete. Recently it was shown that marked 
hydrolysis occurs in the stomach of the preterm neonate [14]. ~CTs can also be 
absorbed in part as triglycerides [15]. ln most cases a total of more than 99 % are 
absorbed [3,16,17]. If absorption as a triglyceride takes place, hydrolysis by an. 
intestinal lipase will follow within the enterocyte [15]. 
Unlike long-chain triglycerides (LCTs), the medium-chain fatty acids ~CFAs) 
derived from ~CTs are not reesterified, so all ~CTs will leave the intestinal cells 
as ~CFAs and reach the liver via the portal vein as free fatty acids in solution in 
the plasma or bound to albumin [18]. 
To study the metabolism of ~CTs, sodium-13C-octanoate has been used as a 
tracer in adults [19]. Octanoate can be regarded as a tracer representative of triocta-
noin metabolism, considering the fact that both the free fatty acid and triglyceride 
with a chain length of eight carbons will enter at one stage the free fatty acid pool in 
the intestinal cells. 
~CTs have been included in preterm infant formulas because of their high rate 
of absorption. They are also referred to as a readily available source of energy, 
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implying a rapid and almost complete oxidation of MCTs [15,20,21]. Even the 
existence of an obligatory oxidation of MCFAs with increased heat production has 
been suggested [22,23]. In this study, we found that in both AGA and SGA infants 
an average of no more than 47% of the administered octanoate was oxidized, with a 
range of 32 to 64% . 
In a study using the bolus technique and 13C labeled trioctanoin as a tracer in a 
small number of preterm infants, a cumulative oxidation of 27% of the tracer was 
found [24]. Recent studies showed that MCTs might have a tendency to adhere to 
the feeding tube, due to its hydrophobic properties [25]. If part of the trioctanoin 
used as a tracer adheres to tubing during the experiment, this can give falsely low 
results on recovery of the tracer. By using the water-soluble potassium salt of 
octanoic acid we minimized the risk that tracer would adhere to the tubing. This 
might explain the fact that we found a higher oxidation rate, although the bolus 
technique is not fully comparable to the constant infusion technique. When 
discussing the physiological significance of our findings we will have to consider the 
further steps in the metabolic pathways followed by MCTs. 
In the liver, MCFAs readily cross the membrane into the mitochondria, where 
they are activated and broken down into acety1-CoA. This acetyi-CoA can enter the 
tricarboxylic acid cycle and, under the conditions of our study, will be detected as 
labeled C02 after oxidation. When there is excess acetyl CoA, a major pathway is 
formation of ketone bodies; in fact, MCFAs are known to be ketogenic [26]. 
Feeding of a MCT-containing formula for four days promotes a mild ketosis in 
preterm infants [27]. These ketone bodies will be quickly utilized peripherally, 
especially after a period of adaptation [28]. Because the conversion to ketones is a 
rapid process [29] most of the excreted 13C02 due to the oxidation of ketone bodies 
derived from MCTs will also contribute to the 13C enrichment in expired air, thus 
being included in our calculation. 
One of the conditions that have to be fulfilled to make this assumption is that 
the pool of ketones remains constant, which means that the concentration of ketone 
bodies in the plasma should not change during the experiment. We think this was the 
case during these studies, because these infants were on the same intake of the MCT 
formula for at least three days before starting the study, and were in a clinical stable 
condition. Hence, there is no reason to assume that in the groups studied an increase 
in the ketone body pool during the experiment could have been responsible for 
retention of the label. 
We conclude that both ways of immediate oxidative disposal of MCFAs, 
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entering the Krebs cycle directly or via the fonnation of ketone bodies, are included 
in the values for oxidation of MCTs we found in this study. Following this line of 
reasoning, about half of the MCTs in this feeding regimen follows other pathways 
than oxidation. Urinary loss of dicarboxylic acids that can exist during MCT feeding 
probably accounts for less than 1% of the dietary intake of l>!CTs in preterm infants 
[30]. 
Furthermore, MCFAs are not to a significant amount activated by coenzyme A 
in the extramitochondrial space to participate directly in triglyceride and 
phospholipid synthesis [31]. Accordingly storage of octanoate as a triglyceride in 
adipose tissue does not seem to be of great importance [32-34]. Apparently, l>!CFAs 
have to be converted into long-chain fatty acids (LCF As) before they can be stored 
as LCTs in the body fat tissue. Probably the most important route quantitatively for 
this is the breakdown of MCTs into acetyi-CoA, whereafter LCTs are fanned 
through de novo lipogenesis [35]. 
The relatively low oxidation rate we found is consistent with the findings that 
breakdown of MCFAs and lipogenesis occur sequentially during !>!CT feeding [36]. 
The oxidation rates we found might indicate that in these patients lipogenesis is an 
important pathway for MCTs, whereas fitting less well with the assumption of an 
obligatory oxidation as a cause of the enhanced thermogenesis that is sometimes 
encountered on a MCT diet [22,23]. If we assume a mean absorption of 85% of the 
LCTs in these patients [16,17], MCTs would account for around 45% of the 
absorbed fatty acids. Combining the mean value for total fat oxidation we obtained 
by indirect calorimetry with results from the isotopic studies, we find that oxidation 
of MCTs accounts for 65% of the fat oxidation in SGA and 85% in AGA infants .. 
Apparently there is a preferential oxidation of MCTs, but whether this aspect of 
MCT metabolism is advantageous remains to be proven. 
Remarkably, although SGA infants have a significantly higher metabolic rate, 
we found no increase in the MCT oxidation suggesting there might be a limit to the 
amount of MCTs that can be completely oxidized by the small pretenn infant. 
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CHAIN TRIGLYCERIDE§. 
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SUMMARY 
Several formulas for preterm infants contain medium-chain triglycerides (MCTs) 
to enhance fat absorption. Although fat absorption with MCTs was slightly higher io 
several studies in preterm iofants, a beneficial effect on growth has only been 
reported in one publication. We hypothesized that when part of the fat blend of 
preterm formula is substituted by MCT oil, this might lead to a different metabolic 
pattern io which, due to the preferential oxidation of MCTs, an increase in · 
lipogenesis from glucose could lead to an increase in metabolic rate. To study the 
impact of MCTs on glucose metabolism, 18 preterm infants were randomized to 
receive either a MCT or a long-chain triglyceride (LCT) formula, containing 38- and 
6%-by-weight medium-chain fatty acids (MCFAs), respectively, in their fat blend. 
At 4 weeks of age, the metabolic rate, substrate utilization, glucose kinetics, and 
oxidation were measured by indirect respiratory calorimetry in combioation with a 
constant-rate oral infusion of [U-13C]-glucose. The "true" rate of appearance of 
glucose (Ra "true") was measured from the dilution of the uniformly labelled (m+6) 
species of infused tracer whereas "apparent" rate of appearance of glucose (Ra 
"apparent") was measured from the dilution of infused tracer C (carbon). The latter 
was measured by an on-line combustion method using a gas chromatograph-isotope 
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ratio mass spectrometer. At a carbohydrate intake of 8.4 mg/kg/min, total utilization 
of carbohydrate was equal in both groups at 7.6 mg/kg/min. However, glucose 
oxidation, as measured by the appearance of 13C in breath C02 was significantly 
lower in the MCT group (4.5 ± 0.83 vs. 5.7 ± 0.67 mg/kg/min, MCT vs. LCT). 
Therefore, it can be assumed that a larger proportion of the glucose intake in the 
MCT group was used in the nonoxidative pathway, e.g. synthesis of fat as compared 
with the LCT group. There was no difference in the rate of endogenous glucose 
production and glucose C recycling between the two groups. ln addition, the 
metabolic rate calculated from the rate of oxygen consumption was also similar (59 
± 5 vs. 62 ± 4 kcal/kg/d, MCT vs. LCT). We conclude that, in preterm infants fed 
·a formula containing 38% MCTs in their fat blend, glucose oxidation is significantly 
decreased whereas lipogenesis is probably increased. These findings may provide a 
mechanism for the so-called metabolic inefficiency of MCTs. 
INTRODUCTION 
Tne fat blend of several special formulas for preterm infants consists of 30% to 
50% medium-chain triglycerides (MCTs) to enhance fat absorption. In several 
studies in which MCT -containing fat blends were used in preterm infants, increased 
fat absorption without improved weight gain was reported [1-3]; thus, one might 
expect that infants fed a MCT -containing formula either have an increased energy 
expenditure or lay down relatively more fat per gram new tissue, resulting in a 
higher energy cost of growth. We hypothesized that an increased energy 
expenditure, which has been described before in animals and human adults during 
overfeeding with MCTs [4-7], explains the lack of increase in growth rate at the 
higher energy absorption in preterm infants fed MCT formulas. We furtber 
speculated that an increased metabolic rate might result from an increased 
lipogenesis with ongoing fat oxidation, as MCT feeding is known to be associated 
with increased lipogenesis. ln a previous study [8], using the same methods as in the 
present article, we showed a higher metabolic rate in parenterally fed infants 
receiving only glucose as their nonprotein energy source compared with infants 
receiving glucose and lipids. Moreover, we showed strong evidence that the higher 
metabolic rate was due to the conversion of glucose into fat, resulting in a lower 
food efficiency. To elucidate the mechanism of the apparently lower food efficiency 
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in MCT feeding, we compared the effects on glucose metabolism and metabolic rate 
in two groups of very low birth weight infants fed formulas with different MCT 
content. 
PATIENTS AND METHODS 
Subjects 
Eighteen infants with a birth weight of less than 1600 g were included in the 
study. Infants were eligible for inclusion if they were free from major metabolic 
problems and congenital malformations and if they were clinically stable and 
breathing room air at the introduction of oral feedings. At one week of age, after 
permission was obtained from the parents, the infants were randomly assigned to 
receive either a MCT or a LCT formula, with nine infants entering each group. 
Enteral feedings were gradually introduced from day 7 by continuous nasogastric 
tube feeding until a full intake of 150 rnllkg/day was reached. Both formulas were 
especially manufactured by Nutricia (Zoetermeer, The Netherlands) with a 
composition that was completely equal, except for their fat blend. The batch of 
MCT formula in this study contained 38% MCFAs, derived from MCT oil, and the 
batch of LCT formula 6% derived from coconut oil. Both provided 8 g 
carbohydrates (lactose/polycose 50/50), 2.2 g protein and 6.8 g fat/100 ml of 
prepared formula. Similar formulas are commercially available and recommended 
for preterm infants. One and the same batch from each formula was used during the 
study. The study was performed at least 3 days after the infant had received full oral 
feedings. The median day of study was 22 in the MCT and 24 in the LCT group; 
the total range was 19 to 37. Patient characteristics and average intakes are 
described in table 1. The study protocol was approved by the medical ethical 
committee of the Erasmus University Academic Hospital/Sophia Childrens Hospital, 
Rotterdam, The Netherlands. 
Methods 
Indirect calorimetry 
Metabolic rate and substrate utilization were measured in a closed-circuit 
indirect calorimeter. Continuous measurements were performed for 6 to 7 hrs, as 
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Table 1 
Patient characteristics 
MCT LCT 
Birth weight (leg) 1.2 ± 0.24 1.2 ± 0.16 
Gestational age (wks) 31 ± 1 32 ± 2 
Study weight (leg) 1.5 ± 0.27 1.6 ± 0.21 
Caloric intake (lccal/kg/d) 126 ± 3 126 ± 2 
Carbohydrate intake (mg/kg/min) 8.4 ± 0.21 8.4 ± 0.10 
Fat intake (mg/kg/min) 4.7 ± 0.12 4.7 ± 0.06 
Protein intake (mg/kg/min) 2.3 ± 0.06 2.3 ± 0.30 
Weight gain (g/kg/d) 16 ± 4 16 ± 3 
previously described in detail [9]. During the study period, feeding was continued by 
a syringe pump at the same rate as during the three days before the study day. Urine 
was collected in plastic bags over periods of three days. Urinary nitrogen concentra-
tion of a pooled sample was determined by combustion in an automatic nitrogen 
analyzer (ANA 1400 Carlo Erba, Milano, Italy). 
Glucose oxidation study 
During the calorimetry study, a stable isotope study was performed using 
uniformly labeled [U-13C]-glucose (Merck Isotopes, Montreal, Canada; 98.9% 13C) 
to quantitate the oxidation of glucose. 
To determine the natural background abundance of 13C in expiratory air, three 
baseline breath samples were collected during 10 minutes each before starting the 
isotope infusion. The bicarbonate pool was then primed with 6.9 l'moVkg of a 6.9 
mmoVl solution of NaH13C03 (80% purity, Merck Isotopes) and a [U-13C]-glucose 
priming dose of 2. 7 !'mol/kg was given, followed by a constant infusion of 2. 7 
l'mollkg/hr for 6 to 7 hrs. All isotopes were administered through a separate naso-
gastric tube. Once the isotope infusion was started, 10-min C02 breath collections 
were made every hour for 4 hours, and every 15 minutes for 2 to 3 more hours. 
Breath C02 was collected by passing a sample of the air leaving the calorimeter 
through an all-glass spiral condenser, containing 10 ml of a fresh 1 mol/1 NaOH 
solution. Samples were transferred to Vacutainers (Becton Dickinson, Etten-Leur, 
The Netherlands) and stored at -20°C until analysis. Trapping of C02 was shown to 
be complete for at least 15 minutes at the sample flow used. 
In a study conducted without the administration of isotopes, a shift in natural 
background over time was ruled out, as could be expected during a continuous 
feeding regime. 
Mass spectrometric analysis 
Breath C02: Respiratory C02 trapped in NaOH was liberated at < 10-3 torr by 
adding 85% phosphoric acid to the NaHC03 solution. C02 was collected by 
cryogenic distillation and analyzed on a VG S!RA 10 isotope ratio mass spec-
trometer (Vacuum Generators, Winsford, Cheshire, UK). Results of 13C abundance 
of both baseline and plateau were calculated as atom % excess (APE) relative to the 
reference C02 tank standard sample. Isotopic plateau during the final part of the 
study was confirmed by simple regression analysis on the last five data points. Fig. 
1 shows an example of the curves of enrichment obtained in expiratory C02. 
Blood glucose: Immediately before and after the study, blood was obtained by 
heel-stick from a warmed heeL After separation, plasma was stored at -80°C for 
analysis of the isotopic enrichment of plasma glucose: 1) in uniformly labeled 
species, i.e. (rn+6); and 2) for the overall enrichment of glucose C by combustion 
using a gas chromatograph-isotope ratio mass spectrometer (GC-IRMS). 
The (m+6) enrichment of glucose was measured by chentical ionization gas 
chromatography-mass spectrometry (GC-MS) of the aldononitrile-pentacetate 
derivative of plasma glucose with selective ion monitoring of m/z 328 and 334, as 
described before [11]. 
The 13C enrichment of glucose C was also measured with a new technique, the 
on-line combustion using a GC-IR.l\1S (Isochrom-ill, VG, Middlewich, Cheshire, 
UK) [12]. With this technique, the effluent of the GC, containing the same 
pentacetate derivative of plasma glucose, is combusted on-line in a catalytic furnace, 
and the resulting C02 is driven by a helium flow into the ion source of a standard 
IRMS after passing through a water trap. In this way, the tedious manual isolation of 
plasma glucose before combustion to C02 necessary for the determination of 13C 
enrichment of glucose as the precursor for glucose oxidation [13] is circumvented. 
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Fig. 1 
13CO., enrichment in expiratory air during a primed constant oral tracer infusion 
of [U)3c]-glucose in one infant. 
Calculations 
Metabolic rate was calculated using the approach of Lusk [10], assuming an RQ 
of 1.00 for glucose and 0. 72 for fat: 
np V02 = V02 - (N x 6.25 x 0.9963) (1) 
where npV02 = nonprotein 0 2 consumption in mllkg/min, V02 = total 0 2 
consumption in rnlfkg/min, N = urinary nitrogen in mg/kg/min, and 0.9663 = ml 
0 2 consumed/mg protein oxidized 
VC02 - (N x 6.25 x 0. 7739) 
npRQ = -:-. -=--------
V02 - (N X 6.25 X 0.9963) 
(2) 
where VC02 = C02 production in mllkg/min, and 0. 7739 = ml C02 producedlmg 
protein oxidized 
MR = 1.44 x [4.702 + npRQ - 0·72 x 0.345] x npV02 + en£rgy 0.28 (3) 
from protein oxidation 
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where MR = metabolic rate (kcal/kglday), 1.44 = conversion factor for ml/min to 
1/day, 4.702 = caloric equivalent of 1 1 0 2 at a np RQ of 0.72, and 0.345 = 
difference between caloric equivalents of 1 l 0 2 at np RQ of l and 0. 72 
The percentages of the 0 2 consumed by carbohydrate or fat are calculated 
according to the following formulas: 
% Carbohydrate = npRQ - 0·72 
0.28 
% Fat = 1 - npRQ 
0.28 
(4) 
(5) 
The term carbohydrate utilization is used in accordance with Frayn [14], arguing 
that the rate of carbohydrate oxidation as measured with indirect calorimetry is the 
net result of glucose oxidation, lipogenesis from glucose, and gluconeogenesis from 
amino acids. At a high caloric intake when gluconeogenesis is low and lipogenesis 
can be high, the total carbohydrate "balance" or utilization as measured by indirect 
calorimetry is equal to the sum of the rate of true carbohydrate oxidation (c.,) and 
the rate of conversion of carbohydrate to fat (<f), or c = c0 + cf. 
For this reason, the difference between carbohydrate utilization from indirect 
calorimetry and true carlJohydrate oxidation measured independently, e.g. by 
isotopes, can give an indication of the rate at which the process of lipogenesis is 
occurring [8]. 
The fraction of infused tracer appearing in respiratory C02 is calculated 
according to the following formula: 
Fraction of infUsed tracer in C02 = 
vco2 x 1Ec02 
0.989 X F X 6 X C 
(6) 
where VC02 is the rate of C02 production, IEcoz is the increase in isotopic 
enrichment of C02 at plateau value, 0.989 is the infused tracer enrichment, F is the 
tracer infusion rate, 6 is the number of C atoms/glucose molecule, and c is the 
correction factor for C02 retention in the bicarbonate pool. Instead of taking a fixed 
fraction of 0.81 for c, we calculated it individually according to the regression 
equation we described in an earlier publication [15]: 
c(%) = 64.2 + intake(kcallkgld) x 0.1667 (7) 
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The "true" Ra of glucose in the plasma pool was calculated from the dilution of 
the (m+6) species of the labeled glucose. 
[
£. 
Ra true = --' 
EP 
(8) 
where E; = (m+6) enrichment of infused tracer = (0.989)6, ~ = (m+6) 
enrichment of plasma glucose, and F = rate of infusion of the tracer 
This is considered a measure of true Ra of glucose because the opportunity for a 
uniformly labelled (m+6) species to recycle back via Cori cycle is considered to be 
negligible [16]. 
The "apparent" rate of glucose appearance in the blood was calculated from the 
enrichment of glucose C measured by the combustion method using the same 
dilution equation. In this case E; = 0.989, i.e. the 13c enrichment of infused tracer, 
and EP = the 13C enrichment of blood glucose C. It should be recognized that 13C 
enrichment of blood glucose C measured by the combustion method includes the 
recycled carbon, and therefore will result in a lower rate of glucose appearance (Ra 
"apparent") as compared with the true Ra. 
Glucose oxidiuion = (9) 
Ra apparent x fraction of infused tracer in C02 (Eq. 6) 
Glucose production was calculated by subtracting the glucose intake (calculated 
from the individual intakes of the continuously fed formula) from the rate of glucose 
appearance obtained by isotope dilution, Ra true. Glucose intake was calculated from 
the glucose part of lactose plus the glucose within the glucose polymers, assuming 
there is complete intestinal hydrolysis and absorption of complex carbohydrates in 
preterm infants, as has been shown before [17]. The galactose was not included in 
the glucose intake. If galactose is converted into glucose by the liver, it will be 
measured as glucose production upon release. The calculation also assumes there is 
no significant first-pass extraction of glucose in the splanchnic area of the (labeled) 
glucose. A validation study in five orally fed preterm infants was performed where 
we measured (m+6)-glucose enrichment with both an oral and an intravenous tracer 
infusion protocol two days apart. Fig. 2 shows the enrichment in plasma obtained 
after infusion of [U-13C]-glucose in five orally fed preterm infants (represented by 
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individual lines). The enrichment obtained by i. v. infusion would be expected to be 
higher than the enrichment obtained by oral infusion of tracer if there had been a 
significant amount of label retained in the liver, but in this case was 98 ± 10% of 
the "oral enrichment". This result indicates that all (labeled) glucose passes the liver 
into the circulation and no significant amount is being extracted on the first pass. 
These results are in accordance with studies in adults [18] showing an initial 
splanchnic extraction of glucose between 2.4 and 8%. 
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Fig. 2 
Rise in (m +6)-glucose enrichment after continuous infusion of [U-13C]-glucose in five 
patients. Labeled glucose was infused i.v. on one day and orally two days later. Individual 
patients are indicated by individual lines. average enrichment oral vs. i.v. shows no trend 
towards one method (see text). 
Recycling ~ Ra true - Ra apparent (HI) 
The recycling measured in this way is the amount of glucose recycled from three 
carbon intermediates like lactate through the Cori cycle, as discussed above. 
~-------------------------------------------c~~~~R~5 
net glucose storage = (11) 
carbohydrate intake - carbohydrate utilization from calorimetry 
Statistics 
Data are presented as mean ± 1 SD. Differences between the MCT and the LCT 
group were tested using Wilcoxon's rank-sum (Mann-Wbitney two-sample) test. A 
value of p < 0.05 was considered to be statistically significant. 
RESULTS 
There were no significant differences between the two study groups in any of 
the parameters described in table 1. 
Results of the glucose studies are described in table 2. Carbohydrate intake was 
equal at 8.4 mg/kg/min in both groups, and carbohydrate utilization was 7.6 
mglkg/min in both groups. In both groups, a small but significant amount of glucose 
was being stored, but this was not different between the two feeding groups. There 
were also no differences in fat utilization or metabolic rate as measured with indirect 
calorimetry. The Ra of glucose calculated at the two ·different ways used here 
yielded very similar results, and hence the difference between the two tracer 
methods -which is expected to represent recycling through three carbon fragments-
was not different from zero. The glucose production was not significantly different 
between groups and not significantly different from the galactose intake, which was 
2.1 mg/kg/min in both groups. 
A statistically significant difference between the two groups in glucose oxidation 
was observed: 4.5 mg/kg/min in the MCT group versus 5.7 in the LCT group (p < 
0.01). The difference between glucose oxidation measured with stable isotopes and 
total glucose utilization from calorimetry, as a measure of lipogenesis, was 
significantly higher in the MCT-fed group, 3.0 versus 1.9 mg/kg/min in the LCT 
group (p < 0. 05). 
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Table 2 
Glucose metabolism. 
MCT LCT p 
Intake 
Carbohydrate intake [I] 8.4 ± 0.21 8.4 ± 0.10 NS 
Glucose intake [2] 6.3 ± 0.16 6.3 ± 0.08 NS 
Calorimetry 
Glucose utilization [3] 7.5 ± 0.96 7.6 ± 0.87 NS 
Fat utilization 0.97 ± 0.59 1.24 ± 0.53 NS 
Metabolic rate (kcal/kg/d) 59± 5 62 ± 4 NS 
13C-glucose 
Ra "true" [4] 9.0 ± 1.0 9.0 ± 0.83 NS 
Ra "apparent" [5] 9.1 ± 1.0 8.7 ± 0.90 NS 
Glucose oxidation [6] 4.5 ± 0.83 5.7 ± 0.67 <0.01 
Calculated variables 
Glucose production [4]-[2] 2.79 ± 0.90 2.38 ± 0.97 NS 
Recycling [4]-[5] -0.06 ± 0.69"' 0.25 ± 0.83"' NS 
"Lipogenesis" [3]-[6] 3.0 ± 1.3 1.9 ± 1.1 <0.05 
Net storage [1]-[3] 0.85 ± 1.0<0.0S 0.78 ± 0.78<0 -05 NS 
All values in mglkg/rnin, except metabolic rate in kcal/kg/d. Values between brackets are 
arbitrarily designated numbers, for use in the calculated variables. 
NS: comparison between groups not significantly different. 
<0.01 or <0.05, comparison between groups significantly different atp < 0.01 or 0.05 
ns: value in itself not significantly different from zero. 
< 0-05 : value in itself significantly different at p < 0.05. 
DISCUSSION 
Our initial hypothesis that MCT-fed infants would have a higher metabolic rate, 
to explain that their growth is often not higher even though their metabolizable 
energy intake is higher, cculd not be substantiated in this study. 
In an earlier study, we showed that infants fed a MCT-containing formula 
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absorbed an extra amount of approximately 5-6 kcal!kgld of fat [19]. A remarkable 
result in the present study was the decrease of 1.1 mg/kglmin of glucose oxidation 
in the MCT group, which means a decrease of over 6 kcal/kg/d in the energy 
derived from direct glucose oxidation. This strongly suggests that MCTs very 
specifically decrease glucose oxidation in the well-fed preterm infant. In contrast 
with this we found carbohydrate utilization from calorimetric data to be virtually 
identical. 
Body stores of glycogen in adults can probably rise to a maximum of about 100 
g [20], equivalent to an estimated maximum in the neonate of around 2 glkg total 
body stores. As the infants have been and are continuously fed high caloric feedings 
that provide 12 g/kgld of carbohydrates, it can be expected that glycogen stores are 
filled. Galactose presented to the liver in that case can not lead to net glycogen 
accretion. This is consistent with our finding that glucose production rate was not 
significantly different from the galactose intake. Also, in a recent publication [21], 
Spedale et al. have measured in vivo a preferential first-pass hepatic uptake for 
galactose and the absence of a net hepatic uptake of glucose in the postabsorptive 
newborn lamb, confirming the idea that galactose is taken up preferentially by the 
newborn lamb, with a net hepatic glucose output approximately equal to the 
galactose uptake in the postabsorptive state. 
Glucose probably cannot be stored as glycogen to a significant extent after a 
period of continuous delivery of 120 kcal per kg/day as argued before, and it seems 
likely that the nonoxidized glucose will be shuttled into ·lipogenesis. The increased 
difference between stable isotope and calorimetric measurement of glucose 
metabolism in the MCT group also points at an increased rate of lipogenesis from 
glucose, as we have argued before [8,22]. Indirect calorimetry measures utilization 
of fat and carbohydrates where the amount converted ultimately into C02 is the 
entity measured and the pathway taken does not influence the total stoichiometry. 
For instance, ketones formed from fat and consequently oxidized have the same 
effect on stoichiometry as direct fat oxidation, and carbohydrate conversion into fat 
with subsequent fat oxidation results in "measurement" as carbohydrate oxidation. 
Thus, in some states of excess energy supply where lipogenesis is occurring with 
ongoing fat oxidation, RQ might not rise above 1 (no net lipogenesis), but still, the 
carbohydrate utilization obtained by the calorimetric measurement overestimates the 
real glucose oxidation. As Frayn [14] showed that (in the absence of some other 
processes like ketogenesis with urinary loss of ketone bodies) calorimetry 
quantitatively overestimates glucose oxidation by the amount of glucose converted 
into fat, we can estimate from the significantly increased difference between the two 
techniques that an extra L I mglkg/min of glucose was converted into fat in the 
MCT group (table 2). For the absolute amount of fat oxidized to be determined, an 
estimate should be made of what part of the difference between glucose oxidation 
and glucose utilization already existing in the LCT group was due to lipogenesis and 
what amount could be ascribed to other causes. One such cause would be the 
underestimation of glucose oxidation by the tracer technique due to intracellular 
oxidation of glycogen that did not enter the plasma pool and hence made no 
contribution to the measured glucose production [13]. Although fairly confident 
about increased lipogenesis as the cause of the increased discrepancy between the 
two measurements of glucose metabolism in the comparison MCT vs. LCT, we feel 
that it would be too speculative to suppose that the difference between stable 
isotopes and calorimetry can always be quantitatively converted into values for 
lipogenesis. 
The finding in a recent study [23] of a significant difference between 
isotopically determined glucose oxidation and indirect calorimetry values during 
hyperinsulinemic euglycemia, but not during saline infusion, confirms the idea that 
both methods can yield identical results in the fasting state, whereas a difference 
attributable to lipogenesis is present during hyperinsulinemia. 
In one study, most relevant to ours [13], the effect of elevated Free Fatty Acid 
(FFA) levels on glucose oxidation was studied using the same two techniques as 
ours. It was concluded that FFA lowers carbohydrate utilization as measured with 
calorimetry, whereas plasma [U-13C]-glucose oxidation was not influenced. It was 
concluded that FFA probably lowered intracellular glycogen oxidation under those 
particular circumstances. Although there was no effect of FFA on plasma glucose 
oxidation in the latter study even though there was an additional caloric intake due to 
the infusion of an intravenous fat emulsion, in the present study [U-13C]-glucose 
oxidation was significantly decreased with isocaloric replacement of part of the 
LCTs in the fat blend by MCTs, again pointing at a very specific effect of MCTs. 
The presence of carbons with chain lengths < 16 is negligible in the fat emulsion 
used, and, to our knowledge no reports have been published on the effect of MCTs 
on isotopically measured glucose oxidation in vivo. 
Apart from the original indication of fat malabsorption, MCT supplementation is 
currently being recommended for a variety of purposes [24], including seemingly 
contradictory objectives like (parenteral) hyperalimentation and obesity controL The 
literature does not definitively analyze the benefits of MCT administration. 
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Moreover, all trials have been performed comparing MCTs with LCTs. In light of 
our study showing a more pronounced effect of MCTs than LCTs on plasma glucose 
oxidation, reconfirming the conclusion of the carbohydrate-like behavior of MCTs as 
suggested 25 years ago [25], it might be more realistic to also compare MCT 
administration to simply additional carbohydrates administration. Obviously, these 
considerations do not apply to specific indications like general malabsorption. 
The overestimation of glucose oxidation obtained with calorimetry in our study 
shows that at least part of the lipogenesis with MCT feeding occurs from glucose in 
preterm infants on regular preterm MCT formula. In an earlier study, similar 
indirect evidence of increased lipogenesis was found to be associated with a 
decreased food efficiency (higher metabolic rate at equal energy intake) in the 
glucose-only parenteral feeding regimen [8]. Although not confirmed in the present 
study, an increased metabolic rate during overfeeding with MCTs has been described 
in animals and adult human volunteers [4-7]. In these cases, the observed increase in 
metabolic rate has been ascribed either to ketogenesis [4], obligatory oxidation [5,6], 
or lipogenesis from MCTs [7]. 
In summary, we propose that the following metabolic picture can be derived 
from our results: In preterm infants receiving an energy intake of 120 kcal/kg/d 
providing 8.4 mg/kg/min carbohydrates, approximately 10% of the carbohydrate 
intake is stored or converted nonoxidatively in this period of rapid growth 
( z 1.6%/d). Another two thirds of the glucose in the LCT group is directly 
oxidized, whereas the remaining glucose is either oxidized intracellularly corning 
directly from glycogen or converted to fat. When MCTs are replacing part of the 
LCT fat in the diet, a significant decrease in the glucose oxidation is observed, but 
as carbohydrate balance is strictly regulated this does not show in the carbohydrate 
utilization measured with calorimetry. This observation indicates that the extra 
glucose not oxidized in the MCT group is probably converted into fat, which 
influences the calorimetric measurement and not the direct glucose oxidation 
measurement. In this way, an inefficient consequence of the supposed "obligatory 
oxidation" of MCTs could exist, as lipogenesis occurs together with ongoing fat 
oxidation. However, in our study design, this did not lead to a higher total metabolic 
rate. 
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CHAPTER VI 
CONVERSION OF OCTANOIC ACID INfO LONG-CHAIN 
SA'fURATED FATTY ACIDS IN PREMATURE INFANTS 
FED A FORMULA CONTAINING MEDIUM-CHAIN 
TRIGLYCERIDES. 
V.P. Camielli, E.J. Sulkers, C. Moretti1, J.L.D. Wattimena, J.B. van 
Goudoever, H.J. Degenhart, F. Zacchello1, P.J.J. Sauer. 
Department of Pediatrics, Sophia Children's Hospital and University 
Hospital I Erasmus University Rotterdam, Rotterdam, The Netherlands, 
1Department of Pediatrics, University of Padua, Padua, Italy. 
SUMMARY 
A large number of very-low-birth weight (VLBW) infants are fed formulas 
containing medium-chain triglycerides (MCTs) to enhance fat and calcium 
absorption. Studies are available on the intestinal absorption of MCTs, which is 
nearly complete, but uncertainties exist on the metabolic fate of octanoic acid, the 
major component of MCTs. Oxidation accounts for approximately 50% of the 
dietary intake and losses as dicarboxylic acids in the urine are negligible. As direct 
storage in adipose tissue is limited, conversion to long chain fatty acids (LCFAs) is 
likely to be an important route. To study the nonoxidative metabolism of MCTs five 
preterm infar1ts fed a standard premature formula containing 35 wt% MCTs (54 
mol% medium-chain fatty acids (MCFAs) of which 35 mol% octanoic acid) were 
studied at 4 weeks of age when on full oral inta.<:e and receiving on average 130 
kcal/kg. The study consisted of an oral primed constant rate infusion of [13C]-
octanoate and the measurement of the 13C enrichment of individual fatty acids in 
plasma triglycerides by a highly sensitive on-line combustion method using a gas 
chromatograph-isotope ratio mass spectrometer (GC-IRMS). We observed a 
significant incorporation of the dietary [13C]-octanoic acid in plasma triglycerides 
(10.0 ± 4.5% of the enrichment of the diet). A noticeable incorporation of the label 
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was detected in myristic and palmitic acids (4.6 ± 2.5 and 7.8 ± 4.1% of the 
octanoic enrichment of the diet). When the absolute amount of the fatty acids was 
studied with conventional gas-chromatography, the plasma triglyceride fatty acid 
profile differed markedly from the diet. When expressed as mol percent of the total 
amount of fatty acids, octanoic and decanoic acids were only 7.3% and 32% 
respectively in plasma compared to the mol percent of total fatty acids in the diet 
and myristic and palmitic acids were higher by 225% and 343% compared with the 
mol percent composition of the diet. Our findings demonstrate for the first time in 
vivo, the conversion of octanoic acid into long-chain saturated fatty acids. The latter, 
apart from being metabolically inefficient could be responsible for the high levels of 
long-chain saturated and mono-unsaturated fatty acids found in subjects fed MeT-
containing diets and may interfere with the metabolism of other fatty acids. 
INTRODUCTION 
Medium-chain triglycerides (MCTs) are added to the fat blend of several 
preterm formulas to promote intestinal absorption of fat and calcium [l ,2]. 
However, scanty data are available on the metabolic fate of the medium-chain fatty 
acids (MCFAs) in the small preterm human neonate. After i11testinal absorption, 
MCFAs could be oxidized, deposited as such, or possibly converted into other fatty 
acids. Studies in a1limals and human adults show evidence of almost complete 
oxidation and minor tissue deposition of dietary MCFAs [3]. Nevertheless the 
oxidation of octanoic acid in premature infants was found to be only 50% of the 
dietary intake [4]. Thus, as oxidation in preterm infants apparently is not complete, 
tissue deposition or metabolic interconversion should represent important pathways. 
Octanoic and decanoic acids (the major fatty acids of MCTs) were found to be about 
5% in weight of the fatty acids in adipose tissue of newborn infa.,ts fed MCTs [5]. 
This deposition does not yet explain the incomplete oxidation. Elimination of 
MCFAs as hydroxy fatty- and dicarboxylic acids is a well described pathway [6] but 
it is negligible from the point of view of energy and carbon losses. Conversion of 
MCFAs into long-chain fatty acids could be a significant nonoxidative route. This 
process was described in animal studies [7,8]. It has been hypothesized to occur in 
human adults fed MCTs [9] because of the observation of unexpectedly high levels 
of palmitic acid in plasma triglycerides (TG). This latter finding point towards an 
~C~O~NVE~~RS~I~O~N~OF~O~C~T~AN~O~A~T~E~mT~O~L~C~F~A~s~---------------------------93 
increased palmitate synthesis during MCT feeding. No information is available to 
date on the nonoxidative fate of MCF As in the small premature infants. 
The objective of the present study was to investigate whether the conversion of 
MCFAs into LCFAs does occur in the human newborn infant fed MCTs. This was 
achieved with stable isotope technology and high sensitivity tracer detection, using 
gas chromatography-isotope ratio mass spectrometry (GC-IRMS). 
PATIENTS AND METHODS 
Subjects 
Five premature infants (birth weight 1.5 ± 0.12 kg and gestational age 31.8 ± 
1. 7 weeks), free of major congenital or acquired diseases were studied at 26 ± 6 
days postpartum when on full oral feeds for at least 10 days. All infants were fed a 
MCT formula. Body weight at the time of the study was 1.82 ± 0.12 kg. Individual 
data are reported in table 1. 
Table 1. 
Patients Characteristics 
Patient Birth Gestational Age at Weight Energy Fat Octanoic 
no. weight age (wk) study at Study Intake Intake acid intake 
(kg) (days) (kg) (Kcal/kg/day) (g/kg/d) (g/kg/d) 
1 1.33 33 28 1.82 122 6.3 1.3 
2 1.37 34 20 1.77 132 6.6 1.5 
3 1.63 32 32 1.95 149 7.7 !.6 
4 !.57 31 33 1.92 124 6.0 1.7 
5 !.59 29 19 1.63 132 6.8 1.4 
Mean 1.50 31.8 26.4 1.82 132 6.7 1.5 
SD 0.14 1.9 6.6 0.13 II 0.6 0.2 
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Feeding regimen 
All infants were fed a formula (Mellin 0, Star™ Italia) in which 35 % of the 
fat (wt/wt) is provided as MCTs. This amount corresponds to 54% mol percent 
(mol/mol) of the total fat content (octanoic acid is 35 mol%, decanoic acid 19 
mol%). All infants were on full oral feeding and they were all gaining weight at the 
time of the study. The composition of the preterm formula is given in table 2. All 
infants were fed during the studies via an oro-gastric tube and gavage feeding was 
administered using a syringe pump. 
Table 2. 
Composition of Mellin 0 (Star™, Italy) per 100 ml formula 
Energy 76 kcal 
Protein 2.02 g 
Carbohydrates S.32 g 
Lactose 5.43 g 
Dextrine maltose 2.89 g 
Fat 3.75 g 
MCT CS 22.7 wt% (34.9 mol%) 
CIO 15.0 wt% (19.3 mol%) 
LCT C!6 10.7 wt% (9.7 mol%) 
CIS 4.4 wt% (3.4 mol%) 
CIS: I IS.O wt% (14.1 mol%) 
Cl8:2 17.0 wt% (13.5 mol%) 
CIS:3 1.7 wt% (1.4 mol%) 
Sodium 25 mg 
Potassium 75 mg 
Calcium 72 mg 
Phosphorus 40 mg 
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Study procedure 
Informed consent was obtained from the parents of the infants studied. The 
study consisted of a primed constant oral infusion of either l-13C1 or 1,2,3,4-13C4 
octanoate. The isotope infusion was administered via a second small diameter oro-
gastric tube and infused by a syringe pump. The exact amount of the isotope 
solution administered was verified by weighing the syringe before and after the 6h 
consta,"lt infusion. The amount of tracer infused, when converted into labeled 13C 
carbons contained in the tracer, varied from 0.2 to 0.5 J.'mol/kg/min 13C atoms. 
Venous blood samples for the determination of the fatty acid composition of plasma 
TG and their isotopic enrichment were collected by venipuncture before the infusion 
and again at 6 hours of isotope administration. The concentration and enrichment of 
the isotope tracer solution was checked by gas chromatography (GC) and by gas 
chromatography mass spectrometry (GC-MS). 
Methods 
Sample preparation 
Blood was collected in EDT A-containing Vacutainers and centlli"uged at 4"C for 
10 minutes at 1400 g. The plasma was collected and stored at -70"C. Plasma lipids 
were extracted according to Folch [10]. Trinonanoin and tripentadecanoin were 
added as internal standard to 100 JLI of plasma. Then 1.9 ml chloroform/methanol 
(2:1, v/v) was added and the tube was vigorously shaken. After addition of 0.4 rnl 
0.9% NaCI solution the mixture was again shaken and centrifuged during 10 minutes 
at 2500 g and the lower phase was collected. An additional extraction was performed 
with 2 ml chloroform. The extracts were pooled and dried under nitrogen at 45 ·C. 
The lipids were dissolved in 0.10 ml chloroform/methanol (2:1, v/v) and applied on 
a Kieselgel 60 thin layer plate using a Camag Linomat IV (Merck, Darmstadt, 
Germany). The TLC-plate was developed with hexane!diethylether/acetic acid 
(80/20/l, v/v/v). After drying the plate the lipids were visualized by spraying with 
Rhodamine-G and detection under UV -light. The lipid fractions were scraped off 
with a scalpel and collected in glass tubes. Methylation was performed as follows: l 
rnl 3 M dry HCl in methanol was added to the tubes and after flushing with nitrogen 
the tubes were capped and incubated during 60 minutes at 95 ·C. After cooling, HCl 
was neutralized by adding 0.8 rnl 1.5 M K2C03. The methylesters were extracted 
with 2 ml pentane and the pentane phase was transferred into an injection vial and 
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stored at -20- C. Before analysis the vial was placed on ice and the pentane phase 
was concentrated under nitrogen until a volume of about 0.1 mi. 
Quantitation of fatty acids in plasma triglycerides 
The separation and identification of fatty acid methyl esters from plasma 
triglycerides was performed in a gas chromatograph (GC) (Hewlett Packard 5890 II) 
equipped with a fused silica column (Supelcowax 10, 60m x 0.25 mm ID, 0.25 I'm 
film thickness), a flame ionization detector (260'C) and a split-splitless injector used 
in splitless mode. The GC was operated with the following temperature program: 
so·c initially for 4 min, thereafter 25'C per minute until 205'C and held at this 
temperature for 13 min. The temperature was increased again at 0.3 • C per minute 
until 225 • C. Helium was used as a carrier gas (2 mllmin) and peak areas were 
calculated by HP-Chem station software using nonanoic acid and pentadecanoic acid 
as internal standards. Fatty acids were identified by comparing retention times with 
known standards (Nu Chek Prep, Elysian, Minnesota, USA). All reagents were 
analytical grade. 
Isotopic enrichment of plasma fatty acids 
Methods and instrumentation 
The GC-JRMS system used was the newly developed Isochrom ill (VG Isotech, 
Middlewich, Cheshire, UK). Briefly, it consists of a Hewlett-Packard 5890 Series II 
gas chromatograph, connected with a combustion interface to a VG-Optima isotope 
ratio mass spectrometer IRMS. The GC-column was a low bleeding 25 meter SGE 
fused capillary column with an internal diameter of 0.25 mm and 0.!1 I'm HT-5 
liquid phase. The injector temperature w-.s 260°C. The oven temperature was held 
during 3 minutes at 45°C and ramped with 50°C/min to 120°C for 2 minutes, 
thereafter the oven temperature was programmed with 3°C/min to 270°C. During 
solvent elution the effluent of the column was directed towards the flame ionization 
detector and after a timed interval the column effluent was directed towards the 
combustion interface where the compounds are combusted to C02 and H20. The 
water was trapped in a liquid nitrogen cooled metal coil held at -l00°C, while the 
C02 was introduced into the lRMS. A representative example of the tracing obtained 
is shown in figure 1. 
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Fig. l 
GC-IRMS tracing of a free fatty acid spectrum (mass 44 signal only), including octanoate 
itself and several of the measured longer-chain saturated fatty acids. 
Linearity of the system. 
To test if the measured ratio was independent of the pressure in the ion source 
we introduced different amounts of C02 gas into the mass spectrometer using 
reference gas pulses both introduced directly or via the GC column. While the peak 
heights for mass 44 ranged from lE-10 to 5E-9 Ampere, indicating a 50-fold 
difference in in the amount of C02 reaching the ion source, the measured ratio 
showed no tendency to increase or decrease and was very constant, the mean atom 
% being 1.1167 with a standard deviation of only 0.0002 atom % for 10 analyses. 
Calibration curve. 
A calibration curve was constructed by adding different amounts of enriched 
[l-13C]-octanoate to naturally enriched octanoate. After methylation with 3 M dry 
HCl in ethanol the formed methylesters were analyzed. The linear regression line 
(Y = Ax + b) was calculated with the Opos on the Y -axis and the mol % excess 
(MPE) on the X -axis (figure 2). The MPE was calculated from the weighed amounts 
of [l-13C]-octanoate added to weighed amounts of unlabeled octanoate. As 1 
molecule of methyloctanate consists of 9 atoms, the atom % excess will be one ninth 
of the mol % excess. 
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Calibration curve obtained by spiking naturally enriched octanoic acid with different amounts 
of [i-13C]-octanoic acid. 
Practical detection limit and starulard deviation. 
According to the manufacturer the system cculd analyze a minimum of 0.5 nmol 
of a CIO ccmpound (220 ng carbondioxide) with a standard deviation of 0.0003 
atom %. We modified the open split interface, by placing a small length of fused 
silica capillary (length 30 em x 0.32 mm internal diameter), so preserving the same 
pressure in the ccmbustion tube, while reducing the helium outflow and hence 
lowering the GC-effluent dilution. Also the capillary between the open split interface 
and the watertrap was replaced with a shorter capillary, with a smaller diameter. in 
this way the residence time of the compound and peakwidth broadening were 
reduced. After this modification we were able to analyze 0.09 nmol methyloctanoate 
(38 ng CO:J with a standard deviation of 0.0002 atom % (n = 5) or 32 pmol 
methyloctanoate with a standard deviation of 0.0008 atom % (n = 3). 
Over 4 months we prepared plasma samples for lipid analysis with tripentadecanoyl-
glyceride as internal standard. By analyzing the internal standard as methylpen-
tadecanoate we found for 28 analysis a mean o PDB value of -27.0 ± 0.4. This 
corresponds with a mean of 1.0940 ± 0.0004 atom %. Because in biomedical stable 
isotope work we are dealing with delta values (basal value subtracted from measured 
value) the standard deviation becomes v'2sd2 or 0.0006 atom %. Thus, the minimum 
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detection limit of our system will be 0.0017 atom % excess, assuming that a signal 
should be at least 3 times as high as the standard deviation. For quantitative work a 
safe margin would be 20 x sd = 0.011 atom percent excess. 
Calculations 
Results obtained from the instrumentation are based on the 13 C enrichment of 
the C02 of the combusted sample and are expressed in atom percent excess (APE) 
compared to a reference C02 gas of known mass 45/44 ratio. The enrichments of 
the C02 deriving from the combustion of the fatty acids methyl esters (FAMEs) at 
baseline and at 6 hour infusion are used to calculate the increase in enrichment (in 
APE) in individnal fatty acids. No attempt was made to correct the enrichments of 
the FAMEs for the relatively minor contribution of the methyl group added during 
the transesterification of the fatty acids. 
RESULTS 
Individual data for energy, fat and octanoic acid intakes are reported in table 1. 
Total fat intake and the octanoic acid intake averaged 6.6 ± 0.6 and 1.5 ± 0.2 
g/kg!day respectively. In f"~gUre 3 a comparison is made between the fatty acid 
profiles of the formula and that of the plasma TG of the patients studied. Medium 
chain fatty acids (C8:0 + C!O:O) represent almost 55 mole % of dietary fat but are 
much lower in plasma TG. Conversely, palmitic and stearic acid, the most abundant 
saturated fatty acids are higher by a factor of 3 and 1.5 respectively, e.g., palmitic 
acid was 9.7 mol% (or 10.7 wt%) in the fat of the formula and 32 mol% in plasma 
TG. The 13C enrichment of saturated fatty acids in plasma TG is reported in table 
3. Patients I through 3 received l-13C1 octanoate and patients 4 and 5 received 
1,2,3,4-13C4 octanoate. The calculated C8:0 enrichment of the diet ranged from 0.4 
to 1.4 APE, depending on the relative infusion rates of tracer and feeding, averaging 
0.8 APE. Average C8:0 enrichment in plasma was only 0.08 APE, being 10.0 ± 
4.5 % of the enrichment of the diet octanoate. Of the longer-chain saturated fatty 
acids measured, decanoic and dodecanoic acids were not significantly enriched while 
myristic and palmitic acids show average enrichments of 0.04 and 0.07 APE, 
respectively 4.6 ± 2.5 and 7.8 ± 4.1% of the octanoic enrichment of the diet. The 
latter two values were on average 56 and 96% of the enrichment of octanoic acid. 
100~------------------------------------~~~~R~6 
40 % of total fatty acids 
30 
20 
10 
0 
1111 DietTG iP«"¥@ Plasma TG 
Fig. 3 
Comparison between the fatty acid composition of the premature formula (mean values of 3 
determination) and the plasma triglycerides (mean values of the 5 patients). 
Table 3. Isotopic enrichment of plasma triglyceride saturated fatty acids (APE). 
Diet enrichment was calculated from the known intake of tracer and diet. 
diet Triglycerides 
Patient Octanoic Octanoic Decanoic Dodecanoic Tetradecanoic Hexadecanoic 
no. (Caprylic) (Capric) (Lauric) (Myristic) (Palmitic) 
C8:0 C8:0 CIO:O C12:0 C14:0 C!6:0 
1 0.398 0.041 0.001 n.d. 0.010 0.018 
2 0.682 0.087 0.001 0.005 0.059 0.098 
3 0.673 0.!08 -0.002 0.002 0.017 0.028 
4 1.006 0.057 0.000 0.004 0.059 0.101 
5 1.421 0.093 -0.002 n.d. 0.068 0.115 
Mean 0.836 0.077 0.000 0.004 0.043 0.072 
SD 0.392 0.027 0.002 0.002 0.027 0.045 
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DISCUSSION 
With the use of stable isotope technology we present in this paper direct 
evidence of incorporation of dietary octanoic acid into longer-chain fatty acids in the 
plasma TG fraction, as we could demonstrate a significant 13C carbon atom 
enrichment in the longer-chain saturated fatty acids myristic and palmitic acid after 
administration of [13C]-Iabeled octanoate. The latter finding indicates that synthesis 
of saturated long chain fatty acids from MCFAs does occur in premature infants fed 
MCT -containing formulas. 
The incorporation of labeled octanoic acid into plasma TG could have occurred 
both in chylomicron TG and in very-low-density lipoprotein (VLDL) TG. 
Unfortunately, we were not able to perform lipoprotein analysis in this study. 
Although the majority 'of MCFAs is absorbed and transported to the liver via the 
portal system [11,12] it has been described that a minor portion is incorporated into 
triglycerides synthesized in enterocytes and into chylomicrons [7,13]. If triglycerides 
from intestinal origin were the only circulating TG we would expect octanoic acid to 
have the same 13C enrichment as the diet. The enrichment of octanoic acid in plasma 
triglycerides was on average 10% of the enrichment of the diet thus indicating that a 
dilution of the tracer must have occurred. Since the major site for triglyceride 
synthesis is the liver, the majority of the circulating TG octanoate was probably 
incorporated in very low density lipoproteins in the liver. The question of the origin 
of the unlabeled octanoate, is difficult to answer. Incomplete iS-oxidation of long 
chain fatty acids (chain shortening) in the liver or in the gut, MCFA production 
from intestinal bacteria, liver/adipose tissue cycling of octanoic acid and incomplete 
lipogenesis from glucose could be potential sources of unlabeled octanoic acid. 
Data obtained from adult patients with liver cirrhosis given radio labeled long-
chain fatty acids suggest that under fasting conditions 60% to 80% of the serum 
octanoate was obtained from incomplete iS-oxidation of long-chain fatty acids and 
that 20% to 40% may be formed de novo [14]. The concentration of octanoic acid in 
adipose tissue of infants fed formulas containing MCTs when measured with new 
techniques is not negligible [5] as previously thought, even though the storage is still 
much lower wit.!J. CS:O than with LCFAs or even with the "intermediate-chain fatty 
acids" Cl2:0 and Cl4:0. 
Studies indicate that octanoic and decanoic acid -unlike fatty acids with chain 
length of 12 and more- are not a good substrate for phospholipid synthesis [15, 16], 
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and are only incorporated very slowly into hepatic TG via 1,2-diacyl-sn-glycerol 
acyltransferases [16]. Even so, at the moment we cannot conclude whether the 
octanoic acid incorporation into liver triglycerides could be the result of an overload 
of the liver capacity for oxidation or chain elongation of octanoate. 
Palmitic acid in plasma TG of our patients was on average more then 3 times as 
high as in the formula fat blend. Since plasma TG fatty acids are generally known to 
reflect the dietary fatty acid pattern, this difference depicted in figure 3 is 
remarkable. From this fatty acid pattern it can be argued that de novo fatty acid 
synthesis may have occurred. This finding parallels the data from Hill eta!., during 
overfeeding studies in adults fed MCTs [9]. In the present study we give direct 
evidence that saturated fatty acids in plasma TG can be derived from octanoic acid. 
This finding may (partially) explain the high levels of saturated fatty acids found in 
our five patients. No significant enrichment was detected in decanoic and dodecanoic 
fatty acids while the average enrichments of Cl4:0 and C16:0 were 57% and 96.7% 
of octanoic acid enrichment. 
L"l the present work we cannot provide information on the possible biochemical 
mechanism involved in the transfer of carbon atoms from octanoic acid into myristic 
and palmitic acids. Especially since the enrichment in palmitate is just as high as the 
enrichment in octanoate in TG (and even tJgher in one patient), we can only 
conclude that TG octanoate is probably not a good representative of the precursor 
pool for palmitate synthesis, i.e. octanoate ;,., TG probably underwent significant 
dilution at some stage in its metabolism after its conversion into long-chain saturates. 
Thus, we don't want to speculate on the fractional synthetic rate of palmitate 
synthesis from octanoate and data in table 3 should only be considered qualitatively. 
The site of palmitic acid synthesis from octanoic could be the intestinal mucosa or 
the liver. Incorporation of octanoic acid derived radioactivity has been demonstrated 
in fatty acids with chain length greater than 12 carbon atoms in intestinal slices [7]. 
Chain elongation of long chain fatty acids is also described in the small intestine 
[17]. Furthermore, octanoic chain elongation occurs efficiently in liver mitochondria 
[18]. Synthesis of LCFAs from octanoic acid should be considered an energetically 
costly activity and it has been speculated that it could account for a substantial 
portion of the increased energy expenditure reported in adults with excess MCT 
feeding [19,20]. 
There are similarities between the changes in blood lipids produced by MCT 
feeding and those reported with feeding high carbohydrate diets. Although we have 
demonstrated that lipogenesis from octanoate does occur in our patients we did not 
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measure lipogenesis from glucose. A glucose sparing effect of MCTs was described 
in a similar group of preterm infants fed MCT formula [21]. lt is conceivable that a 
decrease in carbohydrate oxidation in nutritionally replenished patients as is the case 
in the growing premature infant fed 120-130 kcallkg/d could be associated with 
enhanced lipogenesis from glucose, also leading to increased saturated fatty acid 
levels. 
We did not measure the 13C enrichment in oleic acid, however, the absolute 
levels of the mono-unsaturated oleic acid were also almost two-fold higher in the 
plasma TG fatty acid spectrum compared to the diet. It is tempting to hypothesize 
that this fatty acid could also be endogenously produced via lipogenesis and 
desaturation by the ,:l9-desaturase [22]. Leveille et al. [8], in their rat studies and 
Hill et al. [9] in studies in human adults have similarly noticed an increase in mono-
unsaturated fatty acids. This may indicate that the fatty acid desaturases may also be 
involved in processing of the metabolic derivatives of MCFAs. In a recent study 
[23] it was shown in newborn piglets that feeding MCTs vs. coconut oil resulted in 
higher Cl6:0 and Cl8: 1 levels in all lipids, concomitantly with a decrease in tissue 
phospholipid arachidonic acid (C20:4n-6), an essential longer-chain poly-unsaturated 
fatty acid thought to be important for growth and development [24]. 
Our data suggest that the elevated saturated fatty acids found in preterm infants 
fed MCTs were derived, at least partially, from octar10ic acid. Further studies using 
lipoprotein analysis and appropriate isotopic modelling could give insight into the 
mechanisms involved and the possible influence of MCT diets on (poly-unsaturated) 
fatty acid metabolism. 
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SUMMARY 
Several formulas inteoded for premature infant feeding contain medium-chain 
triglyceride (MCT) oil, supplying medium-chain fatty acids (MCFAs), to enhance fat 
absorption. These fatty acids of eight and ten carbon atoms were assumed to be 
almost completely oxidized as capacity for storage as such is limited. Doubt has 
been expressed on the ability of the premature infant for $-oxidation of these 
MCFAs, as the excretion of dicarboxylic acids is known to increase during MCT 
feeding. The oxidation of octanoate as a tracer of MCFA metabolism in three 
premature infants was studied using a dual isotope approach with determination of 
plasma [l-13C]-octanoate enrichment by the novel technique of GC-IRMS. The 
rrxovery of label after both intravenous and intragastric administration was 34 ± 3% 
of the intake. The fractional extraction of the liver during the initial splanchnic 
passage was high, 79 ± 8%. The part of the infused octanoate passing through the 
splanchnic bed, underwent a very significant systemic dilution, the "production" of 
octanoate being 1.4 ± 0.5 gram per kg per day, compared to an intake of !.5 ± 0.2 
g/kg/d. Calculated oxidation percentages in the liver (or splanchnic tissue) and the 
peripheral tissues were quite similar, 34 ± 7% vs. 34 ± 2%. The "total" octanoate 
oxidation that could be quantified using this new model was 66 ± 6% of the 
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octanoate intake. We conclude that the oxidation of MCFAs, although higher than 
reported earlier was not complete in preterm infants. 
INTRODUCTION 
Special formulas intended for the needs of prematurely born infants contain up 
to 80% by weight of the fatty acids as medium-chain fatty acids (MCFAs), with a 
chain length of eight and ten carbon atoms. This socalled "MCT oil", which is 
reesterified from hydrolyzed and fractionated coconut oil, is added to preterm 
formulas to enhance fat absorption and to provide a "readily available source of 
energy". Storage of octanoate or decanoate does not seem to be a major route in the 
disposal of these MCFAs [1-3], and it is generally assumed that oxidation of 
MCFAs is nearly complete [4-6]. In the premature infant, the excretion of 
dicarboxylic acids is enhanced when fed a 40% MCT formula [7], leading to 
questions on the maximum percentage of MCT that can be ~-oxidized by the 
preterm infant. However, no methods were available to quantitate in vivo the whole-
body oxidation of MCF As. In an earlier study we measured the oxidation of orally 
administered [l-13C]-potassium-octanoate, and found that an average of 47% of the 
administered tracer was recovered in expiratory air [8]. We argued that there was 
not much dilution in the precursor compartment, due to the fact that very low stores 
of C8:0 had been described, and thus estimated the ·oxidation of C8:0 to be 
approximately 50 %. This number, although higher than the oxidation rate for 
normal fat blends in preterms as calculated from indirect calorimetry, is still much 
lower than the supposedly complete oxidation of MCTs. From these results we 
concluded that a very significant part of the MCF As administered is not oxidized by 
the preterm infant. Furthermore, because storage as part of triacylglycerols in 
adipose tissue is minimal, almost half of the administered MCT has to undergo chain 
elongation, probably de novo lipogenesis, before the body can store this excess of 
MCFAs. 
However these conclusions were made under the assumption of a negligible 
production -and hence isotope dilution- of octanoate. To validate the conclusions we 
studied C8:0 oxidation in three infants administering the tracer on two separate 
occasions either intravenously (iv) or intragastrically (ig). 
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PATIENTS AND METHODS 
Subjects 
All children were admitted to the neonatal intensive care unit (NICU) of the 
Padua University Hospital, Padua, Italy. Infants with a birth weight below 1600 
gram were included in the study if they had been on full oral feedings for at least 
ten days and still had a patent i. v. catheter. This relatively rare occurrence on a 
NICU was present when the infant was doing clinically well, but was receiving 
intravenous antibiotics because of suspected or proven infection. In all cases the 
clinical suspicion of invasive infection was not present any more and cultures were 
negative, but the "minimal course" of the antibiotic treatment was still taking place. 
The amount of formula feeding was decided upon by the responsible clinician. After 
obtaining permission by at least one of the parents, the first study was undertaken 
with intravenous administration of the tracer and oral administration of the formula 
feeding. Two days later, a similar study was undertaken but now with oral 
administration of both tracer and formula feeding. The sequence of tracer 
administration mode was not randomized, because in virtually all cases the infants 
were on the last day(s) of their antibiotic course, once they had been selected and 
permission was obtained from the parents. As it was regarded unethical to leave the 
infusion catheter in for study purposes only, we decided to study first the i.v. 
administration. 
Mean birth weight was 1.4 ± 0.!6 kg, mean gestational age was 33 ± 1.5 
weeks. The weight of the infants during the study is described in table 1. 
Feeding regimen 
Infants received a formula (Mellin 0, Star™, Italy) containing 3.75% fat, of 
which 38 % consisted of MCFA, supplying 0.85 gram of C8:0 per 100 m1 formula. 
Infants were studied at least 10 d after attaining a full oral intake. The decision if 
the "full" oral intake should provide the standard 150 mllkg/day, or a higher amount 
in case of a relatively low growth rate, was made by the responsible clinician. 
However, care was taken that the amount of feeding did not change between 
measurements 1 and 2. 
During the studies the oral feeding was administered continuously by a syringe 
pump, whereas normally the feeding was administered in a semi-continuous fashion 
by hand. 
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Methods 
Indirect calorimetry 
During the study period with infusion of the tracer, the infant was nursed in an 
incubator which contained a custom-made ventilated hood calorimeter. VC02 was 
measured using an infrared diapherometer (Biomedin™, Padua, Italy). Calibration 
was checked by combustion of butane, the resulting respiratory quotient (RQ) being 
within 2% of the theoretical value. 
Measurement of [J_13C]-octanoate recovery 
Measurement of octanoate oxidation was essentially the same as described 
before [8]. One minor difference was that in the present study, the octanoic acid 
tracer was administered as the sodium salt in stead of the potassium salt. 
Labeled [l-13C]- sodium octanoate (99% enriched, MSD isotopes, Montreal, 
Canada) was dissolved in sterile water at the hospital pharmacy and passed through a 
0.22 I'm filter into 10 ml vials, which were then sterilized by autoclavation at 
l20°C. In order to determine the natural background of 13C, three baseline breath 
samples were collected during 15 minutes each before starting the isotope infusion. 
The bicarbonate pool was then primed with 6.9 l'mol.kg·l of a 6.9 mmol/1 solution 
of NaH13C03 (80% enriched, Merck Isotopes). At the same time, a [1-13C]-
octanoate priming dose of 2 mg/kg was given, followed by a constant infusion of 2 
mg/kg/hr for 6-8 hrs. In two infants (B and C in table 1), double doses of labeled 
bicarbonate and octanoate were used. The delivery rate of the pump during the study 
was measured by dividing the difference in weight of the syringe before and after 
the experiment by the duration of the experiment in order to determine the actual 
quantity of [l-13 C]-octanoate administered. Once the isotope infusion was started, 
15-min C02 breath collections were made every hour for 7 hours. Before and after 
the isotope infusion, 100 !'I blood samples were obtained by capillary heelstick from 
a warm heel. Breath C02 was collected by passing a sample of the air leaving the 
incubator through an all glass spiral condenser, containing 10 ml of a fresh 1 molar 
NaOH solution. Samples were transferred to Vacutainers and stored at -20°C until 
analysis. 2 days after the i.v. administration of the label, the study was repeated 
using oral administration of label under exactly identical circumstances. 
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Isotopic Ratio Mass Spectrometric Analysis of C02 
Respiratory carbon dioxide was liberated at < 10·3 torr by adding phosphoric 
acid 85% to the NaHC03 solution. Pure C02 was collected in a small glass 
container in liquid nitrogen while the water was trapped in a methanol/dry ice bath. 
The glass container with pure C02 was connected to a VG Sira !0 isotope ratio 
mass spectrometer (Vacuum Generators, Middlewich, Cheshire, UK). Results of 13C 
abundance of both baseline and plateau levels were calculated as APE/reference C02 
tank standard sample. 
Isotopic enrichmem of plasma fatty acids 
The analysis of the isotopic enrichment of the plasma fatty acids was performed 
as described in detail earlier [9], the only difference being that the free fatty acid 
fraction was analyzed in this study. 
Calculations 
The percentage 13C02 recovery of i.,-,fused label was 
recovery (1) 
where VC02 is the amount of expired C02 in micromoles C02 per kilogram per 
minute corrected to standard conditions, Ec02 is the expired C02 atom percent 
enrichment, E; is the enrichment (mole percent excess, MPE) of the tracer infusate 
and F is [I-13C]-octanoate infusion rate in !'moles per kilogram per mi.,-,ute. c is the 
correction factor (as a fraction) for 13co2 retention in the bicarbonate pool, 
calculated individually from the energy intake of the infant [10], where the 
correction factor c (%) = 64.2 + 0.1667 x caloric intake (kcal/kg/d). 
Because a significant retention in the splanchnic bed of the enterally 
administered tracer was expected, systemic octanoate fluxes were calculated using 
the enrichment of octanoate in plasma during i. v. tracer infusion only. The systemic 
octanoate flux (octanoate Ra,.y,, l'mol!kg/min) is 
Octanoate Rasys ~ [ :: - 1] x F (2) 
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where F is the [1-13C]-octanoate infusion rate (/Lmol!kg!min) during the i. v. tracer 
study and E; and ~ are the [1·13C]·octanoate enrichment in the infusate and in 
plasma during the i. v. tracer administration (Mole Percent Enrichment), 
respectively. 
The fraction of this systemic flux derived from the dietary octanoate was calculated 
by the standard precursor-product relationship: 
fraction of plasma octanoate from diet = plasma [13C]Octanoate(ig) MPE (3) 
diet [ 13 C] Octanoate MPE 
where [1·13CJoctanoate MPE is the 13C enrichment of plasma (after intragastric 
tracer administration) and in the diet respectively. The enrichment of the diet was 
calculated from the known intakes of tracer and formula octanoate. 
Therefore, the actual Ra of octanoate derived from the diet in the plasma space 
after splanchnic extraction (Radiw JLmol/kg/min) was 
Radie,= Rasys x fraction of plasma octanoate from diet 
The fraction of dietary octanoate extracted on its first splanchnic passage/was 
f 
Octanoate intal<e - Ra dier 
Octanoare intal<e 
(4) 
(5) 
where octanoate intake was calculated from the amount of formula administered and 
the known concentration of octanoate in the formula. lt should be mentioned that 
these calculations are made under the assumption that intermediary pools are at 
steady state (likely if C02 enrichments already have reached plateau) and if 
absorption of the tracer and dietary C8:0 is complete (very likely for C8:0, the 
absorption of which in prematures has been shown to be close to 100% (e.g., [11]) 
Endogenous octanoate Ra CRaendo• JLffiOI/kg!min) is therefore 
(6) 
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Calculation of octanoate oxidation 
So far, dual isotope approach calculations have been used, similar to ones used 
before to investigate metabolism of glucose (e.g., [12]) and leucine [13]. Mostly, a 
combination of a carbon-labeled and a deuterium labeled tracer (or their radioactive 
counterparts) are used for intragastric and intravenous tracer infusion. Naturally, in 
these cases only the carbon labeled tracer can be used to calculate oxidation rates, 
and both the intragastric and the intravenous route have been used for the carbon 
labeL There is probably not much objection against using the two routes 
interchangeably in t!Je case of protein or carbohydrate oxidation, as in the case of 
glucose initial splanchnic extraction is quite low, and in the case of leucine the 
intracellular precursor enrichment of its keto-acid ("-KICA) can be used in the 
equation. Also, oxidation of both glucose and leucine occurs predominantly in the 
peripheral tissues (i.e. muscle) 
As the fractional extraction of octanoate is thought to be higher than several 
other metabolites, and a large fraction of the oxidation is supposed to occur in the 
liver, knowledge of the two recovery rates of carbon-labeled tracers administered by 
different routes is necessary to calculate more exactly both the splanchnic and the 
peripheral oxidation rate of octanoate. As, to the best of our knowledge, no such 
calculations have been published, we derived the following equations solving the 
oxidation term in parameters directly measured when two carbon labeled tracers are 
used. 
The recovery of the tracer delivered intravenously equals the percentage of 
oxidation in the peripheral tissues. 
recovery(iv) ~ ox%(p) (7) 
where recovery(iv) is the recovery (in percent) of 13C02 dnring the intravenous 
tracer administration calculated according to Equation 1, and ox%(p) is the 
percentage of the labeled (and unlabeled) octanoate appearing in the plasma pool that 
is oxidized by the peripheral tissues. 
The recovery of label during intragastric tracer administration (rec(ig)) will 
include a part that is derived from the oxidation of octanoate taken up by the 
splanchnic bed and the oxidation of the label that has bypassed the liver (and other 
splanchnic tissues) and is oxidized in the peripheral tissues 
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recovery(ig) =fx ox%(s) + (l -f) x ox%(p) (8) 
where recovery(ig) is the recovery in percent of 13co2 during the intragastric tracer 
administration calculated according to EquaJion 1, and ox%(s) is the percentage of 
the labeled (and unlabeled) octanoate oxidized by the splanchnic bed. 
The "total" oxidation of octanoate, assuming that unlabeled octanoate is handled 
in the same way as labeled octanoate will equal 
Oxidation= I xfx ox%(s) + Rasysx ox%(p) (9) 
where Ra,ys is derived in EquaJion 2, and I is the total intake of (unlabeled) 
octanoate. Using EquaJions 7 and 8 the latter can also be written as 
Oxidation = I (rec(ig) - (1-j) x rec(iv)) + Rasys x rec(iv) (10) 
The oxidation rate calculated earlier [8], assuming no endogenous production, 
was obtained by multiplying the intake of octanoate by the recovery of the (orally 
administered) tracer, or: Oxidation = Intake x rec(ig). Comparing this with 
EquaJion 10, it is clear that the total oxidation will be higher, the difference being 
I x (-I +f) x rec(iv) + Rasys x rec(iv) (H) 
or 
rec(iv) x (Rasys- (1 -f) xI) (12) 
the latter term being only zero when the endogenous production is zero (then Ra,ys 
in plasma will equal I x (1-f), the latter being the amount passing through the liver). 
Even when the intragastr:ic recovery equals the intravenous recovery, it can only 
be concluded that the ox%(p) and ox%(s) are equal in that case, as it follows then 
according to EquaJions 7 and 8, ox%(p) = f x ox%(s) + (1-f) x ox%(p), or f x 
ox%(p) = f x ox%(s) 
Thus, the "total" oxidation of octanoate can be calculated using EquaJions 9 
and 10, while using all information available (recovery and plasma dilution, both 
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after i.v. and i.g. tracer administration) is necessary to calculate the true oxidation 
rate, as there are no fixed relationships between these four variables. 
RESULTS 
In all experiments a plateau was obtained after the 4th hr of the study as 
assessed by the lack of a significant slope in the breath enrichment by linear 
regression analysis. For sake of simplicity we took the average of the four delta 
values obtained during the last 3 hrs of the study as the plateau value. An example 
of two curves obtained in the same patient on the two occasions is presented in 
f'1g11re l. Basal enrichmenis of the oral studies, which were always performed as the 
second in row, were not significantly higher than basal enrichments observed during 
the i. v. studies (data not shown). 
8 
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Time course of 13C~ enrichment in breath after a primed constant oral infusion of [l-13C]-
octanoate in one patient after either intragastric (oral) or intravenous (i.v.) tracer 
administration. 
116, __________________________________________ ~C~~~~E~R~7 
Individual results of this study are described in table l. Recovery of infused 
tracer in breath was 34 ± 3%, with a range between 28 - 37%, This is slightly 
lower than we have reported before in somewhat younger preterm infants [8]. 
I. v. and oral tracer administration yielded almost identical results. The ratio of the 
calculated recoveries on the two experimental protocols was close to 1 (table 1). 
Still, as argued earlier, this doesn't necessarily indicate that total oxidation can be 
calculated without knowledge of the endogenous production, as this is not 
necessarily zero when i.v. and i.g. recovery are equal. 
The derived variables regarding the metabolism of octanoate, calculated 
according to the equations presented earlier, are shown as individual patient data in 
table 2. 
Although calculations were performed in micromoles per kg per day, we found 
it easier to discuss the numbers in mg per kg per day, hence to obtain the original 
numbers one should divide the numbers by 207.36 (= 144*144011000). 
To illustrate the results more clearly, approximate "average" values of table 2 
have been taken and are presented in figure 2. 
Table 2 
Calculated parameters of octanoate metabolism. 
Patient A B c 
octanoate intake (mg/kg/d) 1395 1690 1440 
Ra,, (mg/kg/d) 1722 2473 1187 
fraction octanoate from milk 0.18 0.18 0.15 
splanchnic extraction f 0.77 0.73 0.88 
Radiet (mg/kg/d) 309 440 176 
Raendo (mglk:g/d) 1366 1934 914 
oxidation % splanchnic (%) 37 26 38 
oxidation % periphery (%) 35 35 32 
"total" octanoate oxidation(%) 69 69 60 
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Table 1 
Patient, 
mode of 
infusion 
A iv 
A ig 
B iv 
B ig 
c iv 
c ig 
Patient characteristics and stable isotopic measurements. 
Weight Isotope Formula Recovery ratio 
infusion intake (%) i. v./oral 
(kg) (p.mol/kg/min) (ml/kg/d) 
1.70 
1.82 
1.86 
1.95 
1.58 
1.77 
1.8 ± 0.1 
NOD 
C02 
367 
1500 
Intake 
0.22 
0.21 
0.47 
0.45 
0.47 
0.45 
~ 
169 35 1.05 
158 36 
203 35 0.81 
194 28 
162 32 l.l7 
176 37 
34 ± 3 1.01 ± 0.18 
'" ~(00 
Systemic 1800 / C02 
compartment /~ ::D 
./// 1200 
Peripheral tissue 
MPE 
plasma 
2.69 
0.58 
4.01 
1.01 
8.21 
0.94 
Fig. 2 Approximate model of octanoate metabolism, based on averages of the measured 
parameters in the three patients, with rounded off numbers. NOD = Non-oxidative disposal. 
1500 = Intake of octanoate, extraction% f = 73%, ox% in the splanchnic bed = l/3. 
400 = Ra(diet), 1400 = Ra(endo) aod 1800 = Ra(sys). 
Ox% in the peripheral tissues = 1/3. The recovery of an intragastrically administered tracer 
in this example would have been also 1/3 ((1500 x 0.73 x 1/3 + 1500 x 0.27 x 1/3)/1500), 
but due to the endogenous production the total oxidation is actually higher i.e. 64% of the 
intake (1500 X 0.73 X 1/3 + 1800 X 1/3)/1500. 
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DISCUSSION 
In this study we report oxidation rates of infused [l-13C]-labeled octanoate 
(C8:0), as a representative tracer of MCFA metabolism. We have used the oral 
administration of tracer octanoate before, to investigate some peculiarities of MCFA 
oxidation in preterm infants (i.e., possible excess intake of MCFAs and 
consequently less than complete oxidation and redirection towards other pathways). 
In the latter study however we assumed that the oral tracer route was applicable to 
this kind of study, as it is similar to the route taken by the fed formula. We 
implicitly assumed that, because body stores of C8:0 are negligible, endogenous 
production was negligible. 
With the developed set of equations details of octanoate metabolism can be 
investigated further. Some of the calculated variables fit well with what had been 
predicted from perfusion experiments, for instance the high fractional extraction by 
the splanchnic tissue or liver that we calculated, is indeed higher than described for 
other substrates studied more extensively like glucose or amino acids. Also, the 
direct oxidation of a fairly large part of the octanoate by the splanchnic bed is 
consistent with the !mown characteristics of octanoate. The total oxidation of 
octanoate, although higher than calculated earlier and much higher than described 
for most other substrates, especially LCF As, is not complete. It is generally assumed 
that MCFAs constitute a "rapidly available source of energy" that is quickly and 
completely oxidized or converted into ketone bodies and subsequently oxidized. 
If C8:0 (and ClO:O) would not be completely oxidized, the theoretical metabolic 
advantage of MCTs (apart from a high absorption rate) would be decreased, as they 
probably have to be converted into LCFAs before significant storage in the body can 
take place. 
Problems could arise however if a significant part of the administered octanoate 
is oxidized peripherally after having passed the liver, especially if the enrichment of 
octanoate is being diluted peripherally by endogenous production of (unlabeled) 
octanoate. In that case the precursor enrichment for the peripheral oxidation would 
be lower and the oxidation measured by oral tracer administration underestimates the 
total oxidation. We therefore performed a validation study with intravenous and oral 
administration of tracer during exactly identical circumstances. 
The model was constructed, assuming that significant oxidation could occur in 
the peripheral tissues, as several authors (e.g., [14]) have shown that the percentage 
of octanoate oxidized is not significantly lowered after (functional) hepatectomy in 
rats. Results of the study showed that recovery of labeled octanoate was 
approximately 1/3 after both oral and intravenous tracer administration, pointing 
indeed towards a capacity of the peripheral tissues to oxidize octanoate. However, as 
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argued before, this does not indicate that the "true oxidation" is not underestimated 
when only intragastric tracer is infused. It also shows that -unlike what is generally 
done with proteins and carbohydrates- it should be carefully considered by what 
route the carbon-labeled tracer used for measuring oxidation should be given in case 
of dual tracer experiments. The enrichment in plasma after administration of tracer 
both intragastrically and intravenously was measured, and results indicated a very 
significant endogenous rate of appearance of octanoate as the enrichment of [l-13C]-
octanoate in plasma during oral tracer infusion was much lower than the enrichment 
in the administered feeding. Thus, the part of the administered tracer that escapes 
the first pass extraction by the liver is diluted several fold by octanoate present 
elsewhere in the body entering the systemic compartment, thereby explaining also 
the relatively low recovery rates sometimes encountered during bolus tracer 
experiments (e.g., [15]). The question where this unlabeled octanoate originates 
from is difficult to answer. In stead of regarding this as production of octanoate by 
peripheral tissues, it could also be that octanoate just interchanges very rapidly 
between the intracellular- and the plasma compartment. For instance, octanoic acid 
is said to be independent of camitine for its transport via the mitochondrial 
membrane, at least in certain tissues [16]. Also, data obtained from adult patients 
with liver cirrhosis and given radio-labeled long chain fatty acids suggest that under 
fasting conditions 60% to 80% of the serum octanoate was obtained from incomplete 
~-oxidation of long chain fatty acids [17]. 
Radiolabeled studies in animals and in vitro studies have shown that a large part 
of labeled octanoate is being oxidized or present as water-soluble products in the 
hepatic vein [4]. However, this doesn't necessarily contradict our findings, as in our 
study hepatic extraction was very efficient being around 75%, so a relatively minor 
part passes the liver. However, in this study, due to the development of new and 
very sensitive measurement techniques, we were able to show that the part of the 
tracer passing the liver is also oxidized peripherally. Since it is assumed that the 
unlabeled octanoate behaves the same as its labeled counterpart, the endogenous 
production that dilutes the labeled octanoate in the plasma space also has to undergo 
this oxidation, leading to a much higher oxidation rate than the one calculated 
without this additional information. 
Oxidation rate calculated using this new approach was 64%. At toe moment it is 
difficult to explain why the recovery during intragastric tracer administration, in this 
study is lower than found earlier [8]. 
The somewhat older preterm infant studied here, is often receiving MCT 
enriched formulas to approximately 40 weeks postconception, whereas we have now 
shown that a significant part of the MCF As is not being oxidized as was assumed 
earlier. The biological significance of this however remains to be established. Also 
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the fact that so much octanoate is produced peripherally and hence also taken up 
again by the peripheral tissues (as oxidation is only 33%), probably indicates that 
there is quite a large capacity of disposal of octanoate in the peripheral tissues. 
Whether the excretion of dicarboxylic acids that is known to occur with 
increasing intake of MCF As, is related to a relative overload of MCF As that cannot 
be oxidized via the normal route is not certain. However using this new method of 
quantitation of oxidation, more insight can be gained into the regulation of octanoate 
oxidation during high intakes of MCFAs. 
In this study we have developed a new technique of quantifying in vivo whole-
body oxidation of octanoate and shown that healthy prematures oxidized 
approximately two thirds of the oral load of MCFAs. 
REFERENCES 
Zurier RB, Campbell RG, Hashim, Van ltallie TB. Enrichment of the depot fat with 
odd and even numbered medium chain fany acids. Am J Physio/1967;199: 415-419 
2 Jonxis JHP. The fatty acid composition of brown and white fat in newborn infants and 
the influence of the ingested fat on the fatty acid composition of their body fat. In: 
Visser HKA (ed.). Nutrition and metabolism of the fetus and infant. Martinus Nijhoff 
Publishers, The Hague 1979:123-129 
3 Sarda P, Lepage G, Roy CC, Chessex P. Storage of medium-chain triglycerides in 
adipose tissue of orally fed infants. Am J Qin Nutr 1987;45:399-405 
4 Scheig R. Hepatic metabolism of medium chain fany acids. In: Senior JR (ed.). 
Mediwn chain triglycerides. University of Pennsylvania Press, Philadelphia 1968:39-49 
5 Bach A, Debry G, Metais P. Hepatic metabolism of medium chain triglycerides. Bib/ 
Nutr Dieta 1977;25:24-35 
6 Bach AC. Babayan VK. Medium-chain triglycerides: an update. Am J Qin Nurr 
1982;36:950-962 
7 Whyte RK, Whelan D. Hill R, McCiorry S. Excretion of dicarboxylic acids and 
w-1 hydroxy fatty acids by low birth weight infants fed with medium-chain 
triglycerides. Pediazr Res 1986;20:122-125 
~HE~P~A~TI~C~&~P~E~RW~HE~RAL~~O~XID~~ATI~O~N~O~F~OCT~AN~O~A~T~E~--------------------·121 
8 Sulkers EJ, Lafeber HN, Sauer PJJ. Quantitation of oxidation of medium-chain 
triglycerides in preterm infants. Pediatr Res 1989;26:294-2971 
9 Camielli VP, Sulkers EJ, Moretti C, Wattimena JLD, Van Goudoever JB, Degenhart 
HJ, Zachello F, Sauer PJJ. Conversion of octanoic acid into long-chain saturated fatty 
acids in premature infants fed a formula containing medium-chain triglycerides. 1993 
(submitted) 
10 Van Aerde JEE, Sauer PJJ, Pencharz PB, Canagarayar U, Beesley J, Smith JM, Swyer 
PR. The effect of energy intake and expenditure on the recovery of 13C02 in the 
neonate during a 4-hour primed constant infusion of NaH13C03. Pediatr Res 
1985;19:806-810 
II Jensen C, Buist NRM, Wilson T. Absorption of individual fatty acids from long-chain 
triglycerides or medium-chain triglyceride& in very small infants. Am J Qin Nrm 
1986;43:745-751 
12 Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side 
effects of prednisone in humans. J Qin Invest 1990;86:265-272 
13 Cortiella J, Matthews DE, Hoerr RA, Bier DM, Young VR. Leucine kinetics at graded 
intakes in young men: quantitative fate of dietary leucine. Am J Qin Nutr 1988;48:988-
1009 
14 Valdivieso VD, Schwabe AD. Effect of exclusion of hepatic circulation on oxidation of 
octanoic acid in the rat. Proc Soc Exp Bioi Med 1964; 116;290-292 
15 Schwabe AD~ Bennett LR~ Bowman LP. Octanoic acid absorption and oxidation in 
humans. J Appl Plrysioi19M;19;335-337 
16 McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body 
production. Ann Rev Biochem 1980;49:395-420 
17 Rabinowitz JL, Staeffen J, Blanquet P, Vincent JD, Terma R, Series C, Myerson RM. 
Sources of serum [14C]-octanoate in cirrhosis of the liver and hepatic encephalopathy. J 
Lab Qin Med 1978;91:223-227 

CHAPTER VIll 
EFFECTS OF MEDRJM-CHAIN TRIGLYCERIDE FEEDING 
IN EXTREMELY-LOW-BIRTH WEIGHT INFANTS. 
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P.J .J. Sauer. 
Department of Pediatrics, Sophia Children's Hospital and University 
Hospital Dijkzigt I Erasmus University Rotterdam, Rotterdam, The 
Netherlands. 
SUMMARY 
Most of the formulas available for preterm infants include medium-chain 
triglycerides (MCTs), which contain fatty acids with chain lengt.l:• of eight and ten 
carbon atoms, in order to improve fat absorption. Theoretically, the improvement in 
fat and calcium absorption during MCT feeding might be more pronounced in very 
small preterm infants, especially during their first weeks after birth. 
Extremely-low-birth weight (ELBW) infants weighing under 1000 grams at birth 
were Ialldomized to receive a formula containing either 5% (LCT formula) or 33% 
(MCT formula) of fat as MCTs. Anthropometric measurements during the first 
month of life were performed together with three periods of fat and calcium 
balances. Seven infants in both groups were studied; birth weight (876 ± 48 vs. 898 
± 80 gram, MCT vs. LCT; mean ± 1 S.D.) and gestational age (29. 7 ± 2.5 vs. 
29.3 ± 2.4 wks) were comparable between groups. Overall formula tolerance was 
good and caloric intake was comparable between groups, approximately 110 
kcal/kg!day during week 2, and 120 kcal/kg/day during wks 3 and 4. Percent fat 
absorption was significantly higher with MCTs (average 84 ± 3%) than with LCTs 
(average 76 ± 6%, p < 0.01). Calcium absorption was highly variable and not 
significantly different between groups (average 55 ± 13% vs. 46 ± 14%, MCT vs. 
LCT, p = 0.24). There was no clear evolution over time in fat- or calcium 
absorption, possibly related to the cautious feeding regimen with graded introduction 
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of formula during the second week of life. Although fat absorption was significant! y 
higher with MCTs, there were no differences in increments in standard deviation 
scores for weight gain (-0.41 ± 0.58 vs. -0.36 ± 0.66, p = 0.9) and head 
circumference gain ( +0.57 ± 0.91 vs. +0.33 ± 0.34, p = 0.5). Weight gain 
expressed per kg was extremely variable at the age of two weeks, but consistently 
around 20 g/kg/d in both groups during weeks 3 and 4. We conclude that the known 
small beneficial influence on intestinal absorption of fat and calcium with MCT 
formula compared with current LCT formulas containing coconut oil are present to a 
similar magnitude in ELBW infants during the first month after birth as reported 
earlier in older preterm infants. 
INTRODUCTION 
The majority of the commercially available formulas intended for the 
prematurely born infant contain medium-chain triglycerides (MCTs), the 
triglycerides of C8:0 and CIO:O fatty acids, primarily in order to enhance fat and 
mineral absorption. The clinical benefit however of adding MCT oil to preterm 
formula has been questioned. Initial optimistic reports were not followed by more 
evidence on the beneficial effects, whereas there is still a lack of knowledge on the 
metabolism of this artificially synthesized food stuff. 
The improved weight gain on MCT feeding described initially [1-3], has not 
been confirmed in other studies [4-8]. These studies were performed in preterm 
infants with a birth weight between 1200 and 2000 grams. In only one study [9], 
smaller premature infants with an average birth weight around 1000 gram were 
studied, but the postnatal age was variable with the smallest infants being studied as 
late as six weeks after birth. 
In an earlier study in 28 very low birth weight infants [10], we compared a 
formula containing 38% of fat as MCTs, to a new formula with a fat blend which 
more closely resembled human milk with addition of coconut oil and not of MCT 
oil. Fat and nitrogen balance, energy substrate utilization, and body composition 
were investigated and only a slightly higher fat absorption and -deposition were 
found in the infants fed the MCT-containing formula, without any affect on linear 
growth or weight gain. 
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Most of the physiological limitations to fat absorption and digestion in the 
preterm neonate are related to immaturity and some authors have shown a linear 
correlation between gestational age or postconceptional age and fat absorption under 
certain conditions [11]. 
We therefore hypothesized that the major beneficial effects of MCTs were most 
likely to be present when feeding sick and/or very small premature infants during 
their first weeks after birth. The scarcity of data on effects of MCTs in these infants 
is probably related to the fact that they are often considered "too ill to study", even 
though an appropriate caloric intake might be critical, especially in this group of 
patients. 
To investigate the possible beneficial effects of MCT feeding we randomized 30 
extremely-low-birth weight (ELBW) infants, weighing less then 1000 grams at birth, 
to receive either a formula containing 5% medium-chain fatty acids (MCFAs) by 
weight (Long Chain Triglyceride (LCI) formula) or a standard MCT formula 
containing 33% MCFAs. Anthropometric measurements were made during the first 
month of life together with three periods of 72-hours fat- and calcium balances. 
PATIENTS AND METHODS 
Subjects 
All infants with a birth weight between 750 and 1000 grams that were initially 
admitted to the neonatal intensive care unit (NICU) of the Sophia Children's 
Hospital between november '91 and december '92 were considered eligible for the 
study. 
During the first week after birth, in the absence of an immediate life threatening 
condition and exclusion criteria like congenital disorders or inborn errors of 
metabolism, permission was sought from at least one of the parents. At that lime 
infants were receiving total parenteral nutrition (fPN) as is routinely done in ELBW 
infants in our ward [12]. 
Permission for the study was obtained for 30 infants. Eight of these infants were 
withdrawn in an early stage (four because of decision of the mother at a later stage 
to feed with mothers own milk, three because of transfer to another hospital and one 
surgical intervention). 22 infants proceeded with the study, of which a total of eight 
infants were withdrawn during the study. Three of these infants were withdrawn by 
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the attending physician because of need for fluid restriction due to patent ductus 
arteriosus, unexplained neonatal hypertension, and cardiac failure. One infant was 
withdrawn because he was prescribed a topical ointment for Candida infection of the 
perineal region which might influence by its high fat content the fat measurements in 
stools. One infant was withdrawn because of blood-containing stools and gastric 
aspirates probably secondary to a coagulation disorder. 
Three infants were excluded by the attending physician for reasons (possibly) 
related to the feedings: In two infants fed the MCT formula the daily residuals were 
more than 25% of the daily amount, fed for more than one day, and one infant fed 
LCT formula developed a necrotizing enterocolitis. 
Thus, a total of fourteen infants completed the study, seven infants in both 
groups. The composition of the fat blends of the MCT and LCT formula used is 
given in table 1. Fat concentration was 4.20 g/100 mJ in the LCT formula and 4.31 
g/100 mJ in the MCT formula and calcium concentration was 80 mg per 100 mJ in 
both formulas (measured by us after simulated gavage feeding). 
Table 1 Composition offormula fat blends (wt%) 
MCT formula LCT formula 
C6:0 0.!3 0.26 
C8:0 19 2.9 
CIO:O 14 2.3 
C12:0 0.48 18 
Cl4:0 0.33 7.4 
Cl6:0 5.5 8.6 
Cl6:1 0.14 0.14 
C18:0 2.6 3.5 
CIS:! 31 30 
Cl8:2 23 22 
Cl8:3 1.9 1.8 
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Both formulas were prepared in one batch by Nutricia, Zoetermeer, The 
Netherlands. The composition of the LCT formula was comparable to most of the 
current commercially available special formulas for premature infants, containing 
coconut oil and no MCT oil. 
After randomization, oral feedings were gradually introduced, as is routinely 
done in our ward, following the scheme in table 2. 
Table 2 Feeding schedule 
AA; Amino Acids. 1:1 signifies the dilution with 5% dextrose. 
Day Glucose iv AA iv Fat iv Volume iv Formula Energy 
ml/kg/d ml/kg/d ml/kg/d ml/kg/d ml!kg/d kcal/kg/d 
I 60 - - 60 - 22 
2 62 12 6 80 
-
41 
3 64 24 12 100 - 61 
4 84 24 12 120 - 68 
5 104 24 12 140 - 76 
6 124 24 12 160 - 83 
7 124 24 12 160 
-
83 
8 104 24 12 140 20 (1:1) 84 
9 84 24 12 120 40 (1:1) 84 
10 64 24 12 100 60 (1:1) 85 
II 82 12 6 100 60 97 
12 62 12 6 80 80 105 
13 42 12 6 60 100 114 
14 22 12 6 40 120 123 
15 20 - - 20 140 119 
> 16 - - - - 160 128 
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Infants were fed on a 24-hour schedule through nasogastric gavage feeding using 
syringes with 2-hr dosages. Semi-continuous feeding was achieved by nursing staff 
administering a small volume approximately every 15 min, or by use of gravity with 
an opened syringe in the upright position in case of artificial ventilation. Gastric 
residuals were checked every 4 hrs, Any gastric residuals were returned to the 
infant, but the volume was subtracted from the following 2-hr dosage of formula, 
thus leading to a lower intake of formula, Feedings were withheld, or progression 
was delayed, in cases where over 25% of the formula prescribed was not fed to the 
infants due to gastric retention, A delay of maximal one day in following the study 
design was tolerated before exclusion from the study, 
Methods 
Balance studies 
At day 12, on the second day of receiving undiluted formula, a carmine-red 
marker was administered. The first passage of colored feces (usually the next day) 
was included in the collection period and from that moment on records were kept of 
the amount of feeding prescribed, and the actual volume administered due to gastric 
residuals in order to be able to calculate the caloric intake. 72 hours after the first 
marker, a second carmine-red marker was administered. All feces were collected 
until the second period of colored feces, usually on day 16, the latter being excluded 
from the total feces collection. Feces was collected on pre-weighed diapers and 
immediate! y put at -20 o C. Results of this balance period are referred to as period L 
Similar balance studies were done starting on day 19 (period II) and on day 26 
(period Ill). AJ1 overview of the study design is given in figure L Weight, skinfold 
thickness, and head circumference were recorded from the first day of the balance 
studies (day 12) to day 29, Weight gain was also calculated using the birth weight as 
a starting point. 
Z-scores for weight and head circumference, indicating the standard deviations 
below or above the mean for the postconceptional age, were calculated using the 
data of Usher and McLean [13]. The latter was done by calculating the exact post-
conceptional age for each time-point and by linear interpolation of the available data 
of weekly intervals of gestational age. Weight was measured to the nearest 5 gram, 
and head circumference was measured using individual measuring tapes kept with 
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each infant during its stay on the ward. Skinfolds were measured after one minute 
compression at three sites (subscapular, mid-thigh and triceps area) with a 
Harpender caliper. Measurements were made by the same research nurse in all 
infants, and the c.v. for 10 measurements on one day was approximately 4%. 
Length gain was also measured, but not analyzed any further as this measurement 
proved to be highly variable. 
marker administr3.tion 
& intake recording 
balance collection 
oral 160 
ml 100 
day 0 
F.g. 1 Study design 
DetermiTUJiions in feces 
7 
head circumference-
skinfolds-
& weight gain 
weight gain 
14 21 28 
Fat excretion in feces was determined using a modified Jeejeebhoy method [10]. 
Calcium excretion in feces was measured by atomic absorption spectrophotometry as 
described before [14]. 
Statistics 
Data are presented as mean ± 1 SD. Differences between the MCT and the 
LCT feeding group were tested using one way ANnalysis Of VAriance (ANOV A). 
Gestational age was included as a continuous variable in a two-way ANOV A design 
with continuous variables from the Stata™ statistical software package for the 
analysis of increments in anthropometry. Since there was no significant time effect, 
as checked by linear regression on the three balance data points, data were treated as 
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repeated measures, and tested with ANOV A with gestational age as a covariate using 
the SPSS ™ statistical software package for the PC. 
RESULTS 
Balance data 
Formula tolerance was good in the infants who completed the study. All infants, 
except the three discussed in the methods section, could progress according to the 
feeding schedule. Caloric intake, although slightly lower than intended, was followed 
according to the schedule in all infants (with maximal one day delay). The small 
difference between the actual and the intended intake of formula, was caused by 
delay in increasing the daily amount appropriate for weight on the ward and was not 
due to intolerance. Formula intake was not different between groups (table 3), 
although during the final days of the study it tended to be slightly lower on the LCT 
group. Gastric retention was low, and decreased from an average 8 ml/kg/d to 2 
mllkg/d from weeks two to four (table 3). Retention of formula in gastric aspirates 
was not significantly different between the two feeding groups. 
Results of the fat and calcium balances are presented in table 3. There was no 
relation between postnatal age (or balance period) and fat absorption. This was 
confirmed by simple linear regression analysis on the three different time periods in 
both groups. Fat absorption in the MCT group was significantly higher during the 
second and the third balance period. As there was no time related effect on fat 
absorption, data were analyzed with repeated measures ANOV A for feeding effect. 
A p value of 0.007 was found for the combined data. The latter significance value 
did not change when gestational age was included as a covariate. Also, when the 
arcsin transformation was performed to "correct" for the fact that percentages were 
compared, significance value was still 0.027. 
On the other hand, calcium absorption was not different in any of the three 
periods, although it tended to be higher on MCTs. Regression analysis on individual 
data showed the absence of a time effect also with calcium (coefficients for the 
regression not significantly different from zero; 0.000 ± 0.076 for MCT and 0.027 
± 0.126 for LCT), even though the averages seemed to increase with time. But 
even when repeated measurements ANOV A was performed on the calcium data 
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there was no significant difference between groups in the percentage of calcium 
absorbed. 
The difference in metabolizable energy intake between feeding groups was 
relatively small and only significant during period TI (table 3). 
Anthropometry 
Results of anthropometric measurements are described in table 4. Initial 
measurements were made on day of birth only for weight, whereas initial values for 
head circumference and skinfolds thickness were obtained on day 12. 
All variables were similar on MCT and LCT feeding. The difference between 
Table 3 
Intake and absorption data 
Period 
I II Ill 
Caloric intake kcallkg/d 
-MCT 107 ± 12 123 ± 4 115 ± 3 
-LCT 107 ± 10 122 ± 6 121 ± 7 
Gastric retention ml/kg/d 
-MCT 8±6 3 ± 3 2 ± I 
-LCT 7±5 3±4 I± 2 
Metabolizable kcal/kgld 
intake -MCT 84 ± 9 104 ± 6 107 ± 7 
-LCT 87 ± 12 110 ± 5 108 ± 4 
p<0.05 
Fat absorption percent 
-MCT 85 ± 8 81 ± 5 86 ± 6 
-LCT 79 ± 10 71 ± 7 77 ± 8 Combined: 
p<O.OI p<0.02 p < 0.01 
Ca absorption percent 
-MCT 50± 30 57± 20 59± 19 
-LCT 46 ± 20 42 ± 14 51± 20 Combined: 
p = 0.24 
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groups in total weight gain was not statistically significant (p = 0.3). With ANOVA 
a significa.1.t effect of gestational age was noted, but the p value for the comparison 
of feeding groups remained 0.3. 
If weight gain was expressed as gram per kg per day, variable results were 
obtained in the first two weeks of life, showing no significant differences between 
groups (MCT 10 ± 9 vs. LCT 0 ± 15 g/kg/d). In the latter two weeks of the study, 
with most infants recovering from their critical illness, rates of weight gain were 
more stable with 22 ± 10 vs. 20 ± 10 g/kg/d at three weeks of life and 15 ± 11 
vs. 22 ± 10 g/kg/d (MCT vs. LCT) at four weeks of life, values which were all not 
significantly different between groups. 
Table 4 
Anthropometric data. 
Weight 
-MCT 
-LCT 
Head circumf. 
-MCT 
-LCT 
average skinfolds 
-MCT 
-LCT 
start day 29 
(day 0) 
876 ± 48 1269 ± 193 
898 ± 80 1201 ± 116 
(day 12) 
26 ± 1.1 29 ± 1.9 
26 ± 1.3 28 ± 1.3 
(day 12) 
0.22 ± 0.02 0.27 ± 0.06 
0.18 ± 0.02 0.24 ± 0.04 
increment p value of factor 
lli!fu!g gest age 
393 ± 168 
304 ± 110 .3 .03 
2.6 ± 0.94 
2.3 ± 0.21 .5 .I 
0.052 ± .046 
0.058 ± .039 .6 .05 
Similar results were obtained when the increment in anthropometric variables 
was expressed as z-scores (table 5), thus correcting for differences in distribution of 
gestational age among study groups. No significant differences between the MCT 
and LCT feeding groups were found in any of the parameters (table 5). 
Using one-way ANOV A, p values of 0.9 for weight z-sccre increments (both from 
birth to day 29 and from day 12 to day 29) and 0.5 for incremental z-score on head 
circumference were found. 
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Table 5 
Z-scores of standard deviations on anthropometric data. 
All comparisons not significantly different. 
day 0 day 12 day 29 
Weight 
-MCT -2.2 ± 0.43 -2.5 ± 0.66 -2.9 ± 1.0 
-LCT -2.0 ± 0.54 -2.4 ± 0.47 -2.8 ± 1.0 
Head eire. 
-MCT 
-3.0 ± 0.80 -2.4 ± 0.87 
-LCT -3.1 ± 0.71 -2.8 ± 0.53 
DISCUSSION 
~d29-d12 ~d29-Q 
-o.41 ± 0.58 -o.70 ± 0.71 
-o.36 ± 0.66 -o.77 ± 0.68 
0.57 ± 0.91 
0.33 ± 0.34 
VVith the increasing survival of extremely-low-birth weight infants, providing 
adequate feeding for this patient group becomes increasingly important. Although a 
number of studies have reported on the optimal feeding of preterm infants, little 
relates specifically to the feeding of those, weighing under 1000 gram at birth. 
Factors that account for this lack of knowledge may include the high morbidity, and 
the small numbers in individual centers. 
Several studies have focussed on the use of MCTs in formulas especially 
adapted for the preterm neonate, but none of these studies have reported on the 
absorption of MCT formulas by ELBVV infants during their first four weeks of life . 
.In this study we have compared the effects of MCT versus LCT feeding in the 
young and tiny premature, because we expected that the largest differences would be 
obtained in this vulnerable group of patients. Formula tolerance was comparable 
between the two feeding groups. After one week of TPN, actual caloric intake 
corrected for gastric retention reached approximately 110 kcal/kg/d at the end of the 
second week and approximately 120 kcallkg/d during the last two weeks of the 
study. Although there were two cases of feeding intolerance in the MCT group and 
one case of necrotizing enterocolitis in the LCT group, we cannot comment on side 
effects attributable to the feedings as numbers are clearly too small to draw any 
conclusions. 
134'------------------------------------------~C~~~~E~R~S 
Weight gain was quite acceptable in these children after the establishment of full 
oral feedings, with a median of 20 gram/kg/d being in the upper part of the 
intrauterine weight gain curves. MCTs showed no advantage over LCTs in terms of 
weight gain. When expressed as relative standard deviation score, or z-score, all 
anthropometric measurements were similar between MCT and LCT feeding groups. 
The use of this score "corrects" for differences in (distribution of) gestational age 
between groups. Interestingly, z-scores of weight gain show small negative values, 
whereas z-score increments for head circumference were positive, probably pointing 
towards a relative brain-sparing effect. It is not clear if the absence of an increase in 
z-score for weight indicates that catch-up growth cannot be achieved in the first 
month in ELBW infants, or that caloric intake is still not optimal during the first two 
weeks. 
Fat absorption was higher with MCTs showing results comparable to the ones 
measured earlier in older preterm infants [10]. Although the intake was slightly 
lower at the end of the fourth week for MCTs, it is clear that in the third and fourth 
week of life an advantage of approximately 6 kcallkg/d in energy absorption is 
achieved by MCTs. This could lead to an extra weight gain of roughly 2 g/kg/d, as 
the energy cost of growth is approximately 3 kcallgram [15, 16]. Whether this is 
clinically relevant in this group of infants with a satisfactory growth rate especially 
during the third and fourth week of life is unclear. However, in several clinical 
situations, e.g. when fluid restriction is indicated, the use of MCTs might have 
advantages that have to be weighed against the possible side-effects. 
In this small group of infants, calcium absorption was not significantly different 
between groups, even not when measurements were combined. Even so, the mean 
absorption of calcium was slightly higher in all three periods in the MCT group and 
probably a larger group of infants would show that calcium absorption is also 
improved by MCT feeding in the ELBW infant. Due to the relatively large variance, 
a fairly large number of infants however will need to be studied, using the data 
obtained here we can calculate that approximately 120 infants would have to be 
studied, using the present relative standard deviation when studying calcium 
absorption at only one time point. The large variance in the calcium absorption data 
is in our view probably not due to the analytical variance, which is quite small 
compared to the biological variance. It can also not be fully explained by variance 
inherently part of measurements using fecal collections, due to variation in transit 
time, as the variance in the calcium data seems larger than the variance in fat 
absorption which is subject to the same interfering factor(s). The influence of MCT 
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feeding on calcium and fat absorption is however relatively small, and future studies 
designed to prove a possible benefit of MCTs on calcium absorption certainly will 
have to include measurements on outcome variables like bone densitometry to ensure 
that a real benefit is present. 
One remarkable finding was the absence of a significant relation between 
absorption of nutrients and postnatal age. This finding is in agreement with the 
findings of Hamosh et al. [9] in a slightly different population of preterm infants of 
different postnatal ages. One explanation in our study could be that the formula load 
was small in this study during the first two weeks of life, posing less stress on the 
absorptive mechanisms and leading to absorption rates similar to the ones later in 
life when 120 - 130 kcal were fed orally per kg per day. In other words, the 
cautious feeding regimen might have prevented significant malabsorption with both 
formulas. 
We conclude that in a relatively small group of extremely-low-birth-weight 
infants ntinor beneficial effects were present of the addition of medium-chain 
triglycerides to specialized preterm formulas. The larger differences found earlier 
between MCT and LCT formulas even in the more mature preterm infant, have 
disappeared when a comparison is made with an LCT formula containing larger 
amounts of lauric (CI2:0) and myristic (Cl4:0) acid, derived from coconut oil, than 
in the earlier days. Furthermore, with current formulas, differences between LCTs 
and MCTs are not more pronounced during the first weeks after birth. 
The present study shows that the intestinal absorption of fat and calcium in 
extremely-low-birth weight infants is not enhanced by MCTs to a larger extent than 
it is in the older and larger preterm infant, even not during the first weeks of life. 
The effect on outcome variables therefore will have to be investigated in larger 
groups of infants. Nevertheless, in a limited number of patients with a more 
pronounced malabsorption, the use of MCTs can be considered, although the 
possible side effects are not yet fully understood. 
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CHAPTER IX 
GENERAL DISCUSSION 
Advances in perinatal medicine have resulted in an increased survival of very-low-
birth weight infants (VLBW; birth weight < 1500 gram) and extremely-low-birth 
weight infants (ELBW; birth weight < 1000 gram), with some infants as small as 500 
gram surviving. The increased survival is probably due to improvements in the 
treatment of ventilatory and circulatory problems, but also to improvements in 
nutritional care. 
Between 22 and 32 weeks, the fetus doubles its body weight approximately every 
five weeks, and this rapid intrauterine growth is often hard to maintain in the 
prematurely born. Several factors contribute to the decreased growth in the prematurely 
born infant, one of them being the existence of "physiological" limitations in the 
digestion and absorption of nutrients, especially in relation to fat, probably due to a 
relative deficiency of pancreatic lipase and bile salts. 
Approximately 50% of the nonprotein energy in human milk and formula is 
provided by fat. Furthermore, most of the energy lost in excreta consists of fat, whereas 
carbohydrate absorption is always above 95%, even in the smallest infants during the 
first weeks of life. 
Medium-chain triglycerides (MCTs), which are manufactured from glycerol and 
medium-chain fatty acids (MCFAs) with a chain length of eight and ten carbon atoms, 
are less dependent on sufficient levels of pancreatic lipase and bile salts than the long-
chain fatty acids (LCF As) with chain lengths of sixteen and eighteen atoms that 
dominate in our regular food fats. After a few optimistic repcrts showing improvements 
in fat, mineral, and nitrogen absorption, the clinical benefits of addition of MCT oil to 
preterm formulas could not be confirmed. The latter could be related to the fact that fat 
blends in general have changed, where predominantly saturated fats from cow's milk 
were replaced by fats from vegetable oils. 
Several studies have repcrted on an improved fat absorption with MCT-containing 
formulas, without any beneficial effect on weight gain. As overfeeding studies in 
animals as well as adult human volunteers showed evidence for an increase in metabolic 
rate during MCT feeding, we studied heat production and body composition in preterm 
infants fed either a MCT or a LCT formula (Chapter l). An improvement in fat balance 
was noted in the MCT group, but there was no increase in weight gain or nitrogen 
retention. However, in this study the absence of increased weight gain in the presence 
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of a higher metabolizable energy intake was not due to an increased metabolic rate in 
the MCT group as we had hypothesized. ln contrast, a significantly higher percent of 
new tissue was composed of fat in the MCT group, as could be calculated from 
individual weight gain related to the fat balance. 
Theoretically, the benefits of MCT formula should be most pronounced in the 
smallest infants during their first weeks after birth, as the fat malabsorption has been 
shown to be related to immaturity. ln fact, some authors have described a linear relation 
between fat absorption and gestational or postconceptional age. Remarkably, in the 
ELBW infant fed MCT formula during his first weeks after birth, we could not find an 
indication that fat absorption was improved to a larger extent than in the older preterm 
infant (Chapter 8). Growth was very similar in these groups, whether fed a MCT 
formula, or a LCT formula containing coconut oil. It can be estimated from our data 
that if there are significant advantages of MCT on weight gain or linear growth in these 
infants, a very large number of infants would need to be studied to prove this. The 
absence of major differences even in these tiny prematures is possibly related also to 
the use of a cautious feeding regimen and/or the use of an LCT formula containing 
coconut oil and "high oleic safflower oil", with low levels ofpalntitic and stearic acids. 
In conclusion, there is a slight improvement in fat balance when using MCTs, 
leading to an increase in metabolizable energy intake of around 5-6 kcallkg/day 
compared to LCT formula. Theoretically, this ntight lead to an additional weight gain 
of aproximately 2 grams per kg per day in the MCT group, but in both age groups 
studied this difference was not detectable. The latter could be due to the fact that groups 
are too small to detect such a small difference, or to the fact that the percent fat in new 
tissue is indeed higher with MCT feeding. 
From chentical analysis of human fetal material it has been calculated that the mean 
accumulation of calcium and phosphorus is about 130 and 75 mg respectively per kg 
per day between 26 and 36 weeks of gestation. At the moment, preterm formulas as 
well as human milk are unable to provide enough of these minerals to achieve these 
retention rates. Even so, it has been shown that overt bone disease in the preterm infant 
can be prevented with calcium intakes much lower than the theoretical intrauterine 
accretion [1]. A significant improvement in calcium absorption using MCT formula has 
been reported [2], but in that study the differences in long-chain saturated fatty acid 
intake between high MCT and control feeding were also very pronounced. As later 
studies concluded that there was no improvement in mineral absorption with MCT, we 
investigated mineral metabolism comparing a current LCT formula with addition of 
coconut oil to a MCT containing formula (Chapter 3). 
~G~E~NE~RAL~~D~~~C~U~~~IO~N~-----------------------------------------141 
Our data do show a significant enhancement of calcium absorption with MCTs. In 
the LCT group there were signs of an imbalance between calcium and phosphorus 
absorption, with increased PTH levels in plasma and high urinary phosphorus levels. 
However, calcium, as well as alkaline phosphatase and 1,25-(0Hl:!-vitamin-D levels 
were not different between groups. Still there is evidence that the amount of calcium 
absorbed was relatively low compared with the amount of phosphorus absorbed in the 
LCT group. The most logical way to resolve this would be addition of calcium to the 
formula. However, the latter is technically difficult and not without risks, regarding 
negative effects on fat balance and increased risk of bolus obstruction. 
A remarkable finding in the group of ELBW infants was that the difference in 
calcium absorption between MCT and LCT formula was also not more pronounced in 
the tiny premature infant during the first weeks after birth (Chapter 8). 
In ~.onclusion, if technical difficulties prohibit the development of new formulas 
with higher availability of calcium, there is a small but definite advantage of MCT 
feeding with regard to intestinal absorption of calcium. 
It is generally assumed that MCFAs are absorbed and oxidized (almost) 
completely when fed enterally and are not present in significant amounts in adipose 
tissue. It is not known whether there is a maximum in the amount of MCFAs that can 
be readily oxidized by the preterm infant, nor whether the increased excretion of 
dicarboxylic acids and other side-effects of MCT feeding are related to the ability to 
oxidize MCFAs. Therefore, the determination of oxidation rates of MCFAs under 
different circumstances might provide important information. Using octanoate labeled 
with the stable isotope 13C ([I-13C]-octanoate), we found oxidation rates corresponding 
to approximately 50% of the infused MCFA (Chapter 4). This confirmed the postulated 
preferential oxidation ofMCFAs also in the preterm infant. However, more than 50% 
of the infused tracer was not oxidized and we speculated that a significant part of the 
MCTs fed had to be chain-elongated before storage in adipose tissue was possible. This 
would be an energy-requiring process, confirnting the "carbohydrate-like" behavior of 
MCTs. 
In a further study, we investigated the splanchnic metabolism of octanoate using 
a dual isotope approach, and derived appropriate equations to compare splanchnic and 
peripheral oxidation rates (Chapter 7). The dual isotope approach consisted of 
administering [J-13C]-octanoate via nasogastric route on one day, and under exactly the 
same circumstances intravenously the other day. Splanchnic first-pass extraction was 
78% for octanoate, which is much higher than for amino acids or glucose, thus being 
consistent with previous estimations from animal studies. About one-third of this 
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extracted octanoate was directly oxidized. The significant dilution of the intravenously 
administered tracer in the systemic circulation is possibly due to exchange of tracer with 
intracellular pools of octanoate coming from ongoing I)-oxidation of fatty acids. Such 
exchange has been described in human adults using radiolabeled. tracers, but was not 
quantitated before [3]. Thus, about one-third of the ingested MCFAs is directly oxidized 
in the splanchnic bed, and a similar part of the MCFAs entering the systemic 
compartment, coming mainly from other sources than the diet, is oxidized in the 
peripheral tissues. At the moment it is not clear whether the sum of splanchnic and 
peripheral octanoate oxidation is a good representative of the total amount of MCFAs 
oxidized, as it might include part of the {3-oxidation of LCFAs. 
In conclusion, further isotopic modeling is needed to validate the calculations used, 
as it is not sure at the moment whether the dilution of tracer in the systemic pool 
represents endogenous production entering the plasma pool and hence, we cannot be 
certain that the sum of the estimated splanchnic and peripheral oxidation truly represents 
the whole-body oxidation. 
A high activity of lipogenic enzymes with MCT feeding as compared with LCT 
feeding has been found by several authors [e.g., 4], and recently it was found that this 
was independent of insulin status [5]. Using a combination of indirect calorimetry and 
stable isotopes, we found that MCT decreased glucose oxidation as compared to LCT, 
but had no influence on total carbohydrate utilization (Chapter 5). Consequently, 
lipogenesis from glucose is probably higher during MCT feeding. This fact points again 
at the "carbohydrate-like" behaviour of MCT, oxidation being high enough to supply 
excess acetyl-CoA and inhibit the oxidation of glucose. In conclusion, we have provided 
indirect evidence that lipogenesis is increased during MCT feeding and thus it can be 
speculated that increased levels of (saturated) LCFAs found during MCT feeding are 
not only the result of chain elongation from MCT, but also due to increased lipogenesis 
from glucose. 
The increase in levels of myristic, palmitic, and oleic acids in plasma on MCT 
feeding compared to the diet given was confirmed in preterm infants using traditional 
gas chromatography. Using a new stable isotope methodology we were able to show in 
vivo the conversion of labeled octanoate into the LCFAs myristic and palmitic acid 
(Chapter 6). Although the data cannot be interpreted quantitatively, it is clear that chain 
elongation of octanoate (either directly or via lipogenesis from acetyl-CoA units) does 
occur. In conclusion, we found an increase in the plasma levels of C16:0, Cl8:0, and 
CIS: I compared to the MCT containing diet, and using stable isotopes we have shown 
that this is at least partially caused by the conversion of MCFAs into nonessential 
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longer chain fatty acids. In a recent study [6] it was shown in newborn piglets that 
feeding MCTs vs. coconut oil resulted in higher Cl6:0 and Cl8:1 levels in all lipids, 
concomitantly with a decrease in tissue phospholipid arachidonic acid (C20:4n-6), an 
essential longer-chain poly-unsaturated fatty acid. Although this could be an important 
disadvantage of MCT feeding, quantitative measurements are necessary to investigate 
this matter further, using lipoprotein separation and appropriate modelling. 
In conclusion, we have shown that there is a consistent enhancement of fat 
absorption with MCT formulas in the preterm neonate. The tolerance of MCT formula 
was good and no side-effects were noticed. However, except for a slight increase in the 
percent fat accretion in new tissue, there are no beneficial effects detectable regarding 
growth. Calcium absorption is also increased on MCT feeding, and this might be of 
advantage to the preterm population at large, regarding the fact that current calcium 
intakes are only marginally sufficient with either human milk or formula feeding. 
On the other hand, our studies emphasize the peculiarities of the metabolism of 
MCTs, which is different from the LCTs which constitute the conventional food fats. 
The direct oxidation ofMCTs is much higher than with LCTs, pointing at a preferential 
oxidation. This is in accordance with our finding that glucose oxidation is significantly 
decreased on MCT feeding, and lipogenesis from glucose is probably increased. 
However, as oxidation was found to be incomplete, MCFAs have to be stored, probably 
after conversion into LCFAs. Our data show that a direct conversion of octanoate into 
longer-chain fatty acids does occur in the preterm infant. Conversion of the unox.idized 
glucose as well as MCFAs into LCFAs requires energy and can lead to higher levels 
of saturated and monounsaturated fatty acids. In our studies, only the higher absolute 
levels of saturated fatty acids in plasma were confirmed, while we found no differences 
in metabolic rate between MCT and LCT groups. The explanation could be that the 
differences are very small and that the demonstration of it requires larger study groups, 
or that an increased heat production only occurs at a higher level of energy intake. The 
influence of MCFAs on saturated fatty acids and PUFA metabolism was recently 
confirmed in newborn piglets and requires further attention. 
Although some authors have argued that milk from mothers who delivered preterm 
contains significant amounts of MCTs, this is not the case for the "true MCTs" with 
chain length of eight and ten carbon atoms [7]. In fact the level of fatty acids with a 
chain length less than 12 carbon atoms just rises from about 1- to 1.5 % in human milk 
with preterm delivery [8], still an insignificant portion of the energy provided when 
breast feeding the preterm infant. 
Regarding the fact that human milk does not contain significant amounts of 
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MCFAs, and the proven effect of MCTs on metabolism of other substrates like glucose 
and (saturated) fatty acids, it seems prudent to continuously reevaluate the indications 
for such "artificial" foodstuff. As clinical benefits are relatively small, even in the very 
tiny preterm infant during the first weeks after birth, the data presented in this thesis 
do not support the use of MCTs in the routine nutritional management of the preterm 
infant. 
REFERENCES 
Laing lA, Glass EJ, Hendry GMA et al. Rickets of prematurity: calcium and phosphorus 
supplementation. J Pediatr 1985;106:265-268 
2 Tantibhedhyangkul P, Hashim SA. Medium-chain triglyceride feeding in premature infants: 
effects on calcium and magnesium absorption. Pediatrics 1978;61:537-545 
3 Rabinowitz JL, Staeffen J, Blanquet P, Vincent JD, Tenna R, Series C, Myerson RM. 
Sources of serum [14C]-octanoate in cirrhosis of the liver and hepatic encephalopathy. 
J Lo1J Qin Med 1978;91:223-227 
4 Crozier GL. Medium-chain triglyceride feeding over the long term: the metabolic fate of 
[ 14C]octanoate and [14C]oleate in isolated rat hepatocytes. J Nutr 1988;118:297-304 
5 Hiremagalur BK, Johanning GL, Kalhan SC, Patel MS. Alterations in hepatic lipogenic 
capacity in rat pups artificially reared on a milk-substitute formula high in carbohydrates 
or medium-chain triglycerides. J Nutr Biochem 1993:3:474-480 
6 Wall KM, Diersen-Schade D, Innes SM. Nonessential fatty acids in formula fat blends 
influence essential fatty acid metabolism and composition in plasma and organ lipid classes 
in piglets. Lipids 1992;27:1024-1031 
7 Blackburn GL, Babayan VK. Medium-chain triglyceride storage in adipose tissue of orally 
fed infants [letter]. Am J Qin Nutr 1987;46:862-863 
8 Bitman J, Wood DL, Hamosh H, Hamosh P, Mehta NR. Comparison of the lipid 
composition of breast milk from mothers of term and preterm infants. Am J Oin Nutr 
1983;38:312 
CHAPTER X 
SUMMARY 
For many years, medium-chain triglycerides (MCTs), with a chain length of eight 
and ten carbon atoms, have been included in preterm infant formulas. MCTs are 
manufactured by reesterification of medium-chain fatty acids (MCFAs) from coconut 
oil, and their intestil1al absorption is assumed to be nearly complete, in contrast with 
"regular" long-chain triglycerides (LCTs). There is however no consensus on the exact 
benefit of their routine use in the preterm neonate. 
Chapter 1 summarizes the history of the development of MCTs, and the possible 
clinical indications for adults. The knowledge regarding the use of MCTs in premature 
infants is discussed, together with possible side effects of MCTs. 
Chapter 2 describes a study comparing MCT and LCT formulas in one month old 
preterm infants, using balance and indirect calorimetry techniques. Fat balance was 
improved with MCT, but the main result was a higher percent fat in the newly formed 
tissue, with no changes in linear growth or weight gain. 
Chapter 3 describes the results in the same study groups of calcium, phosphate, and 
magnesium balances, and levels of several calciotropic factors. With MCT feeding, 
calcium retention was higher and parathyroid hormone levels were lower, but plasma 
levels of calcium, alkaline phosphatase, and 1,25 dihydroxy-vitamin-D were not 
significantly different between groups. 
Chapter 4 describes the measurement of the oxidation of MCFAs in preterm 
infants, using orally administered octanoate labeled with the stable carbon isotope 13C, 
and collection of breath to determine the 13C enrichment in C02. On average 47% of 
the orally administered tracer was oxidized, a value much lower than reported in some 
studies in animals or adult human volunteers. 
Chapter 5 describes a comparative study between MCT and LCT regarding glucose 
metabolism. Using 13C-Iabeled glucose, evidence was found that glucose oxidation is 
lower with MCT feeding, whereas lipogenesis from glucose is probably increased. 
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Chapter 6 describes the measurement of conversion of octanoate in vivo into longer-
chain fatty acids, using high-sensitivity gas chromatography-isotope ratio mass 
spectrometry (GC-IRMS). A significant enrichment of myristic and palmitic acids is 
found, confirming one of the proposed mechanisms of non-oxidative disposal of MCTs. 
Chapter 7 describes the measurement of splanchnic oxidation of octanoate as a 
tracer representative for MCFAs, using a dual isotope tracer approach in preterm 
infants. There is indeed a high first-pass splanchnic extraction and oxidation of 
octanoate from the feeding. However, the "systemic" rate of appearance of octanoate 
is high, probably due to exchange with octanoate derived from partial !'/-oxidation of 
long-chain fatty acids, leading to difficulties estimating the "true" oxidation rate of 
MCFAs. 
Chapter 8 describes a balance study, performed during the first month of life in 
extremely-low-birth weight (ELBW) infants, with a birth weight below !000 grams. 
The differences found in this particular patient group between MCT and LCT feeding 
with regard to intestinal absorption of fat and calcium, are not more pronounced than 
those in the somewhat larger preterm infants that were studied in chapters 2 and 3. 
SAMENV ATTING 
AI geruime tijd worden middel-keten triglyceriden (medium-chain triglycerides, 
MCTs), triglyceriden met ketenlengte van acht en lien koolstofatomen, toegepast in de 
voeding voor te vroeg geboren kinderen. Deze MCTs, gefabriceerd door verestering 
van middel-keten vetzuren (medium-chain fatty acids, MCFAs) uit kokosnootolie, 
worden in tegenstelling tot de "nonnale" lang-keten vetzuren waarschijnlijk vrijwel 
volledig opgenomen in de darm. De literatuur is echter niet eenduidig over de 
werkelijke voordelen van de routinematige toevoeging van MCTs aan de voeding voor 
de pretenn geboren neonaat. 
Hoofdstuk 1 vat de geschiedenis samen van de ontwikkeling van MCTs, en de 
eventuele klinische indicaties voor gebruik bij volwassenen. De literatuur over het 
gebruik van MCTs bij prematuur geborenen wordt besproken, inclusief de mogelijke 
bijwerkingen van MCTs. 
Hoofdstuk 2 beschrijft een studie waarin MCT en LCT ("long-chain triglyceride") 
voedingen worden vergeleken bij ongeveer 66n maand oude preterm geborenen, met 
behulp van balanstechnieken en indirecte calorimetrie. De vetbalans was sterker positief 
in de MCT groep, maar dit resulteerde slechts in een hager vetpercentage van het nieuw 
gevonnd weefsel, terwijl er geen verschil tussen de groepen viel aan te tonen in 
lengtegroei of gewichtstoename. 
Hoofdstuk 3 beschrijft de resultaten in dezelfde studiegroepen van balansstudies van 
calcium, fosfaat en magnesium en de plasma spiegels van enkele calciotrope factoren. 
De retentie van calcium was hoger, en de parathyroid hormoon spiegel was lager tijdens 
MCT voeding. Echter, er waren geen verschillen tussen de beide groepen in de plasma 
spiegels van calcium, alkalische fosfatase of 1,25-dihydroxy-vitamine-D. 
Hoofdstuk 4 beschrijft de meting van de oxidatie van MCFAs in pretenn 
geborenen, gebruikma..l(end van de orale toediening van octanoaat gelabeled met 13C 
(een stabiel koolstofisotoop), waarbij de uitademingslucht werd opgevangen om de 13C-
verrijking in C02 te bepalen. Gemiddeld werd 47% van de oraal toegediende tracer 
geoxideerd. Deze waarde is veellager dan gewoonlijk gevonden wordt in proefdieren 
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of volwassen vrijwilligers. 
Hoofdstuk 5 beschrijft een vergelijkende studie tussen MCT en LCT voeding wat 
betreft het metabolisme van glucose. Met gebruikmaking van stabiele isotopen, werd 
gevonden dat de glucose oxidatie lager is tijdens MCT voeding, terwijl lipogenese 
vanuit glucose waarschijnlijk is verhoogd. 
Hoofdstuk 6 beschrijft de meting van de omzetting van octanoaat in vivo tot 
langere-keten vetzuren, met gebruikmaking van een zeer gevoelige gaschromatograaf-
isotopen-ratio massa-spectrometer (GC-JRMS). Er werd een significante 13C-verrijking 
in myristinezuur en palmitinezuur gevonden, wat een van de voorgestelde mechanismen 
van verwerking door het lichaam van niet-geoxideerde MCTs bevestigt. 
Hoofdstuk 7 beschrijft de meting van de splanchnische oxidatie van octanoaat, als 
een representatieve tracer voor MCFAs, onderzocht door de tracer zowel oraal als 
i.Tltraveneus toe te dienen. Er is inderdaad een grate extractie van octanoaat tijdens de 
eerste passage door het splanchnische bed en een dee! van de octanoaat afkomstig uit 
de voeding wordt hier direct geoxideerd. De "'systemische" verdunning door 
ongelabeled octanoaat is echter hoog, waarschijnlijk door uitwisseling met octanoaat 
afkomstig van .8-oxidatie van langere vetzuren, waardoor het moeilijk wordt de "ware" 
oxidatiesnelheid te schatten. 
Hoofdstuk 8 beschrijft tenslotte een balansstudie die gedaan werd in de eerste 
maand na de geboorte in preterme pasgeborenen met een geboortegewicht onder de 
1000 gram (extremely-low-birth weight, ELBW). De verschillen die in deze speciale 
patientengroep werden gevonden tussen MCT en LCT voeding wat betreft de opname 
in de dann van vet en calcium, zijn niet grater dan welke worden gevonden in oudere 
preterme pasgeborenen zoals bestudeerd in hoofdstuk 2 en 3. 
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